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ABSTRACT 
 
Phaleria macrocarpa (Scheff.) Boerl and Tinospora crispa (L.) are considered im-
portant traditional medicines commonly used in Malaysia and South East Asian coun-
tries. In this study, the ethanol extracts of P. macrocarpa fruit and T. crispa stems were 
evaluated for their immunomodulatory, gastroprotective and wound healing potential. In 
addition, acute toxicity and antioxidant activities were investigated using DPPH and 
FRAP values as well as the total phenolic and total flavonoid contents. The findings of 
this study suggest that the high antioxidant activity that was found in P. macrocarpa 
and T. crispa was due to the high-level of phenol and flavonoid content. According to 
the results of the acute toxicity study, P. macrocarpa and T. crispa should both be as-
signed to the lowest toxicity class. The potential protective effects of P. macrocarpa 
and  T. crispa  on rat gastric mucosal injury induced by ethanol and to clarify the roles 
of gastrin, pepsin, prostaglandinE2 (PGE2), superoxide dismutase (SOD), catalase 
(CAT), malondialdehyde (MDA), and inflammatory mediators; transforming growth 
factor-beta (TGF-β1) and tumor necrosis factor alpha (TNF-α). Results showed signifi-
cant ulcer protective effects through the reduction of the ulcer area by a significant ele-
vation of gastric juice pH and an increase of mucus production, as well as a significant 
increase in the levels of inflammatory mediators PGE2 and TGF-β1 and a decrease in 
TNF-α. In addition, the groups pretreated with P. macrocarpa and T. crispa  eehibited
increased significant activity of SOD and CAT but significantly reduced MDA, gastrin 
and pepsin levels . For wound healing potential, groups were topically treated with the P. 
macrocarpa and T. crispa extracts daily for 15 days, and wound healing in this group 
was significantly accelerated compared with the control group. This result was attribut-
ed to a significant increase in TGF-β1, SOD and CAT, and a significant decrease in the 
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TNF-α and MDA level in the treated groups. Besides, there was also an effect on the 
apoptosis process by regulating the expression of BAX and BCL2 genes. To achieve the 
immunomodulatory effect of P.macrocarpa, T. crispa and their isolated fractions in ac-
tivated macrophages to release cytokines as IFN-γ, IL-6 and IL-8, a RAW264.7 macro-
phage cell line was used to determine immunomodulatory activity by investigating in-
tracellular cytokine expression. The results showed that there is an immunomodulatory 
effect of P.macrocarpa and T. crispa and their isolated fractions by increasing RAW 
264.7 macrophage cell proliferation in a dose dependent manner, and significant induc-
ing of the intracellular expression of cytokines IFN-γ, IL-6 and IL-8. In conclusion, our 
results prove that P. macrocarpa and T. crispa have a significant immunomodulatory 
effect as immunostimulators, giving protective effects against ethanol-induced gastric 
ulcers. These extracts also possess wound-healing capability by improving the activity 
of endogenous antioxidant enzymes and preventing free radical-mediated tissue injury 
besides significantly stimulating the inflammatory mediators, which also, play an im-
portant role in the inflammation process, apoptosis regulation, and the remodeling phase 
in wound healing.   
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Abstrak  
 
Phaleria macrocarpa (Scheff.) Boerl dan Tinospora crispa (L.) dianggap ubat im- 
portant tradisional biasa digunakan di Malaysia dan Asia Tenggara negara- cuba. Dalam 
kajian ini, ekstrak etanol P. macrocarpa buah dan T. crispa stem telah dinilai bagi im-
munomodulatory mereka, gastroprotective dan luka potensi penyembuhan. Di samping 
itu, disiasat ketoksikan akut dan aktiviti antioksidan menggunakan DPPH dan nilai 
FRAP selain jumlah fenolik dan jumlah kandungan flavonoid. Hasil kajian ini dijelas-
kan aktiviti antioksidan yang tinggi yang ditemui di P. macrocarpa dan T. crispa milik 
kandungan peringkat tinggi fenol dan flavonoid. Menurut hasil kajian ketoksikan akut, 
P. macrocarpa dan T. crispa menunjukkan bahawa kedua-dua tumbuhan harus diberi-
kan kepada kelas ketoksikan terendah. Kesan perlindungan potensi P. macrocarpa dan 
T. crispa pada tikus kecederaan mukosa gastrik disebabkan oleh etanol dan untuk men-
jelaskan peranan gastrin, pepsin, prostaglandinE2 (PGE2), superoksida dismutase 
(SOD), katalase (CAT), malondialdehid (MDA), dan pengantara keradangan, mengu-
bahnya pertumbuhan faktor beta (TGF-β1) dan tumor nekrosis faktor alfa (TNF-α). 
Keputusan menunjukkan ulser yang ketara kesan perlindungan melalui pengurangan 
kawasan ulser oleh ketinggian ketara pH jus gastrik, dan peningkatan pengeluaran 
mukus. Selain itu, peningkatan yang ketara dalam tahap keradangan pengantara PGE2 
dan TGF-β1 dan pengurangan dalam TNF-α. Sebaliknya, kumpulan-kumpulan pretreat-
ed dengan P. macrocarpa dan T. crispa dipamerkan peningkatan aktiviti SOD dan CAT 
tetapi berkurangan MDA, gastrin dan tahap pepsin. Untuk luka potensi penyembuhan, 
Kumpulan sedang topically dirawat dengan P. macrocarpa dan T. crispa ekstrak setiap 
hari selama 15 hari, dan penyembuhan luka dalam kumpulan ini nyata dipercepatkan 
berbanding dengan kumpulan kawalan. Keputusan ini attributed untuk meningkatkan 
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dengan ketara pada TGFβ1, SOD dan CAT, dan penurunan yang ketara dalam TNF-α 
dan tahap MDA dalam kumpulan yang dirawat. Selain itu, kesan ke atas proses apopto-
sis yang dengan mengawal ungkapan BAX dan gen BCL2. Untuk mencapai kesan im-
munomodulatory daripada P. macrocarpa, T. crispa dan pecahan terpencil mereka da-
lam macrophage diaktifkan untuk melepaskan sitokin sebagai IFN-γ, IL-6 dan IL-8. Sel 
macrophage RAW264.7 digunakan dalam kajian kita untuk menentukan aktiviti im-
munomodulatory dengan menyiasat ungkapan cytokines intrasel. Keputusan kajian ka-
mi telah menunjukkan bahawa terdapat kesan immunomodulatory daripada 
P.macrocarpa, T. crispa dan pecahan terpencil mereka dengan meningkatkan RAW 
264.7 sel macrophage percambahan dos cara bergantung dan penting mendorong 
ungkapan intraselular cytokines IFN-γ, IL-6 dan IL-8. Kesimpulannya, keputusan kami 
membuktikan bahawa P.macrocarpa dan T. crispa mempunyai kesan immunomodula-
tory sebagai immunostimulator, kesan perlindungan terhadap etanol yang disebabkan 
ulser gastrik dan mempunyai keupayaan pemotongan lukapenyembuhan yang ketara 
dengan meningkatkan aktiviti antioksidan endogen enzim dan menghalang kecederaan 
tisu radikal bebas-pengantara selain itu, ketara merangsang pengantara keradangan. 
Selain itu, memainkan peranan penting dalam proses keradangan, peraturan apoptosis, 
dan fasa pembentukan semula dalam penyembuhan luka. 
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CHAPTER ONE 
1. Introduction  
1.1  Gastric ulcer 
Gastric ulcer is one of the most common diseases and can be defined as a localized 
breach of the gastric with tissue destruction at least to the depth of the muscularis muco-
sa (Tarnawski et al., 2001).   
Gastric ulcer is one of the most widely distributed serious and chronic diseases among 
the world’s population. About 10% of the population in the Western world will experi-
ence gastric ulcer disease (Barkun & Leontiadis, 2010). In Asia and the South Pacific, 
gastric ulcer has been diagnosed in 11.5% of the population (Scott et al., 2013). In addi-
tion, it is considered  a major cause of morbidity and increased health care costs due to 
rising stress levels that face society, alcohol consumption, nutritional deficiencies and 
drug usage that in the long term of will cause gastric ulcers as will non-steroidal anti-
inflammatory drugs such as aspirin and indomethacin (Abdel-Fattaha & Abdel-Rahman, 
2000). 
Many medications used to treat gastric ulcer such as antacids, H2- antagonists and pro-
ton pump inhibitor (PPI). H2- antagonists and proton pump inhibitors such as omepra-
zole, ranitidin and famotidine work as gastric acid secretion inhibitors. All these drugs 
have side effects. The main side effects are diarrhea, hypercalcemia (leading to kidney 
failure), kidney stones, and osteoporosis. Antacids are rarely used for an anti-ulcer eval-
uation because they are not sufficient for prevention and healing activites (Eid et al., 
2010).  
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   The stomach continues to have contact with active harmful agents, and the main and 
most serious threats to the gastric mucosa as endogenous factors are pepsin together 
with hydrochloric acid (Vetro et al., 2002). Additional important harmful endogenous 
factors are the reflux of alkaline duodenal contents containing pancreatic enzymes with 
bile (Wormsley, 1972).  Cigarette smoking and drugs especially steroids, aspirin and 
NSAIDs have serious exogenous mucosal excitations that can cause mucosal injury (Ko 
& Cho, 2000; Weil et al., 2000). The efficiency of the stomach to protect itself against 
these factors is attributed to numerous agents represented in the defense of gastric mu-
cosa. Defense agents such as bicarbonate and mucus excreted through superficial epi-
thelial cells, PGs and gastric mucosal blood flow are considered important in maintain-
ing gastric mucosal safety (Abdel-Salam et al., 2001). Mucus could act as a bacterial 
trapper agent and be excreted in feces. In addition, mucus has antioxidant activity to re-
duce mucosal damage caused by factors produced from bacteria and immunocytes 
(Grisham et al., 1987). Eicosanoid bioactive lipids that include prostaglandins, leukotri-
enes and thromboxanes play an essential role in gastric physiology. Prostaglandins regu-
larly inhibit gastric acid secretion and preservation of mucosal blood flow (Wallace & 
Mcknight, 1990). Other factors that have a potential role in maintenance of gastric mu-
cosal integrity are epidermal growth factors and transforming growth factor TGF-β. In 
the human gastrointestinal tract, TGF-β plays an important function as mediator of the 
epithelial cell interactions where it regulates epithelial cell proliferation, inflammation 
and tissue repair. Its expression also increases after acute epithelial injury and in pa-
tients with inflammatory bowel disease (Frey & Polk, 2006; Hellmich & Evers, 2006). 
The body is usually under an active balance between free radical generation and scav-
enging. The physiological defense systems employed to face free radicals include en-
dogenous enzyme systems, such as superoxide dismutase, catalase, glutathione reduc-
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tase and coenzyme Q, as well as exogenous factors like vitamin C, vitamin E, selenium 
and β-carotene. All these molecules have  a central antioxidant function in the fight 
against oxidative stress through their ability to convert reactive oxygen species (ROS) 
into stable and harmless compounds or by scavenging ROS with a redox based mecha-
nism (Brambilla et al., 2008). The normalize and scavenge reactive oxygen species level 
to keep up physiological stability done through enzymatic and non-enzymatic antioxi-
dant protection systems that include  catalase (CAT), superoxide dismutase (SOD) and 
glutathione peroxide (GPx). The existence of an elevated concentration of alteration 
metal (Fe/Cu) ions, ischemia-reperfusion or drug metabolism causes ROS generation to 
overpower the cellular antioxidant defense which leads to oxidative stress (Verma et al., 
2013).  
       In recent years, people have tended to use traditional medicine for the treatment of 
diseases. Medicinal plants are assumed to possess  numerous secondary metabolites as 
flavonoids, alkaloids, terpenoids, tannins and others that help to protect the body from a 
variety of diseases. Furthermore, there are many medications that have been made from 
plant sources such as taxol as an anticancer drug from the Yew tree (Slichenmyer & 
Von Hoff, 1991; Strobel et al., 1996), artemisinin as an antimalarial drug from Artemi-
sia annua leaves (Graham et al., 2010; Li & Wu, 2003), and carbenoxolone as an an-
tiulcer drug from Glycyrrhiza glabra. Lately, researchers have beenshowing interest  in 
using natural material from plants to investigate new medications which  are more ef-
fective and with less side effects to treat gastric ulcer (Borrelli & Izzo, 2000; Farina et 
al., 1998).  
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1.2  Wound  
     Wound is defined as a kind of damage in which skin is torn, cut or ruptured; this is 
called an open wound. Whereas a closed wound happens when blunt force trauma to the 
skin results in contusion. The pathological definition of wound refers to an injury that 
damages the skin’s dermis (Boateng et al., 2008). There are many kinds of acute skin 
wounds, including incision wounds, incomplete thickness damages and wounds includ-
ing a special tissue lack. Dissimilar wound kinds include diverse phase’s process of 
healing to varying degrees. However, the phases are still the same (Monaco & 
Lawrence, 2003). The healing of wounds comprises a series of events. These events oc-
cur in an accurate to regulate mode. There is overlapping in the wound phases, but they 
are described in a linear manner to make it clear. The phases of wound healing include 
hemostasis, inflammation, cellular migration and proliferation, protein synthesis and 
wound contraction, and finally the remodeling phase. In the healing of the wound, acti-
vation of complicated net cells of blood, tissues, growth factors and cytokines cause in-
creased cellular activity that causes rising metabolic requests for nutrients (David & 
Heather, 2000).     
      Deficiencies  in nutrition could disrupt healing of the wound. Many nutrition agents 
which might enhance healing wound time and results are needed to repair the wound. 
Epithelial and bone formation  require vitamin A, important for immune function. Vit-
amin C is essential for collagen creation, as a tissue antioxidant and for good function-
ing of the immune system. The main lipid soluble antioxidant in the skin is vitamin E 
(Mackay & Miller, 2003). Excess ROS result in the killing of fibroblasts, and skin lipids 
will become less flexible. Because of this, antioxidants seems to be significant in the 
effective treatment and management of wounds. Antioxidants diminish these adversa-
tive effects of wounds through eliminating products of inflammation (Houghton et al., 
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2005). A possible mechanism for antioxidant defense is the direct interface of the ex-
tracts or compounds and hydrogen peroxide instead of changing the cell membranes and 
controlling damage. These compounds have a vast radical scavenging capacity and have 
been shown to enhance wound healing. Because of this researchers have tried to find 
medication from natural sources to cure wounds (Ipek et al., 2012). Numerous cytokines 
responsible for the stimulation of fibroblast and the synthesis of collagen include  TGF-
β, EGF and PDGF. Various factors related to the patient as well as to the wound influ-
ence the rate of collagen synthesis, and this includes age, tension, pressure, and stress 
(Velnar et al., 2009). Probably TGF-β and cytokines participate in contraction of the 
wound (Huebener & Schwabe, 2012). TGF-β, TNF-α, vascular endothelial growth fac-
tor and endothelin-1, are all important enhancers of cell proliferation, migration, chemo-
taxi and angiogenesis in the wound healing process (Tandara & Mustoe, 2004).  
      In the wound healing process, some probable signals for the expulsion of cells in-
volved in tissue repair have been proposed, but the mechanisms of how the cells expire 
require to be studied. Cells participate in each phase, expiring through one of three 
probable ways, which are apoptosis, necrosis and emigration. Eighteen member proteins 
of the BCL2 family have been discovered to be influencers of the apoptosis pathway, 
and the BCL2 family proteins either promote or prohibit apoptosis. The pro-apoptotic 
proteins involve BAX, Bad and Bak, whereas BCL2 and BCL-xL are anti-apoptotic 
proteins. Apoptosis plays a critical function in the synchronization of speedily altering 
cell residents, which is complicated in all tissue healing. For a massive common wound, 
controls of proliferation cause an acceleration of the wound’s closure. Sometimes the 
equilibrium between the increase and decrease in number of cells forfeits its equilibrium 
and causes pathologic tissue repair (Rai et al., 2005).  
Chapter one                                                                                                Introduction                           
6 
  
1.3 Immunomodulatory 
     The immune system is a remarkably developed defense system found inside verte-
brates to guard them from attacking factors of illness. It is capable of producing a di-
verse range of molecules and cells which are able to distinguish and reduce the unlim-
ited changes of external and unwanted agents. The modulation of the immune system 
refers to some alteration in the immune response, which could include stimulation, am-
plification and expression or inactivation of the immune response. Therefore, the im-
munomodulator is a substance used for its effect on the immune system. There are 
commonly two kinds of immunomodulators based on their effects, immunostimulators 
and immunosuppressers. They have the ability to mount an immune response or defence 
against pathogens or tumors (Saroj et al., 2012). Material which has shown a modifying 
immune system response to a threat, is an immunomodulator. Immunomodulators mod-
ulate and potentiate the arm of the immune system by keeping it in a highly prepared 
state against threat (Mishra et al., 2008).   
     In different parts of the world, plant extracts have been widely investigated for the 
possibility of  immunomodulation. Many of the studies have demonstrated the isolation 
of potential bioactive molecules (Alamgir & Uddin, 2010). For example, Acorus cala-
mus rhizome extract inhibited the growth of several cell lines for humans and mice. It  
also inhibited the production of nitric oxide (NO), interleukin-2 (IL-2) and tumor necro-
sis factor-α (TNF-α). In addition, it can cause down-regulation expression of the CD25 
marker (Mehrotra et al., 2003)  and many plant derived compounds like sterols, ster-
olins, polysaccharides, alkaloids, flavonoids, lectin and glycoprotein are used as im-
munomodulators (Kolm et al., 2007; Lien et al., 2003). 
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     Modulation of the immune response to reduce diseases has long been an attraction 
for researchers.  There have been many studies lately on ethnomedicinal plants as im-
munomodulatory agents. Immunopharmacology is a relatively new division of pharma-
cology, which aims to search for immunomodulators. The possible usage of immuno-
modulators for clinical medicine can comprise reconstruction for immune deficiciency, 
for example, treatment of the suppression of normal or exaggerated immune roles like 
treatment of autoimmune diseases and AIDS. An important source of immunomodula-
tors is medicinal plants and their active components. Therefore, the improvement of 
drugs from natural compounds for their immunomodulation and anti-tumor potential is 
an interesting project (Alamgir & Uddin, 2010). 
1.4 Medicinal plants  
     In the past, plants supplied humans with sources of dye, food, perfume, gum, resin, 
fiber and many other useful products. Nowadays, ethno-pharmacologists are paying 
more attention to investigating the bioactive properties and phytochemical analysis of 
medicinal plants to treat a variety of diseases. Medicinal plants have a main therapeutic 
function and could be used as a natural medicine source for treating different diseases 
(Gupta & Sharma, 2006). Recently, many researchers endorsed the traditional belief in 
utilizing medicinal plants to treat a variety of diseases involving gastric ulcer. Many 
studies have reported that plants possess various bioactivities (Alama et al., 2009; 
Yadav et al., 2011). P. macrocarpa and T. crispa are traditional drugs that are used in 
the treatment of inflammation, cancer, and diabetes (Hendra et al., 2011a; Mardina et 
al., 2011). In this study, we used P. macrocarpa fruit and T. crispa stem extracts to in-
vestigate their immunomodulatory, gastro protective potential and their ability in wound 
healing. Ethopharmacological evidence indicates the utilization of P. macrocarpa and 
T. crispa by humans for several purposes. The chief purpose of the plants was as a basis 
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for food additives. However, the plants are also used as a source of natural medicine 
agents and have an extensive diversity of secondary metabolic materials  such as alka-
loids, tannins, terpenoids and flavonoids. There have been studies in vitro of their anti-
oxidant, anti-inflammatory properties and this has been used for developing drugs or 
dietary supplements (Mohammed et al., 2012; Yosie et al., 2011). 
    Traditionally, P. macrocarpa and T. crispa have been used to in the treatment of 
hemorrhoids, cancers, diabetes, blood diseases, allergies, acne, migraine and various 
skin diseases  (Noipha et al., 2010; Widyasari et al., 2011). Previous studies reported 
isolating many active compounds from P. macrocarpa and Tinospora crispa like 
phalerin, mangiferin, benzophenone glucopyranosides, mahkoside, kaempferol-3-O-b-
D-glucoside, dodecanoic acid, and palmitic acid from various parts of P. macrocarpa 
(Asih Triastuti  & Choi, 2008; Tandrasasmita et al.,2010), tyramine and epinephrine 
from the fraction of T.crispa extract, which are  reported to act in the control of blood 
pressure (Pramana et al., 2011) and tinosporaside, cordioside, and columbin (Ahmed et 
al., 2006). 
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1.5  The objectives of this study 
     As an expansion of our initial study on the biological screening of local medicinal 
plants and gastroprotective, wound healing and immunomodulatory, we identified 
P.macrocarpa and T. crispa as potential candidates for further investigation. The pre-
sent study was conceptualized with the following:  
1.5.1 General objectives 
     To investigate gastroprotective, wound healing and immunomodulatory potential for 
P. macrocarpa and T. crispa ethanol extracts as well as to identify the active constitu-
ents of the both plants.  
1.5.2 Specific objectives 
1. To investigate the antioxidant activity (DPPH and FRAP methods), total phenolic and   
     total flavonoid contents in vitro. 
2. To investigate the acute toxicity of P. macrocarpa and T. crispa extract in rats. 
3. To evaluate the gastroprotective ability of P. macrocarpa and T. crispa extract by  
     inducing gastric ulcers in rats.  
4. To evaluate the wound healing potential of P. macrocarpa and T. crispa by inducing 
     excision wounds in rats. 
5. To estimate the change in the gene expression of apoptosis markers (BAX and BCL2)  
    in the wound healing model. 
6. To investigate the immunomodulatory effect of the both plants in vitro using  
    a RAW264.7 cell line. 
7. To fractionate and identify the active constituents of both plants with  
      immunomodulatory effect in vitro. 
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CHAPTER TWO 
2 Literature review  
2.1 Gastric ulcer  
2.1.1 Definition  
Gastric ulcer is one of the most common diseases. Gastric ulcer can be defined as a 
localized breach of the gastric with tissue destruction at least to the depth of the muscu-
laris mucosa Figure 2.1 (Tarnawski et al., 2001). Gastric ulcer is one of the most widely 
distributed chronic diseases amongst the world’s population and around 10% of the 
population in the Western world will experience gastric ulcer disease (Barkun & 
Leontiadis, 2010). In Asia and the South Pacific, gastric ulcer has been diagnosed in 
11.5% of the population (Scott et al., 2013). In a previous study which was done in Ma-
laysia and consisted of 124 participants diagnosed as having gastric ulcer, gastric ero-
sions or duodenal ulcer. Based on ethnicity, Malays comprised 69.4% of the sample, 
whereas 24.2% were of Chinese, 2.4% of Indian, 2.4% of Kampuchean and 1.6 % of 
Thai ethnic origin. This study was conducted in the northeastern peninsular Malaysia, 
where Malays are the overwhelming majority, constituting more than 98% of the popu-
lation, so they comprised the major percentage in the study (Raj et al., 2001).  
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Figure 2.1: Gastric ulcer disease. Adapted from: (Marks, 2012). 
 
2.1.2 Possible etiology and risk factors of gastric ulcer     
2.1.2.1   Acid output  
In up to one third of patients with gastric ulcer, maximal acid output and basal acid 
output (BAO) are raised. The rise in BAO might reveal that a significant percentage of 
patients have gastric ulcer. In addition, an increase in gastric acidity is also observed in 
some patients with gastric ulcer.  Many of these ulcers are situated at the end portion of 
the stomach, where, in one study, 955 of all gastric ulcers were found (Aihara et al., 
2003).   
2.1.2.2 Nonsteroidal anti-inflammatory drugs (NSAIDs)  
NSAIDs drugs are known to be related to gastrointestinal poisonousness and also to 
the creation of gastric and duodenal ulcers. As many as 4 to 10 % of patients who take a 
daily therapeutic dose of NSADs develop gastric ulcer after three months of starting 
therapy and up to one percent of those gastric ulcers are clinically significant. Factors 
related to the rising risk of gastric ulcer found in NSAIDs usage are being female, 
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and/or elderly and heavy and long-term use of NSAIDs drugs (Chan & Leung, 2002; 
Laine et al., 2008).  
2.1.2.3  Life style factors  
Lifestyle factors play a role as risk factors that can elevate the possibility of having 
gastric ulcer disease, such as smoking, which might accelerate gastric emptying and de-
crease the pancreatic bicarbonate formation that may cause gastric ulcer. Alcohol use 
causes gastric mucosal irritation and nonspecific gastritis and also gastric reflux ,one of 
the chief causes of gastric ulcer (Chisholm, 1998).  
2.1.2.4   Genetics  
More than of 20% of patients possess a family history of gastric ulcer in association 
with (5-10) percentage of the control group. The reason for this genetic relation is not 
clear. A rare genetic relation has been found between familial hyperactive pepsino-
genemia type I (genetic phenotype causing improved secretion of pepsin) gastric ulcers. 
Related with gastric acid with gastric acid hyper secretion and the progress of gastric 
ulcer (Atherton, 2006).   
2.1.2.5   Helicobacter pylori infection  
   H. pylori bacteria are small, microaerophilic, spiral in shape, gram-negative rods. The 
existence of H. pylori in the stomach and duodenum may be the most common bacterial 
infection in the world (Atherton et al., 1995). H. pylori infection is usually observed as 
the most important etiologic agent in the progress of gastroduodenal pathology (Chan & 
Leung, 2002). 
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2.1.3 Drugs used to treat gastric ulcer  
There are several drugs used for treating gastric ulcer. These medications have an ef-
fect on the specific receptors and activate certain mechanisms, which contribute to gas-
tric ulcer therapy by neutralizing gastric acid secretion, scavenging free radical mediat-
ed by ulcerogenic agents or by promoting mucosal defenses. Antacids such as maalox 
and mylanta are the first optional drugs used to mitigate heartburn and dyspepsia. Un-
fortunately, this group is inefficient in preventing or curing gastric ulcers, but it can be 
useful via these two mechanisms: neutralizing acidity inside the lumen of stomach with 
the combination of three basic compounds of calcium, magnesium and aluminum or 
they may guard the mucosal layer of stomach through raising bicarbonate and mucus 
secretions (Chisholm, 1998).  
Antibiotics are another group that can be used to treat  gastric ulcers caused by bacte-
rial infection H. pylori (Hentschel et al., 1993). Amoxicillin is an effective antibiotic 
used to diminish bacterial growth and it has been widely used as a positive reference 
drug to evaluate antibacterial activity particularly H. pylori (Malfertheiner et al., 2007). 
H2 blockers are a group of drugs, including cimetidine and ranitidine, that are used 
as a standard treatment for gastric ulcers before proton pump inhibitors and antibiotic 
treatments against H. pylori were developed. They act as suppressors of acid production 
by blocking histamine, a cytokine molecule created through the body that promotes acid 
secretion in the stomach. Although there are many researchers using H2 blockers cimet-
idine and ranitidine (Chisholm, 1998) as the standard group for antiulcer evaluation ex-
periments, these drugs cannot cure ulcers and they are effective only for duodenal ulcers 
(Wallace, 2005).  
Proton pump inhibitors (PPIs) are the common choice of drug to be administrated to 
patients with gastric ulcers. The mechanism of action is via blocking the stomach acid 
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secretion by suppressing H
+
/ K
+ 
ATPase. This enzyme is responsible for regulating acid 
secretions present in the parietal cells of stomach glands. Existing PPIs that are accepted 
for the prevention of ulcer and for healing comprise omeprazole (Prilosec OTC), 
esomeprazole (nexium), lansoprazole (prevacid) and rabeprazole (aciphex) (Wallace, 
2005). All these drugs have lateral effects, the main lateral effects being diarrhea, hy-
percalcemia (leads to kidney failure), kidney stones, and osteoporosis. Antacids are 
rarely used for anti-ulcer evaluation because they are not sufficient for prevention and 
healing activities (Eid et al., 2010). In this project, omeprazole was used as the positive 
control group as it has widely been used as a standard drug to evaluate anti-ulcerogenic 
activity in a variety of plant extracts. Several studies have used omeprazole as a positive 
control drug against the ethanol induction model based on the proposal mechanism that 
omeprazole is able to enhance cytoprotection and scavenge oxidative stress arbitrated 
by ethanol-induced ulcers (Alirashdi et al., 2012; Gupta et al., 2005). 
2.1.4  Gastroprotective factors and gastric mucosal integrity 
The stomach is always in continued contact with potentially harmful factors. Threats 
to the gastric mucosa as endogenous factors are pepsin together with hydrochloric acid 
(Vetro et al., 2002). Additional harmful endogenous factors are the reflux of alkaline 
duodenal contents having pancreatic enzymes with bile (Wormsley, 1972).  Cigarette 
smoking, drugs especially steroids, aspirin and NSAIDs are serious exogenous mucosal 
excitations that can cause mucosal injury (Ko & Cho, 2000; Weil et al., 2000).  The ef-
ficiency of the stomach to protect itself against these factors has been attributed to nu-
merous agents represented in the gastric mucosal defense. These defense agents involve 
mucus and bicarbonate excreted by surface epithelial cells, sulfhydryl compounds, pros-
taglandins and gastric mucosal blood flow, and are considered important in maintaining 
gastric mucosal safety (Abdel-Salam et al., 2001). 
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 The barrier that was formed between the body and the luminal environment is the 
gastrointestinal mucosa, that not only has nutrients but is loaded with actively hostile 
microorganisms and toxins. The gastrointestinal tract  barrier is composed of two major 
parts; the first which is the epithelial cell  lining (the digestive tube) and the second 
which are secretions that influence the epithelial cells and preserve their barrier func-
tion. What is crucial for barrier integrity is the maintenance of intact epithelium and the 
balance between cell proliferation and cell death (Gary & Wallace, 2006). The gastric 
mucosa is consistently exposed to a mix of endogenous and exogenous injuring agents 
including gastric acid, bile, drugs and microorganisms. The agents responsible in muco-
sal protection are; mucus secretion, mucosal microcirculation, acid inhibition, prosta-
glandins and inflammatory mediators (Abdel-Salam et al., 2001).  
Mucus completely coats the gastrointestinal epithelium that is formed by cells. Mu-
cus has a critical function in justifying shave pressures on the epithelium and shares to 
barrier function. Carbohydrates on mucin molecules react with bacteria, which helps in 
avoiding colonization by causing acceleration, aggregation and clearance (Adrian & 
Flemström, 2005).   
Mucus can act as a bacterial trapper agent and is excreted in feces. In addition, mu-
cus has an antioxidant activity that reduces mucosal damage caused by factors produced 
by bacteria and immunocytes (Grisham et al., 1987). Mucus has an important constitu-
tional role in the mucosal surface, which assists in the maintenance of a pH at the sur-
face that is near neutral as well as in performing as a physical barrier against luminal 
pepsin (Allen et al., 1993).  
 Eicosanoids are bioactive lipids that include prostaglandins, leukotrienes and throm-
boxanes that play an essential role in gastric physiology; prostaglandins regularly inhibit 
gastric acid secretion (Callison et al., 1976; Dey et al., 2006). Previous studies have 
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proved the inhibitory effect of PGE2 on acid output in  mice, rats, dogs, monkeys and 
humans (Main & Whittle, 1973; Newman et al., 1975; Robert et al., 1967). Exogenous 
or endogenous prostaglandins stimulates most of the mucosal defense mechanisms 
(Wallace & Granger, 1996) and continued output of PGE2 and prostacyclin are neces-
sary for the safety of the gastric mucosa (Wilson, 1990). Prostaglandins have a signifi-
cant role in the preservation of mucosal blood flow (Wallace & Mcknight, 1990), as 
well as encouraging bicarbonate and mucus exudation in the stomach (Allen & Garner, 
1980). 
Luminal PGE2 production increased seven fold over basal values after exposing the 
stomach to 150 mM HCl at pH 0.8 for 5 min in humans (Aly et al., 1985). Prostaglan-
dins preserve gastric mucosal reliability through stimulating  mucus and bicarbonate 
excretion, preventing acid secretion, mast cell initiation and apoptosis, lessening leuko-
cyte devotion to the endothelium, accumulative or preserving mucosal blood flow and 
therefore avoiding ischemia (Atay et al., 2000).  
Szabo et al. (1985) showed that vascular injury donates to the development of hemor-
rhagic erosions in rats after intragastric administration of ethanol using vascular tracers. 
Intragastric administration of absolute ethanol stimulated increased vascular permeabil-
ity within 1-3min after one hour of 100% ethanol exposure. The areal density of grossly 
visible hemorrhagic lesions also increased patently. Conspicuous hemorrhagic damage 
to the glands of the gastric mucosa occurred due to obvious lesions in the blood vessels 
and increased vascular permeability, so vascular injury could be considered early evi-
dence of pathogenic factors in the expansion of ethanol induced gastric hemorrhage cor-
rosion. In addition, it was found that pretreatment with prostaglandin F2beta  reduced 
ethanol injury. In  previous studies, Tarnawski et al. proved that deep necrosis lesions in 
the gastric mucus layer from absolute ethanol can be totally prevented by 16,16-
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dimethyl PGE2 (Tarnawski et al., 1985). Robert et al. showed that pretreatment 
with16,16-dimethyl PGE2 (10g/kg in 1ml) prevented ethanol from causing histologic  
alterations (Robert et al., 1992). Severe mucosal damage, extending to the capillaries of 
the gastric glandular mucosa, that was induced in rats by absolute ethanol for 1 min, can 
be reduced by pretreatment with PGF at a dose of 0.5mg/100g (Trier et al., 1987). A 
large number of endocrine and paracrine agents affect the normal proliferation of gastric 
epithelial cells and propagation to reaction as the wound causes ulceration. Numerous 
enteric hormones improve the proportion of propagation. Prostaglandins, especially 
PGE2 and prostacyclin, are known to have acytoprotective effect on the gastrointestinal 
epithelium. The cytoprotective influence seems to result from a complex ability to im-
prove mucosal bicarbonate and mucus secretion to rising mucosal blood flow. Other 
factors that have a potential function in the preservation of gastric mucosal safety are 
the epidermal growth factor, transforming growth factor-beta (TGF-β), fibroblast 
growth factor and hepatocyte growth factor. These peptides impasse a corporate recep-
tor and improve epithelial cell proliferation, and additional molecules have a critical 
role for mucosal safety and barrier job as nitric oxide (Barnard & Mchugh, 2006). The 
pathways of the TGF-β superfamily signal are simple controllers of the cellular routes 
comprising differentiation, proliferation, migration, survival and physiological process-
es like embryonic development, angiogenesis and wound healing. Variations in these 
pathways are caused by either somatic mutations or germ-lines, and changes in expres-
sion of these signaling pathways frequently result in human disease (Gordon & Blobe, 
2008). In the human gastrointestinal tract, TGF-β plays a crucial role as a mediator of 
epithelial cell interactions where it regulates epithelial cell proliferation, inflammation 
and tissue repair; its expression also increases after acute epithelial injury and in pa-
tients with inflammatory bowel disease. TGF-β null mice died 20 days after birth due to 
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catching a multifocal inflammatory disease in the stomach and intestine (Frey & Polk, 
2006; Hellmich & Evers, 2006). The gastric mucosa is constantly open to actively inju-
rious factors and the  protection of mucosal integrity is secured through a difficult struc-
ture of interacted mediators. Exaggerated ethanol administration causes gastritis catego-
rized by mucosal edema, cellular exfoliation, sub-epithelial hemorrhages, cell infiltra-
tion, inflammation and ulcers. Exogenous compounds, mostly acetylsalicylic acid, 
NSAIDs drugs and too much ethanol result in corrosive lesions in the gastrointestinal 
mucosa (Jahovic et al., 2007). Ethanol causes increasing superoxide anion activity, lipid 
peroxidation and hydroxyl radical production in the gastric mucosa (Bagchi et al., 
1998). DNA damage, oxidative stress, increased xanthine oxidase activity, malondial-
dehyde level and decreased total glutathione content in gastric mucosal cells are 
prompted by acute ethanol (Marotta et al., 1999). Oxidative stress that disturbs the ener-
gy metabolism of mitochondria and has a serious function for pathogenic ethanol-
induced gastric mucosa injury is another hypothesis suggested explaining ethanol-
induced gastric mucosa injury (Pan et al., 2008). The body is usually balanced between 
free radical generation and scavenging.  The physiological defense systems which face 
free radicals include the endogenous enzyme systems, such as superoxide dismutase, 
catalase, glutathione reductase and coenzyme Q, as well as exogenous factors like vita-
min C, vitamin E, selenium and β-carotene. All these molecules have an important anti-
oxidant function in the fight against oxidative stress through their ability to convert re-
active oxygen species (ROS) into stable and harmless compounds or by scavenging 
ROS with a redox-based mechanism (Brambilla et al., 2008). Physiological replies to 
stressors cause increased activity of the hypothalamic pituitary adrenal axis and altera-
tions in the gastrointestinal tissue. This rise in adrenocortical action is  related to the rise 
in the incidence of gastric ulceration. Oxidative stress in the stomach is the cause of 
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stress ulcers and leads to gastric ulcers (Suzuki et al., 2012). The activation of additional 
ROS production or a decrease in antioxidant defenses are caused by oxidative stress 
which is a case of boosted levels of ROS. The pathogenesis of gastric inflammation, ul-
cerogenesis, H. pylori infection, life style associated diseases such as hypertension, ath-
erosclerosis, ischemic heart diseases, diabetes mellitus and malignancies have all con-
tributed to oxidative stress (Suzuki et al., 2011). The influence of ethanol on the gastric 
mucosa is multifaceted and complicated. It might be associated with a disruption of bal-
ance between gastric mucosal protection and offensive agents. Gastroprotective factors 
preserve the safety of the gastric mucous layer, microcirculatory system, bicarbonate, 
epidermal growth factor, prostaglandins and epithelial cell recovery, whereas the gastric 
mucosa is naked to gastric acid and pepsin. Damage to the vascular endothelial cells of 
the gastric mucosa prompts microcirculatory disturbance, and hypoxia linked to the 
overproduction of oxygen radicals is caused by ethanol (Suzuki et al., 2012). The gener-
ation of ROS is usually a waterfall of responses, which begins with the creation of su-
peroxide that quickly dismutases to hydrogen peroxide. Direct or indirect injurious 
agents may be caused by free radicals through their reaction with other components in 
the cell. Enzymatic and non-enzymatic antioxidant protection systems that include su-
peroxide dismutase (SOD), catalase (CAT) and glutathione peroxide (GPx) keep up 
physiological homeostasisi through  scavenging and regulating overall ROS levels. The 
existence of raised alteration metal (Fe/Cu) ions, ischaemia-reperfusion or medication 
metabolism causes generation of ROS to overpower the cellular antioxidant defense 
which leada to oxidative stress (Verma et al., 2013).   
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2.2 Wound  
2.2.1 Definition  
A wound is defined as any kind of damage  where the skin is torn, cut or ruptured; 
this is called an open wound. Whereas a closed wound happens when blunt force trauma 
to the skin results in contusion. The pathological definition of a wound is a sharp injury 
that damages the skin’s dermis (Boateng et al., 2008).  There are many kinds of acute 
skin wound, including incision wound, incomplete thickness damage and wound includ-
ing special tissue lack. Dissimilar wounds kinds include diverse phase’s process of heal-
ing to a varying degree. However, the phases are still themselves the same (Monaco & 
Lawrence, 2003). The healing of a wound comprises a series of events. These events 
occur in an accurate to regulate mode. There is overlapping in the wound phases, but 
they are described in a linear manner to make it clear. The phases of wound healing in-
cludes hemostasis, inflammation, cellular migration and proliferation, protein synthesis 
and wound contraction and finally the remodel phase (David & Heather, 2000). The 
healing of a wound contributes to the activation of complicated net cells of blood, tis-
sues, growth factors and cytokines which cause increasing cellular activity that causes a 
rising metabolic request for nutrients. Deficiencies in nutrition could disrupt the healing 
of wound. Many nutrition agents are needed for wound repair which might enhance 
healing wound time and results. Epithelial and bone formation require vitamin A, which 
is  important for immune function, and vitamin C which is essential for collagen crea-
tion, as a tissue antioxidant and for the function of the immune system. The main lipid 
soluble antioxidant in the skin is vitamin E (Mackay & Miller, 2003). Because of this,   
researchers are trying to find medication from natural sources to cure wounds.  
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2.2.2  Phases of wound healing  
Wound healing follows a foreseeable sequence of events that occurs in an accurately 
constructed way. The phases of wound healing overlap and can be described in a linear 
manner for the intention of clarification. Wound healing is characterized by five phases: 
hemostasis, inflammation, migration of cells and proliferation, synthesis of protein and 
contraction of wound and the remodeling phase (Figure 2.2).    
 
 
Figure 2.2: The cascade of acute wound healing. The propulsion of acute wound healing from 
hemostasis to the final phases of remodeling is dependent on a complex interaction of varied 
acute wound-healing events. Cytokines play a fundamental role in wound healing and act as a 
central signal for various cell types and healing events. Cited by (Monaco & Lawrence, 2003). 
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2.2.2.1  Hemostasis 
 All hazardous traumas generate vascular damage and therefore start the molecular and 
cellular response which promotes hemostasis. Accomplishment of hemostasis is vital 
for the healing process. Vasoconstriction, platelet aggregation and fibrin deposition are 
primary contributors of hemostasis which results from the coagulation cascades.  Clot 
formation is the outcome of hemostasis. The primary composition of clots is a fibrin net 
with gathered platelets associated with surrounding cells (Lawrence, 1998).  The clot 
formation consequence is ingrained. The external environment causes loss of additional 
fluid and electrolytes from the wound site and the delimitation of contaminates. Fibrin is 
the net substance to the contingent wound medium on to the fibroblasts and other cells 
migration to begin the healing process. There are three stages in the hemostasis phase: 
2.2.2.1.1 Vasoconstriction 
The release of vasoactive amines contributes to the initiation of vasoconstriction 
which happens when the dermis is entered. While stimulus of the sympathetic nervous 
system liberates epinephrine into the peripheral circulation this causes local norepineph-
rine release. Further vasoconstriction is also attributed to prostaglandins such as throm-
boxane that are secreted from the injured cells (Monaco & Lawrence, 2003). 
2.2.2.1.2 Platelet aggregation 
Damaged cells caused releasing to tissue factors that exposure to platelet aggregation 
and fibrinogen. Liberate the substances of alpha granules, dense bodies and lysosomes 
they happen after aggregation and adhesion of platelets inside their cytoplasm (Cines et 
al., 1998). A variety of proteinaceous and immunomodulatory agents, which participate 
in the primary and late phases of healing, can be found inside the alpha granules which 
are mainly, adhesive proteins (vonwillebrand factor VIII, fibrinogen, fibronectin and 
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thrombospondin) as well as,, platelet derived growth factor (PDGF), fibroblast growth 
factor-2 (FGF-2), transforming growth factors α and β (TGF-α & TGF-β), platelet de-
rived epidermal growth factors (EGFs) and endothelial cell growth factors. The TGF-β, 
PDGF and FGF-2 are the greatest substantial. Calcium, serotonin, ADP and ATP are the 
necessary fuel providing compounds that participate in the process of healing found in-
side dense bodies. These compounds share in prompting the coagulation cascades 
(Griendling et al., 2000).  
 
2.2.2.1.3   Fibrin and the coagulation cascades  
The coagulation waterfall is a compound of intrinsic and extrinsic ingredients which 
are triggered separately. The extrinsic cascade is essential whereas the intrinsic cascade 
is not involved in the normal healing process. Thrombin is produced through the activa-
tion of the intrinsic and extrinsic pathways that catalyze the alteration of fibrinogen to 
fibrin. Vascular permeability and facilitation of the extravascular migration of inflam-
matory cells are increased by thrombin stimulates.  Fibrin consists of the net used for 
steadying of the platelet plugs and is a vital element for the temporary matrix that 
changes rapidly in the wound after damage. Serum and platelets derived from vitron-
ectin coats the fibrin and this accelerates the binding of fibronectin that forms via fibro-
blasts and epithelial cells (Dahlbäck, 2005).  
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2.2.2.2 Inflammation 
Erythema, edema, heat, and pain are characteristic features of inflammation. The in-
crease in vascular permeability and the consecutive movement of leukocytes into the 
extravascular area grant a special privilege of inflammation at the tissue level (Figure 
2.3). Conducting inflammation cells to the damaged region to break down bacteria and 
also to remove wreckage from dead cells and the broken matrix is one of the fundamen-
tal functions of inflammation so that the repair processes can proceed (Li et al., 2007).  
Erythema and heat, as signs of inflammation, develop soon after injury due to vaso-
dilatation. Vasodilatation begins after the start of vasoconstriction, which inverts 10-15 
min next wound. To allow the infiltration of plasma from the intravascular area to the 
extravascular chamber, the endothelial cells lining for capillaries in the closed wound 
form a gaps between them (Monaco & Lawrence, 2003). The pain sensation, which is a 
cardinal sign of inflammation, comes from the accumulation of fluid into the area that 
generates edema. Numerous agents mediate the switching from vasoconstriction to vas-
odilation. Endothelial products and mast cell derivative factors such as leukotrienes are 
a group of arachidonic acid metabolites referred to as LTs. Leukotriene B4 is a potent 
chemotactic factor that induces aggregation of neutrophils, whereas  LT4, LTD4 and 
LTE4 cause vasoconstriction and increased vascular permeability,  while prostaglandins 
(PGI2, PGD2, PGE2, and PGF2α) and histamine contribute to vasodilation (Noli & 
Miolo, 2001). The signal to start the cellular reaction of the inflammatory phase is when 
leukocytes flow into the area of the wound. Neutrophils and monocytes are the main 
cells through the early inflammatory phase at the site of injury. Neutrophils and mono-
cytes start migrating from capillaries into the wounded tissue soon after injury. Neutro-
phils initially arrive in large numbers, but later in inflammation, neutrophils decline as 
well as macrophages in number (Li et al., 2007). The most important controlling cell in 
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the inflammatory reaction  is the macrophage as it can phagocytize, digest and kill path-
ogenic organisms and scavenge tissue debris and destroy any residual neutrophil. Mon-
ocytes or macrophages that release enzymatic proteins and biologically active oxygen 
intermediates permit the initiation of angiogenesis and the creation of granulation tissue 
(Lewis et al., 1999; White et al., 2004). Another important role of macrophages is to  
release chemotactic factors which include fibronectin, fibroblast growth factor, vascular 
endothelial growth factor, platlate derived growth factor, TGF-α and TGF-β. These cy-
tokines are important in encouraging cell migration as well as proliferation which at-
tracts fibroblast to the site of injury and matrix production. Macrophages thus appear as 
factories for growth factor production and this plays an essential function in the altera-
tion between inflammation and repair (Bosco et al., 2008). 
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Figure 2.3: Cutaneous wound healing at day 3 after injury. Growth factors thought to be neces-
sary for cell movement and wound healing. In this stage there is expression of TGF-β1, TGF-β2 
and TGF-β3. TGF-α, fibroblast growth factor (FGF), vascular endothelial growth factor 
(VEGF), platelet derived growth factor (PDGF), insulin like growth factor (IGF) and keratino-
cyte growth factor (KGF). Adapted from (Singer & Clark, 1999). 
 
2.2.2.3 Cellular migration and proliferation  
After the first week of the acute wound, the cellular medium in the wound varies 
dramatically. These changes include a heavy infiltration of inflammatory cells to the 
initial fibrin–fibronectin matrix, while the cells which will predominate as healing pro-
gresses are fibroblasts and endothelial cells.  Several days after injury, reestablishment 
of the epithelial surface is initiated for the  revascularization of the injured region. Cy-
tokine systems stay designates a portion of this activity as cytokine production shares to 
fibroplasia, epithelialization and angiogenesis (Hunt et al., 2000). Deactivations of cells 
via negative feedback mechanisms are also fundamental  in the normal healing process 
(Diegelmann & Evans, 2004). A structural molecule, as fibronectin and collagen of the 
early extracellular matrix, participates in granulation tissue formation by providing a 
scaffold for contact guidance and a reservoir for cytokines and growth agents. Collagens 
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act as a foundation for the intracellular matrix formation within the wound (Baum & 
Arpey, 2005). Modeling and establishing of new blood vessels is critical in wound heal-
ing and this happens simultaneously through all stages of the reparative process, while 
attracting neutrophils and macrophages through numerous angiogenic factors secreted 
during the hemostatic phase to promote angiogenesis (Pierce et al., 1991; Takeshita et 
al., 1994). 
2.2.2.4 Protein synthesis and wound contraction 
Four to five days after the wound happens (Figure 2.4), the dominant events that start 
in wound healing are synthesis, deposition of proteins and contraction of wound.  The 
strength of a scar depends on the quality and quantity of deposition during the healing 
stage (Bullard et al., 1999). Collagen forms more than (50%) of the protein in scar tissue 
and its production is fundamental for the healing process. Throughout the repair pro-
cess, fibroblasts are taking charge of synthesis of collagen as well as other proteins 
(Diegelmann & Evans, 2004).  
The numerous cytokines responsible for the stimulation of fibroblasts for collage 
synthesis are PDGF, TGF-β and EGF. Various factors related to the patient as well as to 
the wound influence the rate of collagen synthesis and this includes age, tension, pres-
sure, and stress (Velnar et al., 2009). The synthesis of collagen persists on a top level for 
2- 4 weeks and thereafter begins to slow down. Aberration in healing is predominantly 
the outcome of aberrations in the precipitation of collagen, although there is a variation 
in the underlying causes. In diabetic patients, there is limited collagen deposition and 
impaired healing due to impaired inflammatory cell activation, this is associated with a 
lack in additional features of the healing process (Brem & Tomic-Canic, 2007). As 
aforementioned, fibrin and fibronectin are composed primarily of the initial wound ma-
trix. The composition of the wound matrix changes due to the acceleration of protein 
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synthesis in which fibrins such as primary matrix constituents are replaced progressive-
ly by collagen and proteoglycans. During this phase, numerous proteins are being ac-
tively synthesized such as proteoglycans, which are an essential component of a mature 
matrix, improving cellular staffing and encouraging wound remodeling by thrombos-
pondin I and SPARC (secreted protein acidic rich in cysteine) (Reed et al., 1993). Four 
to five days post-wound, wound contraction starts and actively continues for nearly two 
weeks. Wound contraction persists for longer in wounds which stay open for at least 
two weeks. Wound contraction is evident in an open wound be closed by wound primes 
directs closer to each other. Wound contraction in the case of incisional wounds, simply 
results from limitation of scar and a lesser amount is clear. The percentage of contrac-
tion differs according to anatomic sites but it averages from (0.6 to 0.75 mm) per day. 
The contraction level is also affected by wound shape, such as the case of four-sided 
wounds that contract more rapidly than round wounds. Round holes subsequently have 
fewer possibilities of being exposed to risk as they are minor and narrow. The predomi-
nance of myofibroblasts at the wound periphery is a cardinal feature of wound contrac-
tion. Four to six days after the initial injury, myofibroblasts appear and are usually seen 
in the wound for 2 to 3 weeks (Porter, 2007). Considering that myofibroblasts are the 
‘‘motor’’ that contracts a wound, in the last decade more effort using collagen frames it 
has been proposed that fibroblasts are a fundamental portion of the wound and may be 
more essential for wound contraction. TGF-β and probably other cytokines participate 
in contraction of the wound (Huebener & Schwabe, 2012). All cutaneous wounds heal 
via three elementary mechanisms: connective tissue matrix deposition, contraction and 
epithelization. Through the main mechanism of healing during the formation of connec-
tive tissue matrix deposition, collagen, proteoglycans and attachment proteins are placed 
to form a new extracellular matrix; this is for wounds that are simple and can be closed 
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by tape, sutures or staples and heal faster. In contrast, wounds that continue to remain 
open essentially heal by contraction. The basic devices accountable for contraction do 
not fully understand that there seems to be a multifaceted interface between contractile 
fibroblasts also known as "myofibroblasts" and the matrix constituents (Tomasek et al., 
2002). Nerve growth and IL-8 could moderate the contraction response (Iocono et al., 
2000).    
 
 
Figure 2.4: Cutaneous wound healing at day five after injury. Blood vessels have appeared to 
be  sprouting into the fibrin clot as epidermal cells resurface the wound. Proteinases, thought to 
be important for cell movement. In this phase there is expression of urokinase type plasminogen 
activators (u-PA), MMP-1, 2, 3 and 13(matrix metalloproteinases1, 2, 3 and 13) and tissue 
plasminogen activator (t-PA). Adapted from (Singer & Clark, 1999). 
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2.2.2.5 Remodeling 
Remodeling of the scar starts to predominate by means of the principal wound heal-
ing activity about 21 days after the wound (Figure 2.5). The collagen synthesis rate de-
creases and reaches concurrence with the collagen split-up rate. Interferon-γ, TNF-α, 
and the collagen matrix itself play a considerable function in the down-regulation of 
collagen synthesis (Buck et al., 1996; Mori et al., 2002). Matrix metalloproteinases 
(MMPs) are implicated in a number of roles during wound repair comprising of elimi-
nation of non-vital tissue, stimulation of blood vessel growth, keratinocyte migration, 
regulation of growth factor activity and connective tissue remodeling. MMPs are impli-
cated in the active breakdown of collagen molecules that takes place throughout the re-
modeling process. Therefore, MMPs are engaged in many aspects of the wound healing 
process (Gawronska-Kozak, 2011).   
Currently 23 MMP genes that break down diverse extracellular matrices have been 
identified in humans (Visse & Nagase, 2003). MMPs are created via multiple kinds of 
cell. Different cells commonly manufacture diverse enzymes and the modulation of 
MMP action inside tissues is via tissue inhibitors of metalloproteinase (TIMPs). There 
are four isoforms of TIMPs that have been described (Brew et al., 2000). The equilibri-
um of MMPs and TIMPs inside tissue is pivotal to enzyme action and is controlled 
through cytokines excluding TGF-β, PDGF and IL-1 (Haroon et al., 2000; Hayden et 
al., 2011).  
TIMP-1 and TIMP-2 are mainly used for wound healing by encouraging cell prolif-
eration, inhibiting apoptosis and preventing matrix MMPs that have been associated in 
impeding wound healing directly by destruction of extracellular matrix proteins and in-
directly through out degradation of growth factors and cytokines (Ching et al., 2011). 
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Modification of the extracellular matrix composition is one of the features of wound 
remodeling. Approximately 80% of the dry weight from normal human dermis are the 
main proteins responsible for strength in collagen fibers, which are responsible for the 
structure and hardness of dermal tissue. In healthy adults, type I collagen consists of 
about 80% of all collagen in the dermis and 10% is type III collagen. Early in the repair 
period, the entire quantity of collagen increases reaching a maximum level between 2-3 
weeks after injury. The dermis gradually returns to the normal phenotype, which con-
tains mainly type I collagen after a period of one year or even longer. With wound clo-
sure, regular modification occurs to the type III collagen and it undergoes degradation, 
while type I collagen synthesis increases. Controlled production of new collagen and 
lysis of old collagen, mainly executed by the actions of MMPs are involved in the pro-
cess of  transformation of the dermis collagen (Li et al., 2007).  During the last phase of 
wound healing, the remodeling phase is in charge of the improvement of the new epi-
thelium and final scar tissue creation. Synthesis of the extracellular matrix in the prolif-
erative and remodeling phases  starts with granulation tissue development.  
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Figure 2.5: Cutaneous wound healing in remodeling phase. The remodeling phase of wound 
healing is also cytokine-mediated. Degradation of febrile collagen and other matrix proteins is 
driven by serine proteases and MMPs under the control of the cytokine network. Granulation 
tissue forms below the epithelium and is composed of inflammatory cells, fibroblasts and newly 
formed and forming vessels. Adapted from: (Wahl, 2002). 
 
2.2.3  Factors effects on wound healing 
 Local and systemic factors may influence the rate of wound healing. Local factors 
refer to situations in the direct wound environment whereas systemic factors describe 
entire body effects on the local wounded area (Guo & Dipietro, 2010).   
2.2.3.1 Infection  
An infected wound is usually observed as a wound that heals slowly. The presence of 
bacteria in the wound  generates an inflammatory host response. Exotoxins are secreted 
by living bacteria in the wounded tissue, which can be described as a waste product of 
bacterial active metabolism. Exotoxins are toxic to the cells of wounded tissue and so 
inhibit the normal function of local cells and tissues. Highly cleaned and often-systemic 
antibiotics are needed for infected wounds and foreign bodies found in a wound can be 
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possibly related to infection (Guo & Dipietro, 2010). Inflammation is a normal phase of 
the wound healing process and is essential for removing the contaminating microorgan-
isms. The extended elevation of proinflammatory cytokines as TNF-α and interleukin-1 
lengthen the inflammatory phase that can be caused by both bacteria and endotoxin. The 
wound may come to a chronic stage and fail to heal if this remains. The extended in-
flammation can be an indication for increasing the level of MMPs a family of proteases, 
which could reduce the extracellular matrix (Menke et al., 2007).  
2.2.3.2 Local blood supply 
Cell metabolism, particularly energy production, is crucial for almost all wound heal-
ing processes and needs oxygen. It preserves infection of wounds from angiogenesis, 
increasing keratinocyte differentiation, migration and re-epithelialization, improving 
fibroblast proliferation and collagen production, and encourages wound contraction 
(Bishop, 2008; Rodriguez et al., 2008). Furthermore, the level of superoxide is the key 
to killing microorganisms produced through polymorphonuclear leukocytes, and it is 
dependent on oxygen levels. Impermanent hypoxia activates wound healing, neverthe-
less extended or long-lasting hypoxia interrupts wound healing. Hypoxia aids as a signal 
in acute wounds, which encourages many aspects of the wound healing progression and 
could prompt cytokine and growth agents produced form keratinocytes, fibroblast and 
macrophages. This includes, TGF-β, platelet derived growth factor, TNF-α, vascular 
endothelial growth factor and endothelin-1 which are all important  promoters of cell 
proliferation, migration, chemotaxis and angiogenesis in the wound healing process 
(Tandara & Mustoe, 2004).   
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2.2.3.3 Malnutrition delays healing 
Proteins are the chief building blocks for cell renewal, growth of tissue and restora-
tion post damage. They significantly influence numerous wound healing phases through 
their part in  DNA and RNA production, collagen and elastic tissue formation, nutrition 
of the immune system, epidermal growth and keratinization. With continued protein 
malnutrition, skin will be thinner, more wrinkled and immunity decreases. Diabetic pa-
tients are exposed to a higher threat of damage with protein malnutrition (Dryden et al., 
2013). Adequate protein intake is fundamental to wound healing and a delay in wound 
healing in the case of protein depletion appears to be due to extending the inflammatory 
phase through inhibited proteoglycan and collagen production, inhibition of fibroplasia 
and inhibition of neoangiogenesis via inhibited wound remodeling (Ruberg, 1984).  
Dietary proteins that supply all nine of the necessary amino acids are assumed com-
plete proteins. Poultry, meat, fish, milk products, eggs and soyabeans are considered 
good sources of complete protein. The body needs a sufficient amount to provide neces-
sary amino acids, adequate nitrogen and energy for the production of the eleven other 
amino acids. There is an indication that many amino acids are particularly essential to 
the wound healing process. Cysteine and methionine are implicated in the production of 
collagen and connective tissue. The chief effect on the proliferation of collagen and en-
hanced immune reaction is from arginine (Wild et al., 2010). Glutamine is also im-
portant in the wound for the proliferation of inflammatory cells and as a source of ener-
gy (Dryden et al., 2013).  
Carbohydrates are a fundamental source of energy rich foods. Carbohydrates are es-
sential to fuel the metabolic process in the cells and tissues involved in wound healing. 
Because of this we need an increased intake of energy giving foods in patients with ex-
tensive wounds. As soon as adequate carbohydrates are ready-made, the body does want 
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to break amino acids for energy production (Medlin, 2012). Glucose deficiencies affect 
fibroblast proliferation, and significantly, lower glucose levels have been noted in the 
wound fluid of chronic wound patients (Han et al., 2004).   
Fats are constructed of sub-units called fatty acids; these fatty acids are composed of 
component cells and tissues (cell membranes), so a supply of fatty acids is required for 
tissue regeneration. Fat provides the necessary fatty acid building blocks and acts as a 
source of energy for cell metabolism (Shingel et al., 2008).   
Vital micronutrients in the diet are vitamins (vitamins A, D, E and K) , which are fat-
soluble and may be stored in the body while vitamin B1-B11 and C are water-soluble 
and cannot be stored  A fundamental cofactor for the synthesis of proteoglycans, colla-
gen and other organic components of the intracellular matrix of tissues, skin, capillary 
walls, bones and other connective tissues, is vitamin C (ascorbic acid). Ascorbic acid 
deficit causes irregular collagen fibers and changes in the intracellular matrix that are 
evident in cutaneous lesions, decreased tensile strength of fibrous tissue, poor adhesion 
of endothelium cells and poor immunity (Biesalski, 2010; da Rocha et al., 2002).  
The vitamin essential for epithelial and bone tissue development, immune system 
function and cellular differentiation is Vitamin A. Vitamin A converses  corticosteroid 
and induces the  inhibition of cutaneous and fascial wound healing as well as enhancing 
wound repair in the normal physiological process. Wound through facilitated the early 
inflammatory phase, involving improved localization and stimulation of the immune 
response, increased number of macrophages and monocytes in the wounded tissue, sup-
port of epithelial cell differentiation and modulation of collagenase activity, were en-
hanced by vitamin A (Mackay & Miller, 2003).  
Inorganic nutrients required in small quantities for health are minerals. Zinc is an es-
sential mineral needed for wound healing, and this is perhaps important for the re-
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epithelialization process. Around three hundred enzymes require zinc for their action 
and  zinc is fundamental for cell division, DNA synthesis and protein synthesis, 45 as 
well as all necessary procedures for tissue renewal and repair. Deficiencies in zinc have 
been related to delayed wound healing and the decreased break strength in animal 
wounds that comes from decreased collagen and protein production throughout the heal-
ing process in zinc-deficient animals (Prasad, 1995).  
 A deficiency of zinc is accompanied by an immunodeficiency causing an increased 
number of infections. Zinc has an effect on keratinocytes, osteocytes and leukocytes, 
and different concentrations of zinc are required for a specific cellular response (Rink & 
Gabriel, 2001). A cofactor of enzymes (prolyl and lysyl hydrolysis), which are im-
portant for the synthesis of collagen, is iron. Therefore, a greater iron deficiency strong-
ly impedes the wound healing process. In addition, iron as a part of hemoglobin plays 
an important part in the oxygen transport to regenerate wounded tissue (Brown & 
Phillips, 2010).  
Water is also crucial for optimal healing as  cell proliferation and migration sideways 
chemotactic gradients formed by cytokines, metal ions and growth factors are encour-
aged by hydration. Dehydration causes epidermal hardening and dermal necrosis that 
delays healing and adds to patient discomfort (Dryden et al., 2013).  
2.2.3.4 Age effects  
Young adults and children generally heal well. Wounds need all the necessary nutri-
ents for wound healing as well as the conventional requirements for growth and devel-
opment. Wound healing may be slow due to a small amount of fibroblasts in the tissues 
and this consequentially reduces amounts of collagen creation in the elderly. The con-
traction of the wound and re-epithelialization is slower in older people. The underlying 
disease processes in the elderly may adversely affect wound healing as in cases of pe-
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ripheral ischemia, heart disease and diabetes mellitus. More sustainably, to have reduc-
ing mobility with increasing risk of pressure sore formation is elderly (Gosain & 
Dipietro, 2004; Oriana et al., 2012).   
2.2.3.5   The reactive Oxygen Species 
The process of wound healing is controlled by a selection of disparate cytokines, 
growth factors and hormones. Continuing studies have shown that nitric oxide and reac-
tive oxygen species (ROS) are pivotal regulators of wound healing (Schwentker et al., 
2002). ROS is needed for protection from microbial invasion, and intracellular signal 
transduction also requires a low level of ROS. For example, hydrogen peroxide at low 
levels is essential for efficient angiogenesis of the wound. However, excessive ROS is 
poisonous because of the high reactivity. Both hyperoxia and hypoxia increase ROS 
formation but a raised level of ROS exceeds the beneficial influence and results in addi-
tional tissue damage (Guo & Dipietro, 2010). During the course of normal metabolic 
processes, for example, respiration, ROS is produced by all cells. In wounded and in-
flamed tissues, inflammatory cells produce high levels of NADPH oxidase that in turn 
produces a particular level of ROS (Schreml et al., 2010).   
 Cells form highly reactive superoxide radical anions, which are rapidly dismutated to 
hydrogen peroxide (H2O2) and water. This is enhanced by many superoxide dismutases. 
Even though, H2O2 is not a radical, it can cause serious cell injuries because of the gen-
eration of hydroxyl radicals in the presence of iron or copper. Hydroxyl radicals are a 
highly aggresive factor resulting in the oxidation of cellular macromolecules, and for 
this reason, H2O2 must be quickly detoxified and this is achieved by catalase and vari-
ous peroxidases. If the production of ROS occurs in an excessive amount or in the case 
of unsuccessful detoxification, oxidative stress occurs, these results in serious cell dam-
age, premature aging or even neoplastic transformation (Steiling et al., 1999). ROS is 
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formed in high amounts at the site of the wound as a protection mechanism against in-
vading bacteria (Srinivas et al., 2008). However, the existence of increased numbers of 
neutrophils and ROS overpowers the anti-protease substances that normally defend the 
tissue cells and the extracellular matrix. At high concentrations, ROS can prompt severe 
tissue injury and even cause neoplastic transformation and reduce the healing process 
via damage to the cellular membranes, proteins, DNA, and lipids (Ipek et al., 2012). Ex-
cess ROS results in the killing of fibroblasts, and skin lipids will be less flexible. Be-
cause of this, the general role of antioxidants seems to be significant in the effective 
treatment and management of wounds. Antioxidants diminish the adverse effects of 
wounds through eliminating products of inflammation (Houghton et al., 2005). The 
most probable mechanism for antioxidant defense is the direct interface of the extracts 
or compounds and hydrogen peroxide, instead of changing the cell membranes and con-
trolling damage. Compounds have a high radical scavenging capacity shown to enhance 
wound healing (Ipek et al., 2012). Numerous low molecular weight antioxidants suggest 
regulating the redox environment in skin wound healing. Those involved in the endoge-
nous molecules are glutathione, uric acid and lipoic acid, in addition to compounds 
found in food such as vitamins C and E, carotenoids and phenolic compounds. The use-
ful significance of these antioxidants in wound healing is confirmed by their depletion 
in healing skin wounds (Mackay & Miller, 2003).  
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2.2.4 Role of apoptosis in wound healing  
In the process of wound healing, some probable signals for the expulsion of cells in-
volved in tissue repair have been proposed but the mechanism by which the cells die is 
still required. Emigration, necrosis and apoptosis are three probable mechanisms. Patho-
logical tissue repair, necrosis happens, but for most wounds, healing proceeds without 
an exaggerated inflammatory response to tissue injury. Tissue inflammation is obvious-
ly induced by necrosis and so the mechanism that reduces wounds cellularity is possibly 
not controlled by necrosis (Greenhalgh, 1998). There is little evidence to support cellu-
lar migration away from the wound, which would be wasteful of energy and inefficient. 
Apoptosis is a reasonable mechanism for the diminishing number of cells throughout 
the healing phases. The elimination of undesirable cells and tissues are commonly via 
apoptosis in a phagocytotic process that does not elicit an inflammatory response. Sub-
sequently, removal of dead tissues and invading pathogens and inflammatory cells 
would be expected to diminish and disappear from the wounded area without inciting 
more inflammation via apoptosis. Similarly, when appropriate deposition of collagen, 
latterly of the proliferative phase, takes place, fibroblasts would begin to be apoptotic. 
Ultimately, after maturation of the wound is completed a slow disappearance of endo-
thelial cells and remaining fibroblasts will take place. There is much evidence of an as-
sociation between apoptosis and the resolution of tissue repair in the wound healing 
process. For example, in one study, during the early phase of tissue repair the inflamma-
tory cells experienced apoptosis as early as 12 hours after wounding (Singer & Clark, 
1999). There was a clear apoptosis in the inflammatory cells localized under the margin 
of the migrating epithelium and immediately next to the wound margin. The granulation 
tissue wrapped with an epithelium had no apoptosis and minimal inflammatory cell in-
filtration, and auxiliary fibroblasts were observed in the open dermal wound, covered by 
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a polyurethane dressing, of non-diabetic and diabetic mice (Darby et al., 1997). In the 
center of the wound, the open granulation tissue was packed with neutrophil, macro-
phage and lymphocyte inflammatory cells. Apoptosis was observed in the altered region 
which was under a location where the lead margin of epithelium had migrated across the 
granulated tissue. This observation confirms the hypothesis that something in the epithe-
lium is responsible for the inhibition of inflammation. These observations are supported 
by clinical findings. Closure of a wound, firstly, or covering with a graft is associated 
with the start of the elimination of inflammatory cells from the wounded tissue 
(Ashcroft et al., 2003; Rodero & Khosrotehrani, 2010). The function of apoptosis in the 
elimination of fibroblasts in the later stages of tissue repair is through reducing cellular 
infiltration throughout the switch between granulated tissue and scar. If the signal re-
sponsible for down-regulation of fibroblast and myofibroblast action is late and after a 
specific time then the apoptotic process is permanently depressed. Excessive fibroblast 
activity is caused by an imponderable between collagen synthesis and degradation lead-
ing to formation of an extreme scar. Until now, the exact mechanisms contributing to 
excessive scar formation are unknown (Desmouliere et al., 1995).  
Happily, apoptosis is the foundation in the control of the perfect neutrophil response 
to injury so that major wounds do no result in unhelpful tissue responses.  After the 
elimination of invading pathogens in the wound tissue, most neutrophils undergo apop-
tosis and are speedily and efficiently phagocytosed through macrophages without elicit-
ing further inflammation (Rodero & Khosrotehrani, 2010). Multiple possible mecha-
nisms of neutrophil apoptosis are postulated and neutrophil apoptosis may be induced 
via the TNF-α signaling pathway (Ohta et al., 1994), interaction of neutrophils with the 
β2 integrins (CD11b/CD18) potentiating the extent of apoptosis  and migration of neu-
trophils by a monolayer of endothelial cells  and  induced apoptosis  (Larsson et al., 
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2000). TGF-β1 has a high likelihood of being implicated in the down-regulation of the 
inflammatory response. Evidence supporting its function in removing inflammatory 
cells comes from TGF-β1 null knockout animals (Desmoulière et al., 1997). The ab-
sence of TGF-β1 expression in mice is characterized by a normal healthy status until 3 
weeks of age when the pups suffer from a deadly inflammatory response categorized by 
invasion of neutrophils, macrophages and lymphocytes into all tissues. Reaction is re-
lated to elevated expression of TNF-α and IL-1β. Repair of tissue in these pups was 
normal throughout the first three weeks due to the knockout animals receiving TGF-β1 
through their mother
’
s milk and was stopped in the period of weaning when the animals 
became ill from inflammatory cell invasion (Sporn & Roberts, 1992).   
The antiproliferative protein p53 is also included in the apoptosis of inflammatory 
cells during the healing process (Fuchs & Steller, 2011). The control of keratinocyte 
apoptosis has attracted more interest in dermatological diseases. Exposure of keratino-
cytes to ultraviolet light (sunburn) leads to rapid induction of cell apoptosis (Raskin, 
1997). Eighteen member proteins of the BCL2 family have been discovered, which are 
effectors of the apoptosis pathway. The BCL2 family proteins either promote or prohibit 
apoptosis. The pro-apoptotic proteins include BAX, Bad and Bak, while BCL2 and 
BCL-xL are anti-apoptotic proteins. The lack of basement membrane connection is as-
sociated with a decrease in BCL-xL expression and induction of apoptosis. Similarly, 
EGF receptor blockage has been associated with apoptosis and reduced BCL-xL expres-
sion (Rai et al., 2005). Penal et al. looked at the function of BCL-xL, which keeps down 
apoptosis and BCL-xS, which stimulates apoptosis in transgenic mice. They found that 
over-expression of BCL-xL or BCL-xS in mice shows that the keratinocytes have a 
normal appearring epidermis. Post ultraviolet light irradiation, mice with BCL-xL over-
expression had mounting resistance to damage while those with BCL-xS over expres-
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sion had mounting sensitivity. Disparate pathways for keratinocyte apoptosis in injury 
and in response to normal differentiation have been proposed (Pena et al., 1997).  
A decline in p53 levels in keratinocyte by siRNA treatment improved, instead of re-
duced, apoptosis responses to interferon- alpha and interferon-gamma. Results show  
over exposure of the  human keratinocyte cell line to interferon-stimulated apoptotic. 
The mechanism for this boosted apoptosis complicates the stimulation of TRAIL and its 
interaction with death receptors, as obstructing the death receptor pathway using domi-
nant negative FADD or by the addition of neutralizing antibody versus TRAIL, de-
creases  the apoptosis response to IFN-α and IFN-γ (Chaturvedi et al., 2006).  
The range of hypertrophic or keloid scarring is decreased by interferon and IFN-γ 
initiates to diminish the range of keloid formation (Durani & Bayat, 2008; Granstein et 
al., 1990). Systemic treatment of burn patients using IFN-α2b was initiated to decrease 
hypertrophic scar creation (Harrop et al., 1995). Elevated TGF-β serum levels were 
found in patients that tended to have hypertrophic scars (Schmid et al., 1998). This sug-
gests that fibroblast activity is regulated by an interface between interferon and TGF-β 
in a maturing wound. Collagen degradation is also regulated by apoptosis signals via 
induced collagenase action. Bian and Sun commented that p53 binds to the promoter of 
human type IV collagenase (matrix metalloproteinase 2) (Bian & Sun, 1997). They pro-
posed that apoptosis signals are implicated in the down-regulation of collagen deposi-
tion by both diminishing fibroblast numbers (thus decreasing collagen synthesis) and by 
stimulating collagenase activity. A previous study on the effects of recombinant human 
TNF-α on collagen production and gene expression in cultured fibroblasts  proved that 
TNF-α reduction transcription of the collagen gene, expression of collagen mRNA lev-
els and collagen production in cultured fibroblasts (Solis-Herruzo et al., 1988).  
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Cellularity and the extracellular matrix in granulation tissue found in the late phase 
of wound healing decreases to produce a mature scar. It has been proposed that apopto-
sis is a mechanism facilitating the conversion from granulation tissue to scar. Nakazo-
no-Kusaba, et al. investigated the influence of benzoyl staurosporine, a protein kinase C 
inhibitor on human keloid derived fibroblasts to study if this agent is capable in the 
treatment of keloid formation. The results show that benzoyl staurosporine could be a 
candidate for antitumor factors by prompting keloid fibroblast apoptosis throughout 
caspase dependent pathway (Nakazono-Kusaba et al., 2004). 
In conclusion, apoptosis plays a critical role in the synchronization of the rapidly al-
tering residents of cells, which are implicated in the healing of all tissues. In massive 
common of wounds, control of proliferation causes an accelerated closure of the wound. 
Sometimes balancing increasing and decreasing cellular numbers forfeits the balance 
and leads to pathologic tissue repair.  
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2.3 Immunomodulatory 
The immune system is a remarkably developed defense system inside vertebrates 
which guards against attacking factors. It is capable of producing diverse molecules and 
cells able to distinguish and reduce unlimited changes from external and unwanted 
agents. Modulation of the immune system refers to some alteration in the immune re-
sponse which includes stimulation, amplification, expression or inactivation of some 
stage of the immune response. Therefore, an immunomodulator is a material used to 
have an effect on the immune system. There are commonly two kinds of immunomodu-
lator depending on their influence: immunostimulators and immunosuppresses (Saroj et 
al., 2012). Materials, which show a modifying immune system response to a threat, are 
immunomodulators. They modulate and arm the immune system by keeping them in a 
highly prepared state against any threat (Mishra et al., 2008). In different parts of the 
world, plant extracts have been widely investigated for their possibile use for immuno-
modulation. Many studies have demonstrated isolation of the potential bioactive mole-
cule (Alamgir & Uddin, 2010). For example, Acorus calamus a rhizome extract exhibit-
ed growth of many cell lines for humans and mice. It could also inhibit the formation of 
interleukin-2 (IL-2), nitric oxide (NO) and tumor necrosis factor-α (TNF-α). In addition, 
it causes down-regulation expression of the CD25 marker (Mehrotra et al., 2003) and 
many other plant derived compounds like sterols, sterolins, polysaccharides, alkaloids, 
flavonoids, lectin and glycoprotein are used for immunomodulation (Kolm et al., 2007; 
Lien et al., 2003).  
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2.3.1  Immunomodulatory dietary 
There are many ways immunomodulation resists a huge range of human and animal 
diseases such as cancers, viral diseases, inflammatory conditions and autoimmune dis-
eases. Living and non-living factors surrounding us interact with the immune system. A 
diet should be balanced with its components coming from vitamins, trace minerals and 
energy. All these have a critical effect on the immune system, starting from their active 
role in developing immunity, therefore any deficiency predominantly ends in disease. 
Both living and non-living factors are able to work as immunomodulators. The living 
factors include many infectious agents such as different plants, parasites, protozoa, fun-
gi, bacteria and viruses, whereas non-living factors include microparticles and food ad-
ditives such as titanium dioxide and aluminium silicate. Other non-living factors which 
co-contribute to the immune system response are environmental factors like air, temper-
ature, radiation, water, pressure, food and toxins (Mahima et al., 2013).   
Microparticles are small, non-biological particles that are used in numerous areas of 
daily life as food additives. The most common food-derived ingested compounds are 
titanium dioxide and aluminium silicate. Titanium dioxide is a white pigment used in 
sugar toppings or toothpaste. Becker et al. (2013) proved that macrophage-like cells eas-
ily take up titanium dioxide after a 6 h incubation period with titanium dioxide resulting 
in the assembly of caspase-1 and increased secretion of IL-1β. In intestinal epithelial 
cells, titanium dioxide microparticles may be swallowed by macrophages and intestinal 
epithelial cells and induce IL-1β and IL-18 secretion. This may trigger inflammation in 
susceptible individuals (Becker et al., 2013). Wischke et al, showed the effect of special 
carriers from poly rac-lactide-co-glucolide to particulate which is to prompt a dose de-
pendent maturing of human monocyte derived dendritic cells to a proinflammatory phe-
notype with a high level of released cytokines (Wischke et al., 2012). Pre- pro- and syn-
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biotics enhance innate immunity. Several plant fibers (prebiotics) have recognized sig-
nificant effects, which are to increase the function of the innate immune system and the 
physical barrier in order to increase resistance to disease (Bengmark, 2012).  
The food that we eat is fundamentally composed of proteins, carbohydrates, fats, 
minerals and vitamins. A suitable integration of these materials is essential to preserve 
the health of humans. Fats have a potential role in manipulating the immune response. 
Fatty acids in the metabolism process are changed to powerful biological mediators, 
which play a crucial role as immunomodulators. For example, linoleic acid converts in 
the individual body to arachidonic acid in the plasma membrane of the immune cell and 
produces leukotrines and prostaglandins, which have an important role during inflam-
mation (Calder & Grimble, 2002).  
Proteins are an essential source of amino acids, important in building cells, and have a 
critical role in the immune system. Antibodies are proteins in origin, arginine is im-
portant in the activation of myeloid cells and includes many different cellular types, 
from polymorphonuclear to monocytes/macrophages (Peranzoni et al., 2008). In one 
study, arginine and glutamine were given as supplementation to a macrophage culture 
media and, the results showed that this enhanced macrophage phagocytosis and killing 
ability and proliferation of T- and B-lymphocytes significantly. These results suggest 
that in vitro, arginine and glutamine are essential substrates and immunomodulators of 
both innate and adaptive immunity responses in fish leukocytes (Pohlenz et al., 2012). 
Vitamins are crucial for the normal body
’
s defense system through their various roles in 
the immune system. Vitamin A, B, C, D and E have been proven in previous studies to 
be  important in improving both the innate and adaptive immune response (Mahima et 
al., 2013). Minerals like vitamins have a main function in the modulation of the immune 
response. A deficiency of copper cause decreases in interleukin2 and T cell proliferation 
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(Percival, 1998). Selenium deficiency in the diet results in the reduction of macrophage 
stimulation (Ren et al., 2012). In conclusion, immunity is the defense system of the 
body. Its optimum function depends on essential factors which can be supplemented by 
diet and the balance between these factors are important to maintain an optimal function 
of the immune system.  
2.3.2   Recent improvements on the ethnomedicinal plants as immunomodulatory 
agents 
Modulation of the immune response to reduce diseases has long then been of interest 
and there have been many studies  on  ethnomedicinal plants as immunomodulatory 
agents. Immunopharmacology is a relatively innovative and developed branch of phar-
macology which aims to search for immunomodulators. The possible uses of immuno-
modulators in clinical medicine include reconstruction of immune deficiency, for exam-
ple, in the treatment of AIDS and suppression of normal or exaggerated immune roles 
as in the treatment of autoimmune diseases. An important source of immunomodulators 
is medicinal plants and their active components. Therefore, the improvement of drugs 
for immunomodulation and anti-tumor potential from natural compounds is an interest-
ing project (Alamgir & Uddin, 2010).   
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2.3.2.1 Immunomodulatory activity of crude plant extracts 
Previous studies have demonstrated that many of the plant crude extracts have im-
munomodulatory activity. Ethanol extract of the Acorus calamus rhizome has immuno-
suppressive potential in vitro. It  inhibites proliferation and encourages human peripher-
al blood mononuclear cells (PBMCs) to produce  interleukin-2, TNF-α, IFN-γ, nitric 
oxide and expression of cell surface markers CD16 (Mehrotra et al., 2003).  
Crude extract of Tinospora cordifolia produces a polyclonal B cell mitogen that im-
proves immune response in mice. Arabinogalactan polysaccharide isolated from the 
stem of T. cordifolia was tested to modulate induction of immunosuppression. Mice 
pre-treated with arabinogalactan polysaccharide showed protection against lipopolysac-
charide (LPS) prompted mortality and increased serum inteleukin-1β, interleukin -6, 
IFN-γ levels and decreased serum in  inteleukin-10 compared to the controls (Desai et 
al., 2007). Other studies  investigated the effect of  polysaccharide isolated from T. cor-
difolia on phenotypic and functional maturation of murine bone marrow derived den-
dritic cells. Results showed enhancement of surface expression of CD80, CD40, CD86 
and MHCII on derived dendritic cells and stimulated T cells for the secretion of TNF-α 
and interleukin-12 (Pandey et al., 2012). Ethanol extract of Boerhaavia diffusa, a plant 
used in Indian traditional medicine, significantly suppressed human NK cell cytotoxici-
ty in vitro and inhibited production of nitric oxide in mouse macrophage cells, interleu-
kin- 2 and TNF-α in human PBMCs. The results  demonstrated the  immunosuppressive 
potential of ethanol extract of B. diffusa (Mehrotra et al., 2002). 
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2.3.2.2   Immunomodulatory activity of plant derived compounds 
The β-sitosterol, phytosterols, and its glucoside, were investigated in vitro. There was 
an enhanced proliferative response of T-cells activated by sub-optimal concentrations of 
phytohaemagglutinin which significantly improved the expression of CD25 and in-
creased the secretion of interleukin-2 and TNF-γ (Bouic et al., 1996). Although most 
studies have focused on the effect of phytosterols on cholesterol-lowering activity one 
study on phytosterols showed a modulatory effect on the T-helper immune response in 
vivo using a mouse model which caused increased interleukine-2 and IFN-γ secretion 
(Calpe-Berdiel et al., 2007).  
Polysaccharides from plants have prompted researchers to study their physical prop-
erties and industrial uses depending on their properties. Over the past 20 years there has 
been an increase of interest in the biological activity of biomolecules that has led to new 
sources of bioactive plant polysaccharides (Smestad, 2001). Botanical polysaccharides 
exhibit a number of advantageous therapeutic properties, and it is assumed that the 
mechanisms implicated in these effects are through the modulation of innate immunity 
and more specifically macrophage function. Moreover, botanical and microbial poly-
saccharides react with common surface receptors and stimulate similar immunomodula-
tory responses in macrophages; this suggests that evolutionarily covered polysaccharide 
structural properties are collaborating with these organisms. Thus, the development of 
botanical polysaccharides provides a unique chance for the discovery of new therapeutic 
agents and adjuvants that exhibit advantageous immunomodulatory properties 
(Schepetkin & Quinn, 2006). 
 Lee et al investigated the immunostimulatory activity of polysaccharides from 
Cheonggukjang in RAW264.7 macrophage cells and in an animal model. The results 
showed that Cheonggukjang polysaccharides stimulate mRNA expressions of inducible 
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nitric oxide synthase and TNF-α. These results suggested that the Cheonggukjang poly-
saccharide has a potential function in promoting immunity through its regulatory effects 
on immunological parameters, nitric oxide, TNF-α productions and alterations in indica-
tors related to stress (Lee et al., 2013). 
The polysaccharides from peduncles of Hovenia dulcis and their bioactivity potential 
was studied in vitro for immunostimulatory activity. Analysis revealed that they could 
significantly induce the proliferation of splenocytes and encourage phagocytosis and the 
nitric oxide production activity of peritoneal macrophages. These results suggest that 
polysaccharides have effective immunostimulatory activity and could be explored as  
potential natural immunomodulatory agents (Wang et al., 2012a). Other studies have 
proved that the in vivo immunostimulatory activity of polysaccharide from Cipangopal-
udina chinensis could signiﬁcantly increase the spleen and thymus signals and enhance 
the macrophage function. These findings suggest that polysaccharides have a potential 
immunostimulatory activity and could prove to be potential natural immunomodulatory 
agents (Xiong et al., 2013). A polysaccharide-enriched fraction isolated from Curcuma 
longa exhibited stimulatory effects on PBMC proliferation and cytokine production 
(Yue et al., 2010). 
Alkaloids and flavonoids are the main components in  plants. Various studies around 
the world have mentioned the bioactivity of these components and their immunomodu-
latory activity. Berberine, a chief alkaloid constituent of Coptidis rhizoma has an anti- 
inflammatory, antibacterial action, and an antitumor and anti- motility effect. A previ-
ous study investigated the effect Berberine had on the simulation of macrophage 
RAW264.7 cells in LPS stimulation. This alkaloid caused suppression of nitric oxide 
gene expression that resulted in the reduction of nitric oxide protein production. Besides 
the production of PGE2 in LPS stimulated RAW264.7 cells was significantly reduced. 
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while there was increased creation of IL-12 in LPS stimulated RAW264.7 cells macro-
phages (Lee et al., 2003).  
 Tripterygium wilfordii hook f. is one of the traditional Chinese medicines that is 
usually used to treat rheumatoid arthritis. The total alkaloids are the constituent part of 
T. wilfordii hook f.  Zhang et al studied the effects of  the total alkaloids of T. wilfordii 
hook f. used to inhibit the symptom of type II collagen induced arthritis in wistar rats. It 
was found that the alkaloids could signiﬁcantly inhibit the symptoms of type II collagen 
induced arthritis and reduce the production of IL-6, IL-8 and TNF-α in serum and the 
expression of IL-6, IL-8, nuclear factor kappa β (NF-kβ) and TNF-α in synovial tissue, 
thus targeting the inflammation. These results show that alkaloids could be used as a 
novel botanical drug for the treatment of rheumatoid arthritis (Zhang et al., 2013b).  
Flavonoids are polyphenols regularly taken in the diet and have been suggested to 
perform a number of helpful activities for human health including anti-inflammatory 
activities. López-Posadas et al. selected nine flavonoids to distinguish their effects on 
leukocyte viability, proliferation, expression of cyclooxygenease 2,  inducible nitric ox-
ide synthase and proinflammatory cytokines (TNF-α, INF-γ and IL-2). Inducible nitric 
oxide synthase was inhibited largely by several flavonoids, especially luteolin, quercetin 
and apigenin, while cell viability was promoted by kaempferol, chrysin, daidzein and 
hesperetin. All flavonoids had powerful antiproliferative effects. These results show that 
falvonoids have a powerful effect on lymphocytes (López-Posadas et al., 2008). Propo-
lis flavone could significantly stimulate lymphocyte proliferation, improve antibody ti-
ter and the concentrations of IgM and IgG and significantly increase the immune organ 
indexes and increase concentrations of IL-2 and IL-6 in serum (Fan et al., 2013).  
  In conclusion, immunomodulation using medicinal plants could supply alternate pre-
dictable chemotherapy for different diseases, particularly once there is a weakened im-
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mune response and when discriminatory immunosuppression happens, as in the case of 
autoimmune syndromes. There is intense activity to detect additional particular im-
munomodulators that imitate or antagonize the biological properties of interleukins and 
cytokines. Improvement of evaluation of these mediators will create sensitive and spe-
cific screenss. We should reconsider natural medications that could be important 
sources of innovative ligands capable of directing specific cellular receptors.  
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2.4  Medicinal plants  
Throughout history, plants have supplied humans with a source of food, perfume, 
dyes, gum, fiber, resin and many other useful products. Nowadays, ethno pharmacolo-
gists are paying more attention to investigating the bioactive properties and phytochem-
ical analysis of medicinal plants to treat a variety of diseases. Numerous medicinal 
plants have significant therapeutic functions and could be used as natural medicine 
sources for the treatment of a variety of diseases (Gupta & Sharma, 2006). Recently, 
many researchers have endorsed a traditional belief in utilizing medicinal plants to treat 
a variety of diseases including gastric ulcer. Many studies have reported that plants offer 
various significant bioactivities (Alama et al., 2009; Yadav et al., 2011).  
Phaleria macrocarpa and Tinospora crispa are traditional drugs that are used in the 
treatment of inflammation, cancer and diabetes (Hendra et al., 2011a; Ihsan et al., 
2011). In this work, we have used P. macrocarpa fruit and T. crispa stem extracts to 
investigate the toxicity of the plants and to investigate their ability in gastro protective, 
wound healing and their immunomodulatory potential. 
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2.4.1  Phaleria macrocarpa  
2.4.1.1   Taxonomy and systematics in plants  
Kingdom: Plantae  
Division: Spermatophyta  
Sub division: Angiospermae  
Class: Dicotyledoneae  
Order: Thymelaeales  
Family: Thymelaceae  
Genus: Phaleria 
Species: Phaleria macrocarpa (Scheff) Boerl 
There are many different names for the plant;   ‘crown god’ and P. papuana in an ar-
ea known as the Malay simalakama, while in Java, it is known as mahkuta dewa, 
mahkuto mewo, mahkuto ratu and mahkuto rojo (Susilawati et al., 2012). Its original 
habitat is  New Guinea and Papua Island, Indonesia and other tropical areas. P. macro-
carpa grows throughout the year in tropical areas reaching a height of 1-6 meters. It is a 
complete tree (stem, leaves, root, flower and fruit) and the fruit shape is eclipse with a 
diameter of around 3cm. The color of the fruit is green before ripening and red when 
fully ripe (Figure 2.6) (Hendra et al., 2011b).  
          Figure 2.6: Phaleria macrocarpa ripe fruit.  
       Cited by: http://id.wikipedia.org/wiki/Mahkota_dewa  
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2.4.2 Tinospora crispa  
2.4.2.1 Taxonomy and systematics in plants  
Kindom: Plantae  
Division: Magnoliophyta  
Class: Magnoliopsida  
Order: Ranunculales  
Family: Menispermaceae  
Genus: Tinospora  
Species: Tinospora crispa  
Tinospora crispa is known by various vernacular names such as akar seruntum, 
Menispermum crispum (Linn.) and Menispermum rimosum (Blanco). Commonly 
known by the Malays as bratawali, andawali and putrawali or akar patawali. T. crispa 
is an indigenous plant and can be found distributed from the southwestern part of China 
to the southeast of Asia including Malaysia. It is a climber plant and can be found in 
tropical and subtropical India, parts of the Far East and in primary rainforests or mixed 
deciduous forests. The plant is woody with a shiny green leaf (Figure 2.7) and is widely 
distributed throughout Indonesia, Malaysia, Thailand and Vietnam (Dweck & Cavin, 
2006). 
          
            Figure 2.7: Tinospora crispa stem and leaves. 
               Cited by: http://home.hiroshima-u.ac.jp/shoyaku/Wam2003.html 
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2.4.3  Ethnopharmacology  
Ethnopharmacological evidence shows numerous uses of P. macrocarpa and T. 
crispa by humans. The main purpose of these plants is as a source of food additives and 
as a natural source of medicinal agents. (Mohammed et al., 2012). A wide variety of 
secondary metabolites such as tannins, terpenoids, alkaloids, flavonoids, fatty acid, car-
bohydrate, benzophenone glycosides and steroids are rich in these plants, which have 
also been screened in vitro, and the indicated antioxidant, anti-inflammatory and anti-
microbial properties are used to develop drugs or dietary supplements (Simanjuntak, 
2008; Yosie et al., 2011 ).  
2.4.3.1 Ethnopharmacology of Phaleria macrocarpa 
Several studies have investigated the ethnopharmacology usage of both P. macro-
carpa as a crude extract or through isolated fraction and active compounds from various 
parts of the plant. Chong et al., 2011 investigated, both in vivo and in vitro, the effects 
of P. macrocarpa fruit on the control of body weight and the systematic basis of its an-
tihypercholesterolemic effect. P. macrocarpa extract significantly reduced body weight 
gain, triglycerides, total cholesterol and up-regulated the hepatic LDL receptor as well 
as PCSK9 proteins in hypercholesterolemia rats. These results were confirmed by test-
ing the effect of P. macrocarpa extract on HepG2 cells.  The extract also significantly 
up-regulated both PCSK9 at the mRNA and protein level and the LDL receptor. This 
study proved the potential usage of P. macrocarpa fruit for regulating body weight of 
obese people and treating hypercholesterolemia. P. macrocarpa fruits have various 
amounts of total phenolic and flavonoid compounds. In the study, different parts of the 
fruit of P. macrocarpa (pericarp, mesocarp and seed) showed high antioxidant, anti-
inflammatory and cytotoxic activities (Hendra et al., 2011a). Administration of P. mac-
rocarpa fruit extract to Sprague Dawley rats for 7 days significantly reduced blood 
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pressure (Yanti & Ringoringo, 2010). There has been much research on P. macrocarpa 
for its anticancer activity. The P. macrocarpa seed has been used experimentally for 
treating cancer. The ethanol extract of the P. macrocarpa seed has been shown to inhibit 
the proliferative breast cancer cell line T47D (Bakhriansyah, 2012). P. macrocarpa bark 
extract has an anti-proliferative effect against human cancer cell lines Hela, Thp-1, Hut-
78 and A-549 (Winarno, 2012). P. macrocarpa fruit extract has been used to treat C3H 
mice with breast cancer (Riwanto et al., 2011). Methanol extraction of P.macrocarpa 
fruits has anticancer activity against myeloma cell culture (Kurnijasanti et al., 2008). 
P. macrocarpa fruit extract can reduce hyperglycemia in both in vitro and in vivo sit-
uations by effectively inhibiting carbohydrate-hydrolyzing enzymes. This finding pro-
poses P. macrocarpa as a natural source for the management of type II diabetes mellitus 
(Ali et al., 2013). Pulp extraction of P. macrocarpa can stimulate the proliferation of B 
cells isolated from the Langerhans pancreas of the rat and decreases blood glucose lev-
els (Arjadi & Susatyo, 2010). 
Benzophenone glucoside was isolated from the P. macrocarpa bark ethyl acetate ex-
tract and was proven to have inhibitory activity against the leukemia L1210 cell line 
(Winarno & Ermin, 2010). A benzophenone aglucon 2,6,4 '-trihydroxy-4-
Methoxybenzophenon isolated from ethyl acetate extract of P. macrocarpa leaves 
showed strong antioxidant activity on DPPH (Susilawati et al., 2011; Tambunan & 
Simanjuntak, 2006). 
Md Othman et al. investigated the cytotoxic potential of two benzophenone com-
pound derivatives from ethyl acetate extract of  P. macrocarpa fruits, identified as 
2,6,4'-trihydroxy-4-methoxybenzophenone (compound1) and 6,4'-dihydroxy-4-
methoxybenzophenone-2-O-β-D-glucopyranoside (compound 2). The cytotoxic activi-
ties of these compounds were tested on the mouse embryonic fibroblast cell line (3T3) 
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and human cervical carcinoma cell line (HeLa). The results showed that benzophenone 
compound 1 revealed low cytotoxic effects against 3T3 cell and HeLa lines, while ben-
zophenone compound 2 was nontoxic against 3T3 cell and HeLa lines (Md Othman et 
al., 2013). Gallic acid, a natural antioxidant was isolated from fruits of P.macrocarpa 
and its effect demonstrated on the inhibition of cell proliferation in cancer cell lines. 
The results showed that gallic acid could induce apoptosis in esophageal cancer cells 
(TE-2), promote apoptosis through up-regulating the pro-apoptosis BAX protein  and 
inducing caspase-cascade activity in cancer cells (Faried et al., 2007).  
Hendra et al., 2011b isolated and identified flavonoid compounds from P. macrocar-
pa. The results showed that myricetin, kaempferol, rutin and naringin were the main 
flavonoids existing in the pericarp, while quercetin and naringin existed in the mesocarp 
and seed. Furthermore, the study investigated the antibacterial activity of various parts 
of the P. macrocarpa fruit and showed a weak ability to moderate antibacterial potential 
against pathogenic tested bacteria, while antifungal activity was only present in the seed 
extract against Aspergillus niger. P. macrocarpa fruit could be considered a natural an-
timicrobial source because of the existence of flavonoid compounds. DLBS1425a com-
pound isolated from an extract of Phaleria macrocarpa was investigated for its effect 
on the breast cancer cell line (MDA-MB-231). DLBS1425 revealed inhibition of prolif-
eration, migration and expansion potential of MDA-MB231 by significantly encourag-
ing proapoptosis genes BAX and Bad thus inducing cellular death signals by activating 
caspase-9 and promoting DNA fragmentation. These results suggest that DLBS1425 has 
potential as an anticancer agent (Tandrasasmita et al., 2010). 
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2.4.3.2 Ethnopharmacology of Tinospora crispa 
The genus of the Tinospora plant has been known as a traditional medicine in South-
east Asian countries. Tinospora has long been used in India as a medication and in the 
preparation of a starch known as gilae-ka-sat or as palo. It is a tonic, a diuretic and an 
antiperiodic. Tinospora crispa, which is abundant in the Philippines, is widely used by 
the population  under the name of makabuhany, which means "You may live". It is used 
as an antidote and is especially valuable in general weakness, malarial fevers and chron-
ic rheumatism. The whole plant contains the bitter principle colombine, alkaloids, fla-
vonoids and glucoside (Dweck & Cavin, 2006). 
A previous study was done to evaluate the nutritional components and mineral con-
tent of the stem of T. crispa. Results revealed that T. crispa contains a high moisture 
content of around 77.9%, carbohydrate content 19.4%, while the percentages of fat, pro-
tein, fiber and ash are low. The most abundant elements are calcium and potassium and 
other trace elements such as silicon, magnesium, chlorine and phosphorus are very low. 
The results also demonstrated that T. crispa extract has a high antioxidant property. This 
result was confirmed by the existence of phenolic and flavonoids in the extract as cate-
chin, luteolin, morin and rutin, which are responsible for the high antioxidant activity.  
Outcomes from this study suggested that T. crispa could be an important source of nu-
trients and natural antioxidant (Amom et al., 2009). The variety in the chemical compo-
nents of T. crispa make this plant useful in the treatment of different diseases and many 
studies have proved the benefits of T. crispa stem extract as an anti-parasite. T. crispa 
stem extract has been used in vivo as an antimalarial agent (Rungruang & Boonmars, 
2009; Vigneron et al., 2005). T. crispa stem extract has been tested in vitro as an antifi-
larial activity against adult worms of Brugia malayi (Zaridah et al., 2001). Isolated alka-
loids from T. crispa stem fraction have been shown to possess in vitro anti-parasitic ac-
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tivity against Toxoplasm gondii (Lee et al., 2012). This plant has been testes as an an-
tinociceptive and an anti-inflammatory in various animal models (Sulaiman et al., 2008) 
and has been shown to have an inhibitory effect on edema formation in footpad injury 
that has been induced by carrageenan in rats (Higashino et al., 1992). The antioxidant 
properties of T. crispa stem extract could be used in the treatment of diseases resulting 
from the oxidative stress of cardiovascular disease (Ihsan er al., 2011). Various parts of 
the plant have been subjected to the study of antimicrobial activity.  One study was per-
formed to determine the in vitro antimicrobial ability of ethanol, methanol, distilled wa-
ter and chloroform crude extract of T. crispa root. The results showed all the different 
extracts had antimicrobial activity against gram-negative bacterial strains of Escherichia 
coli, gram-positive bacterial strains of Streptococcus pneumonia, and fungal strains of 
Candida albicans (Mohammed et al., 2012). Another study evaluated the biological ac-
tivities of the stem bark T. crispa in different solvent extractions (methanol, petroleum 
ether, carbon tetrachloride, chloroform and aqueous). All extracts were subjected to an-
timicrobial screening against gram positive and gram-negative organisms and antioxi-
dant screening by DPPH free radical scavenging activity. The results showed strong an-
tioxidant activity, compared with ascorbic acid and butylated hydroxytoluene (BHT), as 
well as antibacterial activity (Aminul et al., 2011). Stem ethanol extract of T. crispa has 
an effect against Methicillin-resistant Staphylococcus aureus (Al-alusi et al., 2010). T. 
crispa has been traditionally known as an anticancer drug, thus many studies have sub-
jected this plant to investigations of anticancer activity. T. crispa has a dose-dependent 
anti-proliferative activity against cancer cells MDA-MB-231, HeLa and human mam-
mary cancer cells (MCF-7) (Ibahim et al., 2011). The aqueous crude extract of T. crispa 
stem has anti-proliferative activity against the MCF-7 cell line (Amom et al., 2008).  
The influences and mechanisms of the T. crispa extract on blood pressure and a heart 
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disease has been thoroughly studied. Crude extract and active compounds (salsolinol, 
higenamine, tyramine, adenosine and uridine) of T. crispa stem show a positive ino-
tropic impact on the electrical field. It excited the isolated left atria by affecting either 
the adrenergic receptors to increase the force of the atrial contraction or directly through 
encouraging the release of acetylcholine and the purinergic pathways causing negative 
inotropic effectiveness on the isolated left atria (Praman et al., 2013). 
Kongkathip et al. isolated two compound triterpenes from the stems of T. crispa,  cy-
cloeucalenol and cycloeucalenone, and investigated their effect on cardiac contractility. 
They found that cycloeucalenol increased the right atrial force of contraction, whereas it 
showed a preliminary decrease followed by a continued reduction of about 10% in the 
left atria of the rat in vitro. Cycloeucalenone exhibited a small alteration in the control 
of the right and left atrial force. These results propose that cycloeucalenol and cycloeu-
calenone create slight cardiotonic effects (Kongkathip et al., 2002). N-butanol extract 
from the stems of T. crispa extract was subjected to a study on its effectiveness on 
blood pressure and heart rate in rats, and then the four compounds in the extract (epi-
nephrine, tyramine, hordenine, and pseudoephedrine) were identified using the HPLC 
method. These results suggest that T. crispa extract has at least three different cardio-
vascular active components that work directly via B2 – adrenergic receptors to decrease 
blood pressure (Praman et al., 2011). T. crispa stem aqueous extract supplementation in 
a hypercholesterolemia-induced rabbit showed a reduction in triglycerides, total choles-
terol and low-density lipoprotein levels, besides decreasing the value of the atheroscle-
rotic index in a T. crispa treated group compared to the hypercholesterolemia control 
group. T. crispa can be included as one of the therapeutic agents that can be a hypocho-
lesterolemic drug and prevent atherosclerosis (Amom et al., 2011).  
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T. crispa aqueous and methanol extracts prevent the oxidative stress and inflamma-
tion induced by hydrogen peroxide and TNF-α that causes damage to the human umbili-
cal vein endothelial cells, through its effect on inducing antioxidant enzymes CAT, 
SOD and GPx activity (Kamarazaman et al., 2012). 
In Malaysia, an aqueous extract of T. crispa stems is taken orally for treatment of di-
abetes mellitus. A study was done using normal and alloxan diabetic rats to evaluate the 
hypoglycemic potential of the extract. After two weeks treatment with the extract there 
was an improvement in glucose levels. Furthermore, acute intravenous treatment with 
the extract caused an increase in plasma insulin levels. These findings support the tradi-
tional belief that T. crispa extract could improve diabetic conditions by improving pan-
creendocrine function (Noor & Ashcroft, 1989). Many previous studies have shown that 
the antihyperglycemic properties of T. crispa have an effect on intestinal glucose ab-
sorption and glucose uptake into adipocytes (Noor & Ashcroft, 1998). The effect of T. 
crispa  on serum glucose and insulin levels in healthy individuals and patients with type 
II diabetes mellitus has been investigated (Klangjareonchai & Roongpisuthipong, 2011). 
Other studies investigated the effectiveness of T. crispa aqueous extract on glucose 
transport action in the skeletal muscle cell line. The results showed that T. crispa aque-
ous extract enhances glucose transport through an insulin independent pathway in a time 
and dose dependent manner (Noipha et al., 2010). Ruan et al. explored hypoglycemic 
activity in mice for active compounds, borapetosides A, B and C, isolated from the eth-
anol extract of the T. crispa stem. The results showed hypoglycemic effects through 
both the insulin dependent and the insulin independent pathways with an increase in the 
glucose consumption in peripheral tissue, reducing hepatic gluconeogenesis and stimu-
lating the insulin-signaling pathway (Ruan et al., 2012; Ruan et al., 2013).  
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CHAPTER THREE 
3   METHODS 
3.1 Plants collection and extraction 
3.1.1 Plant collection 
 Phaleria microcarapa are dried seedless fruits and Tinospora crispa are dried stems 
collected from the Bandar Baru Bangi, Selangor housing area. The two plants were au-
thenticated by Mr. Shamsul Khamis, a botanist at the Institute of Bioscience (IBS), 
University Putra Malaysia (UPM). A voucher specimen (SK1929/11) for Phaleria mi-
crocarapa and (KLU 45568) for Tinospora crispa were preserved in the herbarium of 
IBS, UPM.  
 
3.1.2 Plant extraction 
3.1.2.1  A solid-liquid extraction 
3.1.2.1.1  Theory of test 
In the simplest form of this operation, the extraction material is mixed with an ade-
quate amount of solvent to allow the solvent to immiscible completely with the extract-
ed material to ensure the the total penetration of the solvent and its ablity to dissolve the 
desired components. The solvent and the dissolved transition material were then sepa-
rated from the raw material and the solvent evaporated.  
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3.1.2.1.2 General procedure 
The dried plant was crushed and the powder (100 g) was placed in a conical flask 
and soaked in 900 ml 95% of ethanol for three days at room temperature (30 ± 2 C
o
). 
The suspension was shaken from time to time to allow the powder to dissolve complete-
ly in the ethanol and the color to change to dark brown. The mix was filtered after three 
days using a filter paper (Whitman, 185 mm) and the extract was distilled under reduced 
pressure in a rotary evaporator (Buchi, Switzerland). The extract was maintained at -20 
ºC prior to usage (Trusheva et al., 2007).  
3.2 Antioxidant and free radical study 
3.2.1 Ferric reducing antioxidant power (FRAP) 
3.2.1.1  Theory of test    
The FRAP assay has been used to assess total antioxidant ability in biological fluids, 
such as plasma and plant extract samples. The method is based on the antioxidant ability 
of the sample as a reductant to reduce oxidants present in the reagent.   Through reduc-
tion-oxidation reaction (redox), the colorimetric assay is linked to react with a ferritri 
pyridyl triazine (FeIII-TPTZ) complex at low pH and produces a blue colored ferrous 
tripyridyl triazine (FeII-TPTZ). FeII – TPTZ has an intensive blue color and is detected 
spectrophotometerically at 593nm (Griffina & Bhagooli, 2004).  
3.2.1.2   General procedure  
This method was done by preparing the working FRAP reagent as described below: 
1) The 300 mmol/L acetate (pH 3.6), buffer was prepared by mixing 3.1g of sodium 
acetate trihydrate (C2H3NaO2_3H2O) with 16ml glacial acetic acid/ L of buffer solu-
tion. 
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2) The TPTZ (2,4,6-tripyridyl-s-triazine) solution was prepared by making a solution 
of 10 mmol/L TPTZ in 40 mmol/L HCL.  
3)  20 mmol/L FeCl3x 6 H2O was added  to distilled water.  
4) The three above reagents was mixed in a percentage of 10:1:1 respectively, by 
adding 25ml acetate buffer, 2.5ml TPTZ solution and 2.5ml FeCl3x 6 H2O solution. The 
working solution was freshly prepared. 
5) A prepared standard of known Fe (II) concentrations (FeSO4_7H2O) run in tripli-
cate was used for calibration in several concentrations between (100-1000 µmol/L). 
6) Usage of FRAP reagent as blank. 
150µl of total FRAP reagent was added to each well in a 96-well (300 µl) micro-
plate, 20 µl of sample was then added to each well in triplicate, then after 15 min the 
absorbance was measured at 593 nm. The relative activities of samples were assessed by 
comparing their activities with that of a Fe
+2 
equivalent (Griffina & Bhagooli, 2004). 
3.2.1.3 Calculations 
A standard curve was then plotted (standard concentration versus the average FRAP 
value for each standard concentration). The FRAP values for the samples was then de-
termined using this standard curve.  
3.2.2  Redical scavenging activity test (DPPH)  
3.2.2.1  Theory of the test  
   DPPH is an easy and inexpensive method used to determine the antioxidant activity 
of foods, plants and compounds. In addition, it is used to quantify antioxidants in a 
complex biological system. The liquid and solid samples can  detect their antioxidant 
ability using this method. Finally, the DPPH method is nonspecific for any individual 
antioxidant compound but can be used for any sample which has antioxidant ability. 
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DPPH (2,2-diphenyl-1-picrylhydrazyl) is a stable free radical that can donate hydrogen 
atoms and can be scavenged by any antioxidant compound. When it is dissolved in sol-
vent, it gives a purple color. The color changes to yellow when a single electron of 
DPPH radical is doubled with hydrogen from a free radical scavenging antioxidant to 
form the reduced DPPH form. The color is become more decolonization that indicates 
an increase in the number of electrons captured (Generalic et al., 2011). 
3.2.2.2  General procedure  
The test was done according to the method described by (Chun et al., 2005; 
Generalic et al., 2011). One mg of plant extract was dissolved in 1ml ethanol 95% to 
make a stock solution and then  five dilutions were made from the stock. A standard L-
ascorbic acid was prepared in the same way as the plant extract. Five µl from each dilu-
tion of plant extract and standard were added to 195 µl DPPH and then loaded in the 96-
well plate in triplicate for each sample. Ethanol was used as the blank. The plate was 
incubated at room temperature for 2hrs and the absorbance was read at 517nm.   
3.2.2.3   Calculation  
The antioxidant activity was calculated as DPPH radical scavenging activity (DPPH 
inhibition %) according to the following: 
DPPH inhibition % = [(absorbance blank – absorbance sample)/absorbance blank] 
x100 
A graph was plotted according to the concentration of sample versus the DPPH scav-
enging activity percentage to evaluate the IC50 (the concentration needed to inhibit 50% 
of DPPH radical scavenging activity (Luís et al., 2009; Scherer & Godoy, 2009). 
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3.2.3  Total phenolic content  
3.2.3.1  Theory of the test  
The Folin-Ciocalteu method was used to determine the total phenolic content in the 
P.macrocarpa and T. crispa extract. The test was based on the oxidation-reduction reac-
tion that happens between the Folin-Ciocalteu reagent solution (phosphomolybdic and 
phosphotungstic acid) and the phenolic compounds in the sample. The reagent oxidizes 
ionized phenolic groups that exist in the sample and reduces the acid to form a blue 
complex. The blue color is developed in an alkaline medium reaction that is supplied by 
sodium carbonate, and the measurment of the blue color optical density is done at 765 
nm (Reynaud et al., 2010).  
3.2.3.2   General procedure 
Total phenolic content is determined as described by (Kubola & Siriamornpun, 2008; 
Reynaud et al., 2010). 10µl from extracts prepared at a concentration of 1mg/ml was 
added to 100µl of Folin-Ciocalteu reagent (prepared earlier in a 10-fold dilution with 
deionized water) then mixed well and left for 5 min at room temperature. After that, 
,100 µl from 10% sodium carbonate was added, the mixture was incubated for 2 h at 
room temperature and then the absorbance of optical density was read at 765 nm. Gallic 
acid was used as the standard. 
3.2.3.3  Calculation 
The standard calibration (0-200 mg/ml) curve was plotted using gallic acid, and the 
total phenolic content was expressed as gallic acid equivalent in mg/ g of dry sample or 
mg GAE/ g sample. 
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3.2.4  Estimation of total flavonoids content  
3.2.4.1  Theory of the test  
Flavonoids are polyphenol compounds soluble in water, which are common and 
largely spread in plants as a product of the glycoside process. An aluminum chloride 
colorimetric assay is used for the determination of total flavonoids. The test is per-
formed by the reaction between aluminum chloride and the C4 keto group and either C3 
or C5 hydroxyl group of the flavonoids forms a stable acid complex (Rajanandh & 
Kavitha, 2010). 
3.2.4.2  General procedure 
The aluminum chloride colorimetric method was used  in determining  flavonoids 
performed as described by (Ghasemia et al., 2009; Pourmorad et al., 2006; 
Ramamoorthy & Bono, 2007).  Briefly, the method was fulfilled by mixing 0.5 ml of 
plant extract (1mg/ml), 1.5 ml of methanol, 0.1ml of 10% aluminum chloride, 0.1ml of 
1M potassium acetate and 2.8ml of distilled water. The mixture was then left at room 
temperature for 30 minutes, and  after that the absorbance reaction was read at 415 nm.   
3.2.4.3 Calculation  
A calibration curve was done to calculate  total flavonoids contents. The calibration 
curve was done by preparing a concentration of 0 – 200 mg /ml from quercetin solution 
in methanol. The total flavonoids content was expressed as a quercetin equivalent in 
mg/g of dry sample or mg QE/g sample.  
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3.3 Acute toxicity test  
3.3.1  Theory of the test  
Groups of animals of both sexes are administrated a single dose by the oral route. 
The dose level is chosen on the basis of an expected dose that will produce some toxic 
signs without causing severe toxicity signs or leading to mortality. Any clinical signs 
that are seen or any death would be recorded. The safety of the dose level depends on 
the results, the level of toxicity that occurs and death if it happens (OECD, 2001).   
3.3.2  Animals 
Adult Sprague Dawley rats, both male and female (6-8 weeks old) and weighing be-
tween 160 g to 180 g, were used. These rats were obtained from the Animal House, 
Faculty of Medicine, University of Malaya, Kuala Lumpur (Ethics No. 
PM/07/05/2008/1111MAA (a) (R) in01/November 2011. All rats were housed individu-
ally and maintained under standard conditions of humidity (50-60%), temperature (22 ± 
3°C) and light (12h light: dark cycle) and were fed purina chow diet and water ad libi-
tum. For the experiment, each rat was caged alone and fasted prior to dosing (food, but 
not water, was withheld overnight). 
3.3.3  Acute toxicity test  
There were four groups of 12 adult Sprague Dawley (SD) rats, each group compris-
ing six males and six females. Each rat was caged alone and fasted prior to dosing 
(food, but not water was withheld overnight). The plant extracts were dissolved in 
Tween 20 (5% v/v) and administered at single doses of 50, 500 and 2000 mg/kg weight 
per rat (5 ml/kg). The control group received the same volume of Tween 20 (5% v/v). 
Both treatment and control groups were administered single doses orally via an oral ga-
vage tube. After the plant extract was administered, food was withheld for 3 h to 4 h. 
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Toxicity symptoms and mortality were observed after dosing once during the first 30 
min and recurrently during the first 24h with special concentration on the first 4 h and 
then daily for a total of 14 days. After the 14th day, the animals from each group were 
anesthetized with 0.01 ml/kg xylazine and 0.09 ml/kg ketamine and then sacrificed. 
Blood, liver, and kidney samples were collected for histopathology and clinical bio-
chemistry examinations. A toxicity study was performed as per Organization for Eco-
nomic Co-operation and Development guideline 420 (OECD, 2001).  
3.4 Gastroprotective ability of the plant extract 
3.4.1  Animals  
Healthy Sprague Dawley female rats weighing between (200 g to 250 g) were used.  
The animals were randomly divided into seven groups (six rats/ group) and were ob-
tained from the Animal House, Faculty of Medicine, University of Malaya, Kuala Lum-
pur. The experimental protocol was approved by the animal ethics committee (Ethics 
No. PM28/09/2006/1111MAA (a) (R) in 1/November 2011.  All rats were housed indi-
vidually and maintained under standard conditions of humidity (50-60%), temperature 
(22 ± 3°C) and light (12h light: dark cycle) and fed purina chow diet and water ad libi-
tum. For the experiment, each rat was caged alone and fasted before treating (food 
withdrawn overnight). Throughout the experiment, all criteria for taking care of animals 
provided via the National Academy of Sciences and defined in the “guide for the care 
and use of laboratory animals” were applied (Clark et al., 1997).  
3.4.2  Experimental design  
Dry extract was dissolved in Tween 20 (5% v/v) and was given orally to rats in dos-
ages of 100, 200, 500 and 1000 mg/kg body weight for each plant. Ethanol 95% at 
(5ml/kg) was administered orally to induce gastric ulcer in all groups except the vehicle 
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control group. Omeprazole 20 mg/kg was dissolved in Tween 20 (5% v/v) and the solu-
tion was orally administered to rats (5ml/kg) body weight (Table 3.1). Water was re-
moved 1h before the experiment. For the first group (vehicle control group), the rats 
were administered vehicle Tween 20 (5% v/v) (5 ml/kg). The second group (ulcer con-
trol group), the rats received Tween 20 (5% v/v) (5 ml/kg) and for the third group (ref-
erence drug group), the rats were pretreated with omeprazole solution. For the fourth 
group, the rats were pretreated with 100, 200, 500 and 1000 mg/kg plant extracts. After 
1 h, all rats received 5 ml/kg 95% ethanol orally to induce gastric ulcer (except for the 
first group) and after 1h, the rats were killed and blood and stomach were collected from 
each rat (Abdulla et al., 2010; Salga et al., 2012). 
 
Table 3.1: Gastroprotective activity of plant extracts experimental design.  
Group Name of 
group 
Orally admin-
istration 
Time  Orally administra-
tion 
1 Vehicle control   5ml/kg Tween 20 After one 
hour 
5ml/kg Tween 20 
2 Ulcer control 5ml/kg Tween 20 After one 
hour 
5ml/kg 98% ethanol 
3 Reference drug  20 mg/kg solu-
tion (5ml/kg) 
After one 
hour 
5ml/kg 98% ethanol 
4 Pretreated 
group 
100mg/kg 
100mg/kg solu-
tion (5ml/kg) 
After one 
hour 
5ml/kg 98% ethanol 
5 Pretreated 
group 
200mg/kg 
200mg/kg solu-
tion (5ml/kg) 
After one 
hour 
5ml/kg 98% ethanol 
6 Pretreated 
group 
500mg/kg 
500mg/kg solu-
tion (5ml/kg) 
After one 
hour 
5ml/kg 98% ethanol 
7 Pretreated 
group 
1000mg/kg 
1000mg/kg solu-
tion (5ml/kg) 
After one 
hour 
5ml/kg 98% ethanol 
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3.4.3  Measurement of ulcer index 
The ulcers were located in the gastric mucosa and appeared as a hemorrhagic extend-
ed band of wounds parallel to the extended axis of the stomach. The gastric mucosa ul-
cer was calculated by measuring the sum of all lesion areas for each stomach and calcu-
lating  the ulcer area (UA) equal to the sum of small squares × 4 × 1.8 = UA mm
2
. The 
ulcer inhibition percentage (UI %) was calculated by (Ketuly et al., 2011).   
UI % = [(UA control-UA treated) /UA control] × 100%.                                                                  
3.4.4  Measurement of gastric juice pH  
After the stomach was opened, he gastric juice was collected and measured for gas-
tric juice pH using a digital pH meter (Barros et al., 2007).    
3.4.5  Histology estimation of gastric lesions 
A piece of the glandular portion of the stomach was fixed in 10% formalin and then 
dehydrated by alcohol using ascending grades in the automated tissue processing ma-
chine (Leica Microsystems, Nussloch, Germany) (appendix I).  The processed tissues 
were embedded in paraffin to prepare for sectioning and a microtome (Leica Microsys-
tems, Nussloch, Germany) was used to cut the tissues in 5 µm sections for hematoxy-
lin–eosin staining  according to standard protocols (appendix I)  (Suzuki et al., 2012).   
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3.4.6  Tissue homogenate sample preparations for assessment of prostaglandin E 2 
(PGE2), superoxide dismutase (SOD), catalase (CAT), and malondialdehyde 
(MDA) 
To assess PGE2 (Cayman PGE2 assay ELISA kit; Cat# 400144), SOD (Cayman, 
Cat#. 706002), CAT (Cayman Cat#. 707002) and MDA (Cayman Cat#. 10009055) in 
gastric tissue homogenate, the gastric tissue was weighed, minced and homogenized on 
ice in 5 ml cold PBS buffer using a Teflon homogenizer (Polytron, Heidolph RZR 1, 
Germany). After each piece of stomach tissue was fully homogenized, the mixture was 
centrifuged at 10.000xg for 15 min at 4 °C. Then the supernatant was collected in a ster-
ile tube and kept at (–80 °C) until use. The concentration of protein was performed by 
the Bradford method using bovine serum albumin as a standard (Barford, 1976). The 
assays were performed as per the detailed instructions of the manufacturer (appendix 
II). The sensitivity limit of these assays was ≤ 15.6 pg for PGE2.  
3.4.7 Preparation of blood sample for assessment of serum gastrin, pepsin, TGF-β1 
and TNF-α 
After the rat blood samples were collected in tubes, they were allowed to clot for 30 
min at 25 °C. Then they were centrifuged at 2000xg for 15 min at 4 
o
C using a refriger-
ated centrifuge Rotofix 32 (Hettich Zentrifugen, Germany). The serum was collected 
and preserved at –80 °C until use. Gastrin was measured by an Abnova rat gastrin ELI-
SA kit (Cat#. KA0319 V.01), pepsin by a Cusabio rat pepsin assay ELISA kit (Cat#. 
CSB-E 08920r). TGF-β1 by an ELISA kit (Abnova, Cat#. KA0279; version 4) and rat 
TNF-α by an ELISA kit (Thermo Scientific, Cat#. ER3TNFA). The sensitivity limit of 
these assays were 7.8 pg/ml for TGF-β1, <15 pg/ml for TNF-α, ≤ 78.10 pg for gastrin 
and ≤ 0.8 ng for pepsin. The assays were performed as per the detailed instructions of 
the manufacturer (appendix II). 
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3.5 Determination of gastric wall mucus content  
The gastric mucus contents were determined according to the assay procedures pre-
viously described (Freitas et al., 2011). Adult Sprague Dawley female rats weighing be-
tween 200g to 250g were fasted for 24h. The animals were randomly divided into four 
groups (six rats per group) and water was removed 1h before the experiment. For the 
first group (vehicle control group), the rats were given vehicle Tween 20 (5% v/v) (5 
ml/kg).  The second group (ulcer control group) received Tween 20 (5% v/v) (5 ml/kg). 
The third group (reference drug group) was pretreated with 20 mg/kg omeprazole solu-
tion (5 ml/kg) and the fourth group was pretreated with 250 mg/kg T. crispa stem ex-
tract. For the fifth group, the rats were pretreated with 250mg/kg P.macrocarpa extract. 
After 1 h of pretreatment, all the rats received 5 ml/kg of 95% ethanol orally to induce 
gastric ulcer (except for the first group). After 1h, all the rats were sacrificed by eutha-
nasia and their stomachs were removed. Each glandular part was weighed and sub-
merged into 1% Alcian blue solution (0.16 M sucrose/ 0.05 M sodium acetate, pH 5.8). 
After 2h of immersion, the excess stain was rinsed with 10 ml sucrose at 0.25 M for two 
consecutive washes: the first time for 15 min and the second for 45min. Then the stom-
achs were transmitted to tubes containing 10 ml magnesium chloride at 0.5 M for 30 
min. After 30 min, 4 ml of the mixture was mixed with 4 ml of ethyl ether and then 
shaken for 2 min. The final emulsion was centrifuged for 10 min at 3000 rpm and then 
the supernatant was discarded. The absorbance was read at 598nm and the calculation of 
the amount of Alcian blue was taken as per gram of glandular tissue.  
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3.6 Wound healing ability of plant extract  
3.6.1 Animal  
The animals used were healthy adult Sprague Dawley female rats weighing 250 gram 
to 300 gram and the rats were obtained from the Animal House, Faculty of Medicine, 
University of Malaya, Kuala Lumpur. The experimental protocol was approved by the 
animal ethics committee (Ethics No. PM28/09/2006/1111MAA (a) (R) on 1/November 
2011. All rats were housed individually and maintained under standard conditions of 
humidity (50-60%), temperature (22 ± 3°C) and light (12h light: dark cycle) and fed pu-
rina chow diet and water ad libitum. For the experiment, each rat was caged alone and 
fasted before  treatment (food, but not water, was withdrawn overnight). Throughout the 
experiments, all criteria for taking care of animals provided by the National Academy of 
Sciences and defined in the “guide for the care and use of laboratory animals” are ap-
plied (Clark et al., 1997).   
3.6.2 Experimental design  
The vehicle used during the study was gum acacia dissolved in normal saline with 
ethanol extract.  Two g of gum acacia was dissolved in (100 ml) of normal saline. Ten 
ml of solution was used to dissolve 1 g and 2 g of ethanol extract and each ml of solu-
tion contained 100 mg or 200 mg of extract (Shetty et al., 2008). The adult SD rats were 
randomly divided into six groups, with five rats in each group (Table 3.2). Each rat was 
housed separately. When the animals were anesthetized, their skins were shaved using 
an electrical shaver and they were disinfected with 70% alcohol. A uniform wound area 
2.00 cm in diameter was  excised from the nape of the neck of all the rats using a round 
seal, as described by Morton et al. (Morton & Malone, 1972) . Incision of the muscle 
layer was avoided and skin tension was kept constant during the procedure.  
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 All of the rats were treated twice a day. As mentioned below:  
 The vehicle control group with 0.2 ml gum acacia. 
 The reference drug group with 0.2 ml Intrasite gel. 
 One of the treated groups with 0.2 ml of 100 mg/ml plant extract. 
 The other treated group with 0.2 ml of 200 mg/ml plant extract. 
The contraction of the wound area was measured on 0 day, 5
th
 day, 10
th
 day, and 15
th
 
day. On the 15
th
 day, all of the rats were administered high doses of anesthesia and the 
skin from the healed wound area was excised to obtain homogenate tissue for histo-
pathological examination. Blood samples were also obtained to measure other parame-
ters. 
 
Table 3.2: Wound healing activity of plant extracts experimental design. 
Group  Name of group  Treated  
1 Vehicle control  Gum acacia solution 
2 Intrasite gel  Topical Intrasite gel 
3 Low dose of extract 100mg/kg  
4 High dose of extract  200mg/kg 
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3.6.3  Histological evaluation of wound healing 
A piece of skin from the healed wound area was fixed in 10 % formalin and then de-
hydrated by alcohol in ascending grades in an automated tissue processing machine 
(Leica Microsystems, Nussloch, Germany). The processed tissue was embedded in par-
affin to prepare the tissue for sectioning. A microtome (Leica Microsystems, Nussloch, 
Germany) was used to cut the tissue into sections of 5 µm to prepare for staining with 
hematoxylin–eosin solutions according to standard protocol (appendix I)  (Suzuki et al., 
2012).   
3.6.4  Homogenate tissue sample preparations for superoxide dismutase (SOD), 
catalase (CAT), and MDA assessment 
      To assess SOD (Item No. 706002), CAT (Item No. 707002), and (MDA) (Item No. 
10009055) in the homogenate skin tissue, the skin tissue was weighed, minced, and 
homogenized on ice in 5 ml cold PBS buffer using a Teflon homogenizer (Polytron, 
Heidolph RZR 1, Germany). After each piece of skin tissue was fully homogenized, the 
mixture was centrifuged (refrigerated Rotofix 32 centrifuge, Hettich Zentrifugen, Ger-
many) at 10.000xg for 15 min at 4°C. Then the supernatant was collected in a sterile 
tube and kept at (–80 °C) until use. Concentration of protein was performed by the 
Bradford method using bovine serum albumin as a standard (Barford, 1976). The assays 
were performed as per the detailed instructions of the manufacturer (appendix II). 
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3.6.5  Measurement of TNF-α and TGF-β1 by enzyme – linked immunosorbent 
assay (ELISA)  
The blood samples of the rats were collected in tubes. The blood was allowed to clot 
for 30 min at 25ᵒC, then centrifuged at 2000xg for 15min at 4 ᵒC using refrigerated cen-
trifuge Rotofix 32 (Hettich Zentrifugen, Germany) then the serum was collected and 
preserved at -80ᵒC until use. The measurement of rat TGF-β1 was by ELISA kit (Abno-
va, Cat#. KA0279; version: 04) and rat TNF-α by ELISA kit (Thermo Scientific, Cat# 
.ER3TNFA). The assays were performed as per the detailed instructions of the manufac-
turer (appendix II). The sensitivity limit of these assays was TGF-β1 is 7.8 pg/ml and 
<15pg/ml for TNF-α.   
3.7 BAX and BCL2 gene expression in vivo (wound healing model)  
The skin samples from the healed wound  (the area in the section of the wound heal-
ing experiment) were kept in an RNA solution (Ambion, Austin, Texas, USA) and pre-
served at 4
ᵒ
C  overnight , then kept at -80
ᵒ
C until RNA extraction was complete. 
3.7.1 RNA extraction 
Total cellular RNA was extracted and purified using a commercialized Gene JET 
RNA purification kit (Thermo Scientific, Cat. No: K0731). The extraction and purifica-
tion processes were performed as per the instruction protocol. 30 mg of frozen tissue 
was weighed, pounded using a mortar and pestle, then 600µl of diluted proteinase K (10 
µl of the concentrated proteinase K diluted in 590 µl of TE buffer) was added. The mix-
ture was vortexed, incubated at 15-25
ᵒ
C for 10 min, then centrifuged for 10min at 
12000xg. The supernatant was transferred into an RNase free microcentrifuge tube. Af-
ter that 450µl of 96-100% ethanol was added to the mix, then 700 µl of lysate was trans-
ferred to the gene JET RNA purification column, centrifuged at 1200xg for 1 min. The 
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purification column was placed in  a new collection tube and 700 µl of  buffer1 (sup-
plemented with kit) was added, before centrifuging at 1200xg for 1min. To eliminate 
genomic DNA contamination the mixture was treated with 80µl DNsaeI (Qiagen, Hil-
den, Germany, Cat.No:79254). The purification column was placed into a new collec-
tion tube and 600µl of wash buffer2 was added (supplemented with kit). The previous 
step was repeated with 250µl of wash buffer2. Finally, the purification column was 
placed in the nuclease free 1.5 collection tube to elute the RNA by adding 100µl of nu-
clease free water and centrifuged for 1min at 1200xg. The purified RNA was kept at -
80
ᵒ
C until use. 
The RNA concentration and integrity were electrophoretically verified by optical 
density (A260/A280 ≥ 1.65) measured by a Nano Drop ND- 2000 spectrophotometer 
(Thermo Fisher scientific, Wilmington, DE, USA), and by ethidium bromide staining 
with 2 % denaturing agarose gel electrophoresis (Bio-Rad, Richmond, CA, USA) and 
ethidium bromide staining (appendix III) (Pfaffl et al., 2003) .  
3.7.2 Reverse transcription (RT) 
The total RNA extracted was used for cDNA synthesis. Reverse transcription was 
performed using a commercialized kit (high capacity RNA to cDNA kit, applied Bio-
systems, Cat.No.4387406). Two μg of total RNA were used /20 μl reaction as instructed 
in the user’s protocol. For every 20μl reaction, the total RNA sample was mieed with an 
equal volume of the 20X Enzyme mix as detailed in (Table 3.3).  The RT reaction was 
aliquoted in the tube and the cap was sealed and briefly centrifuged to eliminate any air 
bubbles. The reaction was then incubated in the thermal cycler (MJ Research PTC-100 
Thermal cycler, USA) at 37
ᵒ
C for 60 min. The reaction was stopped at 95
ᵒ
C for 5 min 
and was held at 4
ᵒ
C, the cDNA was then stored at (-15
ᵒ
C to -25
ᵒ
C) until used in real time 
PCR.  
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    Table 3.3: Composition of the reverse transcriptase reaction 
Component  Component volume/ reaction 
(µl) 
2X RT buffer 10.0 
20X Enzyme mix 1.0 
RNA sample  Up to 9 µl 
Nuclease-free water Quantity sufficient to 20 µl 
Total per reaction 20 
 
3.7.3  Real time reverse transcriptase polymerase chain reaction (RT-PCR) gene   
expression assay 
3.7.3.1 TaqMan chemistry 
The effect of the plant extract on the BAX and BCL2 gene expression was deter-
mined using a real time PCR assay. Reverse transcription PCR based assays are current-
ly the most common method for characterizing and confirming gene expression levels 
from different sample populations. Real time systems for PCR have been improved by 
being probe based. The real time PCR technique as it is used today depends on two im-
portant principles. First, the TaqMan polymerase plays an important role in the (5ʹ–3ʹ 
exonuclease activity) polymerase activity. Second, typical amplification reactions in-
clude the probe; it is an oligonucleotide with both a reporter fluorescent dye and a 
quencher dye attached. Design and synthesis of the probe has been simplified by label-
ing with a reporter fluorochrome (e.g., 6-carboxyfluorescein, or FAM) at the 5ʹ end and 
quenching (e.g.: 6-carboxy-tetramethyl-rhodamine or TAMRA) at the 3
ʹ
 end of the 
probe (Giulietti et al., 2001). The real time method is used to detect only specific ampli-
fication products. During the amplification and annealing of the probe to its target, the 
sequence generates a substrate that is cleaved by the 5
ʹ
 nuclease activity of TaqMan 
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DNA polymerase when the enzyme extends from an upstream primer into the region of 
the probe (Walker, 2002). This dependence on polymerization ensures that the cleavage 
of the probe occurs only if the target sequence is being amplified (Figure 3.1). The 
probe has a melting temperature (Tm) approximately 10
o
C higher than the Tm of the 
primers in order to anneal to the amplicon during the extension phase of the PCR pro-
cess (which is performed at 60
o
C). Consequently (Overbergh et al., 2003), the probe 
will be degraded during the phase by the 5
ʹ
- 3
ʹ
 exonuclease activity of the TaqMan pol-
ymerase. This will result in an increase in reporter fluorescence emission because re-
porter and quencher are separated. The amount of fluorescence released is directly pro-
portional to the amount of product generated in each PCR cycle and thus can be applied 
as a quantitative measure of PCR product formation (Bustin, 2000).  
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Figure 3.1: Schematic representation of the TaqMan principle. A: Primers and probe anneal to 
the target gene. Fluorescence emission does not occur because the probe is still intact. B: During 
the extension phase of the PCR reaction, the probe is cleaved by the 5
ʹ–3ʹ exonuclease activity 
of the TaqMan polymerase, allowing fluorescence emission. FW, forward; RV, reverse; F, 
fluorophore; Q, quencher dye. cited by (Overbergh et al., 2003). 
 
3.7.3.2 Real time amplification assay  
The reaction setup for all TaqMan Gene Expression assays was performed according 
to the manufacturer’s instructions for the TaqMan fast advanced master mix (Applied 
Biosystems Cat. No: 4444557) and generated by the Step One plus system software 
(Ver. 2.0, Applied Biosystems). Briefly the reaction was performed by mixing 5µl of (2 
X) TaqMan fast advanced masters with 0.5 µl of (20X) TaqMan Gene (Table 3.4) and 1 
µl of cDNA; the reaction volume was adjusted to 10 µl with Nuclease-free water. All 
the above components were mixed in a 1.5 ml microcentrifuge tube, briefly vortexed to 
mix and centrifuged to eliminate the air bubbles and spin down the contents After that 
the appropriate volume was loaded in duplicate into the optical reaction plate well (Ap-
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plied Biosystems MicroAmp fast optical 96-well reaction plate with barcode Cat. No: 
4346906), the plate was completely covered with an optical adhesive cover (Applied 
Biosystems MicroAmp optical adhesive film, Cat. No. 4360954), and briefly centri-
fuged to eliminate the air bubbles and spin down the contents. Finally, the PCR reaction 
was run using Thermal cycling conditions as described in (Table 3.5). 
 
Table 3.4: TaqMan Gene investigated 
NO. Gene name and abbreviation  TaqMan Gene Assay 
ID 
NCBI Refer-
ence Sequence 
1 BCl2-associated X protein 
(Bax) 
Rn02532082_g1 NM_017059.1 
2 B cell lymphoma -2  
(BCL2) 
Rn99999125_m1 NM_016993.1 
3 Glyceraldehyde-3-phosphate 
dehydrogenase ( GAPDH) en-
dogenous control  
Rn0177563_g1  
 
NM_017008.3  
4 Hypoxanthine phosphoribosyl 
transferase 1  (HPRT1) endog-
enous control  
Rn01527840_m1 
 
NM_012583.2 
 
 
Table 3.5: thermal cycle conditions 
 
 
 
 
 
 
 
 
Thermal cycling profile 
parameters incubation Polymerase 
activation 
PCR (40 cycle) 
Hold  Hold  Denature  Anneal/extend  
Temperature(
ᵒ
C) 50 95 95 60 
Time (mm:ss) 02:00 00:20 00:01 00:20 
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3.7.3.3 RT-PCR Analysis  
Amplification efficiency in this experiment was performed to ensure that the amplifi-
cation efficiencies of the target gene and endogenous gene were approximately equal. 
The slope of a standard curve is generally used to estimate the PCR amplification effi-
ciency of a real time PCR reaction. A real time PCR standard curve is graphically repre-
sented as a semi-log regression line plot of CT value versus log of input nucleic acid. A 
standard curve slope of -3.32 indicates a PCR reaction with 100% efficiency (Liss, 
2002).  
The comparative CT method (∆∆CT) expression of the investigated genes was normal-
ized with the endogenous control (HPRT1). CT values are means of duplicate measure-
ments. Comparative CT method quantification was determined by the ΔΔCT method 
(Livak & Schmittgen, 2001). For statistical analysis of real time RP-PCR experiments, 
results for a given gene were eepressed as difference from the ∆CT value obtained be-
tween treated versus un-treated (Calibrator). 
The calculation of fold change was done as described below: 
CT Target - CT Endogenous control = ∆CT  
∆CT Sample - ∆CT Calibrator = ∆∆CT  
Fold change = 2
-∆∆CT
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3.8 Profiling and fractionation of crude extracts 
One gram of ethanol crude extract was  dissolved in 5 ml of methanol and subjugated 
to column chromatography fractionation in glass columns at 3.0 x 50 cm (Kontes Scien-
tific Glassware, Vineland, NJ, USA) packed with silica gel G60, 70 - 230 mesh (Merck, 
Darmstadt, Germany) and linked with an EYEL-L4 pump (Tokyo Rikakikai, Tokyo, 
Japan). A gradient concentration of solvent that differed in polarity (25 ml each time of 
five different concentrations; 20, 40, 60, 80 and 100 %) was used to elute the crude ex-
tract. The solvents used were hexane, ethyl acetate, methanol, acetonitrile and water in 
order to increase the polarity, starting with lower polarity and ending with high polar 
solvent.  The yield fractions were collected in a clean class tube and gathered based on 
the similarity of the solvents used. Solvents were evaporated from yield fraction under 
reduced pressure using a centrifuge evaporator. The crude extract and all fractions were 
tested for their effect in vitro on the RAW 264.7 cell line. The fraction will affect   
RAW 264.7 cell proliferation and cause an immunomodulatory effect. It was subjected 
to liquid chromatography mass spectrometry (LC-MS) to determine the active constitu-
ents.   
3.9  Immunomodulatory effect in vitro  
3.9.1 Cell line 
A murine macrophage cell line RAW 264.7 (Figure 3.2) obtained from the American 
Type Culture collection (ATCC, Rockville, MD) was cultured in DMEM and supple-
mented with  4500g glucose/L, 110mg sodium pyruvate/L and 1% penicillin–
streptomycin (Sigma-Aldrich, UK) and 10% heated-in activated, endotoxin level less 
than < 0.1 EU/ml fetal bovine serum (FBS) (BIOWEST, France). The cells were cul-
tured at 37
◦
C  in a 5% CO2 atmosphere incubator (NuAire, Plymouth, MN, USA). For 
the experiments, the cells were sub cultured when they reached 80% confluence, then 
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the cell suspension was diluted to 5×10
5
 cell/ml (Guan et al., 2011). One hour before the 
experiments, 1ml fresh medium (37
o
C) was changed in the 96-well plates (Coster, Corn-
ing, NY). In this experiment the cells were cultured for 24h.  
3.9.2  Proliferation assay 
For detecting the effect of plant extracts on RAW264.7 cell proliferation, the assay 
was performed using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT)  (MTT) assay (Merck, Germany). The MTT test measures the ability of the cells 
to transform MTT to formazan. The cells were plated in 96-well tissue culture plates at 
a density of 5x10
5
 cells / ml, 5000cell/ well in complete DMEM medium and incubated 
in triplicate in a 96-well plate in a final volume of 100µl for 24h at 37°C and 5% CO2  
(Gauley & Pisetsky, 2010). Cells were stimulated with plant crude extract and all frac-
tions were at a final concentration (25, 50, 100, 200, 400, 800, and 1000) µg/ml and in-
cubated for 24h at 37
o
 C and 5% CO2, then 10µl from 5mg/ml in phosphate buffered 
saline MTT solution was added to each well. After 4h of incubation at 37
o
 C the spent 
media and MTT were aspirated before the addition of 100 μl of dimethyl sulfoeide 
(DMSO) (Fisher Scientific, UK) to dissolve the yellow MTT tetrazolium salt produced 
metabolically and change to purple MTT formazan salt.  
The amount of MTT formazan salt produced is proportional to the amount of viable 
cells. The cell proliferation rate is determined by measuring the absorbance at a wave-
length of 570 nm with the microplate reader (Groesdonk et al., 2006; Guan et al., 2011).  
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   Figure 3.2: A murine macrophage cell line RAW264.7 
 
3.9.3  In vitro stimulation for intracellular cytokine production  
To evaluate the ability of plant extracts in the stimulation of the RAW 264.7 cell to 
produce cytokine, RAW264.7 cells (1×10
6
 cells /ml, 6 ml /well) were incubated in 
complete DMEM medium  for 24 h at 37
ᵒ
C in 5% CO2 (Gambelli et al., 2004). Then the 
cells were stimulated with LPS (1 µg/ml) (Escherichia coli 055: B5, Difco, Detroit, MI, 
USA), (1 µl/ml) brefeldin A (BD GolgiPlug
TM
) and (100 µg/ml) of two plant crude ex-
tracts, P.macrocarpa fraction1 100 µg/ml (P.m F1) and then T. crispa fraction2. One 
hundred µg/ml (T. c F2) were incubated for 6 h (Carahera et al., 2000; Guan et al., 
2011). Before activation with LPS (1 µg/ml), the medium was removed and the cells 
were washed with 5 ml of PBS and replenished with a complete medium (Connelly et 
al., 2001). Cells stimulated with LPS (1µg/ml) alone were used as control (Gambelli et 
al., 2004) and after  the incubation period, cells were washed twice with PBS and re-
suspended in 0.5 ml of staining buffer PBS containing (1% FBS and 0.09% (w/v) sodi-
um azide) (Carahera et al., 2000). 
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3.9.4  Flow cytometry immunostaining of intracellular cytokines 
Cells were re-suspended with a density of 10
7 
cells/ ml, 100µl of the suspension cells 
were aliquoted into tubes for staining. To reduce  nonspecific immunofluorescent stain-
ing, suspension cells were pre-incubated with mouse BD Fc Block
TM
 purified anti 
mouse CD16/CD32 mAb 2.4G2 (BD Fc Block™; Cat.No.553141) (1 µg/ 106 cells in 
100 µl) at 4
o
C for 15 minutes. The cells were then fieed / permeabilized with 250 μl for 
20min at 4°C of fixation/ permeabilization solution (BD Cytofix/Cytoperm plus Fixa-
tion/Permeabilization, BD Golgi Plug™ protein transport inhibitor, Cat.No.555028). 
Cells were washed two times in 1ml of 1× BD Perm/Wash
TM
 buffer, 250xg and 5min at 
4
o
C. Fixed/permeabilized cells were re-suspended in 50µl of BD Perm/Wash
TM
 buffer 
and incubated at 4
o
 C for 30 minutes in the dark with a fluorochrome-conjugated anti-
cytokine antibody: PE Anti-Mouse IL-6 (≤ 0.25 μg/million cells, BD Cat. No: 554401), 
FITC rat anti-mouse IFN-γ (≤ 0.5 µg/ /million cells, BD Cat. No: 554411) and APC rat 
anti-mouse IL-8 (≤ 0.5 µg/million cells, BD Cat. No: FAB2164A). After incubation, 
cells were washed two times with 1×BD Perm/Wash
TM
 buffer (1 ml/wash) and re-
suspended in Staining Buffer prior to the flow cytometric analysis.  
3.9.5  Flow cytometric analysis 
The samples were analyzed with gated on the two-dimensional forward and side 
scatter of the flow cytometer and fluorescence intensity was analyzed with at least 
10,000 cells collected for each sample. The cytokine analysis was carried out with a 
FACS Canto II flow cytometer and FACSDiva version 6.1.3 software (BD Bioscienc-
es).  
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3.10 Investigation of active constituents 
High-resolution mass spectrometry was used for the identification and characteriza-
tion of active constituents in the fractions that have an effect on the proliferation and 
stimulation of the RAW264.7 cell, P. macrocarpa fraction1 (P.m F1) and T. crispa frac-
tion 2 (T.c F2). High-resolution mass spectra were recorded on an LC-Mass (Agilent 
technologies 6530 Accurate-Mass QTOF LC/MC) using MeOH-Water (40:60) as elu-
ent. With the high resolution mass spectra, the identity of the extracted active com-
pounds could  be confirmed due to the [M+H]
+
, [M+Na]
+
, [M+K]
+
and [M+NH3]
+
 (Di et 
al., 2013; Salman et al., 2013).  
3.11 Statistical analysis  
The value is communicated as mean ± standard division (SD). The statistical exami-
nation of data was done through one-way analysis of variance (ANOVA), Univariate 
analysis of variance and Post Hoc LSD test (comparing the treated groups with control). 
Significance was determined using a P value of P ≤ 0.05 compared with control.
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CHAPTER FOUR 
4  RESULT 
4.1 Extraction of antioxidant compounds 
The P. macrocarpa and T. crispa were extracted according to the method described 
in (Sec 3.1). 13.5g viscous dark brown was the yield from 200g powder of P. macro-
carpa and 34.88g viscous dark green was the yield from 200g powder of T. crispa.  
4.2 Quantitation and evaluation of antioxidant contents and activity 
The antioxidant activity of P. macrocarpa and T. crispa was evaluated by FRAP and 
DPPH test as shown in Table (4.1). The quantity of total phenolic and total flavonoid 
contents were presented. In Table (4.1), the P.macrocarpa extract has a stastically sig-
nificant P ≤ 0.05 high antioxidant potential when compared with T. crispa and standard 
ascorbic acid. The FRAP value of P. macrocarpa extract is (17618.52 ± 2115.9) µmol 
Fe
+2
/mg, while for T. crispa and standard ascorbic acid are (11011.11 ± 1145.42, 
7951.85 ± 330.42) µmol Fe
+2
/mg respectively. In addition, the total antioxidant activity 
was assessed using a DPPH test that detected DPPH inhibition at % (86.79 ± 0.4), as 
well as  IC50 (14 µg/ml) for P. macrocarpa, 55.79 ± 7.995; IC50 (22 µg/ml) for T. 
crispa and 69.03 ± 9.271; IC50 (19 µg/ml) for ascorbic acid. Results reveal the total 
phenolic content of P.macrocarpa extract is (548.51 ± 76.51 mg GAE/g) of dry fruit 
weight and the total flavonoids content was (213.16 ± 1.31 mg QE/g) of dry fruit 
weight, while total phenolic content is (84.598 ± 7.82 mg GAE/g) and total flavonoid 
content (62.07 ± 39.76 mg QE/g) in the T.crispa stem extract as shown in Table 4.1.     
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Table 4.1: Antioxidant activity values, total phenolic and total flavonoid contents for P. 
macrocarpa and T. crispa.  
 
 
 
Values are expressed as mean ± standard, FRAP value is expressed as Fe
+2
 equivalents. IC50 
value for the DPPH assay is expressed as µg/ml. Total phenolic content is expressed as Gallic 
acid equivalent (GAE). Total flavonoid content is expressed as Trolox equivalents (TE). 
*Significant (P ≤ 0.05) compared with ascorbic acid.   
 
 
 
4.3 Acute toxicity study 
During the 14-day experimental period, no records of death or changes to skin and 
hair in both sexes of rats among the groups administered with doses of both plant ex-
tracts (50, 500, and 2000 mg/kg) were observed. In the groups that were treated with P. 
macrocarpa, histological examination and biochemical tests of the kidney and liver 
conducted at the end of the study did not display any symptom of poisonous substance 
(Figure 4.1). In groups treated with T. crispa , biochemical tests of the kidney and liver 
showed normal levels, except for alkaline phosphatase which was significantly elevated 
(P ≤ 0.05) at doses of 500 and 2000 mg/kg in the female and at all dose groups in the 
male rats compared with the vehicle control group (Tables 4.2, 4.3, 4.4 and 4.5). In the 
histological examination (Figure 4.2), the results show that the rats administered with 
500 and 2000 mg/kg doses exhibited normal hepatic structure but minimal inflammato-
ry cell infiltration was associated with mild congestion in the portal area. The few blood 
vessels that were congested, indicated the resolution stage from hepatitis. Based on this 
strict examination, the LD50 value of T. crispa was more than 2000 mg/kg body weight. 
 FRAP assay 
 µmol Fe+2/mg 
 
DPPH  
inhibition% 
IC50  
µg/ ml 
Total phenolic 
contents  
mg GAE/g 
Total flavonoid 
contents 
mgTE/g 
Ascorbic acid 7951.85  ±  330.42 69.03 ± 9.3 19   
P.macrocarpa 17618.52 ± 2115.9* 86.79±0.4* 14 548.51±76.51 84.598 ± 7.82 
T. crispa 11011.11 ± 1145.42 55.79 ± 7.9 22 213.16±1.31 62.07 ± 39.76 
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Table 4.2: Effect of P. macrocarpa & T. crispa on the value of liver biochemical parameters in the female rat  
Groups  
Total protein g/l 
 
Albumin g/l 
 
Globulin  g/l 
 
alkaline phos-
phatase IU/l 
aspartate ami-
notransferase 
IU/l 
alanine aminotrans-
ferase IU/l 
Vehicle control 69.7 ± 2.07 13.3 ± 1.03 56.3 ± 2.7 64.5± 7.89 174.3 ± 28.7 38 ± 5.9 
P. macrocarpa 
50mg/kg 
69.17 ± 5.2 12.17 ± 1.9 57.7 ± 3.27 71.8 ± 14.27 179.2 ± 19.4 44.7 ± 6.98 
P. macrocarpa 
500mg/kg 
68.8 ± 4.5 14.5 ± 1.3 54.5 ± 3.2 52.7 ± 10.6 168.7 ± 32.3 42.2 ± 6.9 
P. macrocarpa 
2000mg/kg 
69.8 ± 4.3 13.7± 2.25 56.17 ± 2.8 70.7 ± 16.7 177.7 ± 42.02 38.7 ± 4.8 
T. crispa 
50mg/kg 
69.2 ±3.9 13 ± 0.9 56.5 ± 3.2 73.5 ± 19.17 179.8 ± 20.6 38.8 ± 4.02 
T. crispa 
500mg/kg 
69.3 ± 1.4 14.7 ± 0.5 54.7 ± 1.4 96 ± 14.5
*
 198.5 ± 21.8 39.7 ± 6.08 
T. crispa 
2000mg/kg 
69.7 ± 3.8 14.7 ± 1.9 55 ± 2.2  92.8 ± 19.1
* 181 ± 21.8 39.5 ± 6.05 
        *Significant P≤ 0.05, Results are presented as mean ± SD. 6rats/group.  
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Table 4.3: Effect of P. macrocarpa & T. crispa on the value of liver biochemical parameters in the male rat 
 
      
 
 
 
    
 
 
 
 
                      
*Significant P≤ 0.05 , Results are presented as mean ± SD. 6rats/group. 
 
 
 
 
 
Groups  
 
Total protein 
g/l 
 
Albumin g/l 
 
Globulin  g/l 
 
Alkaline phos-
phatase IU/l 
Aspartate ami-
notransferase 
IU/l 
Alanine ami-
notransferase 
IU/l 
Vehicle control 60 ± 1.8 12 ± 0.89 48.5 ± 1.4 145.92 ±29.9 171.8 ± 32.95 52.5± 1.34 
P. macrocarpa 
50mg/kg 
61.8 ± 4.02 12.17 ± 0.76 51.3 ± 4.13 197.17 ±57.1 183.8 ± 14.3 45.8 ± 6.9 
P. macrocarpa 
500mg/kg 
63.5 ± 4.04 13 ± 1.09 51.3 ± 4.6 182 ± 34.2 193 ± 23.14 50 ± 7.7 
P. macrocarpa 
2000mg/kg 
61.17±0.41 13 ± 0.9 48.17 ± 1.17 171 ± 44.8 177.7 ± 22.8 54.8±13.03 
T. crispa 
50mg/kg 
63 ± 4.97 12.7 ± 1.2 50.7 ± 3.8 215.2 ± 70.08* 177.3 ± 15.1 47.08 ± 8.6 
T. crispa 
500mg/kg 
63.5 ± 5.3 13.2 ± 1.3 50.7 ± 4.3 257.7 ± 14.4* 197.8 ± 33.6 56 ± 1.5 
T. crispa 
2000mg/kg 
63 ± 4.9 13.2 ± 1.3 50.2 ± 4.1 261.8 ± 12.96* 193.08 ± 31.7 56.5 ± 1.8 
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Table 4.4: Effect of P. macrocarpa & T. crispa on the value of kidney biochemical parameters in the female rat 
 
 
 
 
 
 
 
 
  Results are presented as mean ± SD. 6rats/group. 
 
 
 
 
 
Groups  Sodium  
mmol/L 
Potassium 
mmol/L 
Chloride 
 mmol/L 
Carbone Dioxide 
mmol/L 
Urea  
mmol/L 
Creatinine 
umol/L 
Vehicle control 139.7 ± 1.2 4.5 ± 0.2 98.5 ± 10.7 21.6 ± 1.79 5.9 ± 0.6 41.7 ± 14.8 
P. macrocarpa 
50mg/kg 
140.3 ± 1.3 4.8 ± 0.08 102.17 ± 12.5 18.2 ± 7.3 5.7 ± 1.08 39.5 ± 7.6 
P. macrocarpa 
500mg/kg 
137.8 ± 3.5 4.6 ± 0.3 77.17 ± 34.6 24.1 ± 2.5 8.52 ± 4.8 40.5 ±13.35 
P. macrocarpa 
2000mg/kg 
139.8 ± 1.17 4.7 ± 0.4 100.3 ± 11.6 23.4 ± 1.07 6.8 ± 0.5 32.7 ± 7.4 
T. crispa 
50mg/kg 
139.7 ± 1.9 4.7 ± 0.2 99.7 ± 11.3 20.1 ± 2.6 5.4 ± 0.9 40.8 ± 9.2 
T. crispa 
500mg/kg 
140.3 ± 1.2 4.6 ± 0.2 99.2 ± 10.9 22.3 ± 2.9 6.2 ± 1.4 35 ± 8.4 
T. crispa 
2000mg/kg 
140 ± 1.5 4.5 ± 0.3 99.5 ± 11.1 22.8 ± 2.1 6.6 ± 0.6 40.3 ± 6.5 
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Table 4.5: Effect of P. macrocarpa & T. crispa on the value of kidney biochemical parameters in the male rat 
 
   
 
 
 
 
 
 
 
 
   
Results are presented as mean ± SD. 6rats/group. 
 
Groups  Sodium 
mmol/L 
Potassium 
mmol/L 
Chloride 
mmol/L 
Carbone 
Dioxide 
mmol/L 
Urea  
mmol/L 
Creatinine 
umol/L 
Vehicle control 140.8 ± 2.14 5.05 ± 0.05 102.3 ± 0.5 22.2 ± 1.07 3.95 ± 0.2 31.5 ± 4.03 
P. macrocarpa 
50mg/kg 
141 ± 0.6 4.7 ± 0.33 103.9 ± 1.61 23.65 ± 1.6 4.6 ± 0.84 29.8 ± 6.5 
P. macrocarpa 
500mg/kg 
140.17 ± 0.98 4.8 ± 0.3 103.8 ± 2.04 24.1 ± 1.44 4.2 ± 0.3 24.42 ± 6.8 
P. macrocarpa 
2000mg/kg 
142.17 ± 1.4 5.13 ±0.3 104.3 ± 1.8 24.7 ± 2.91 4.5 ± 0.7 29 ± 3.8 
T. crispa 
50mg/kg 
140.5 ± 1.6 4.9 ± 0.4 98 ± 10.4 22.7 ± 1.7 4.7 ± 1.1 34.8 ± 10.6 
T. crispa 
500mg/kg 
140.8 ± 1.5 4.7 ± 0.3 98 ± 10.4 22.7 ± 1.7 4.7 ± 1.07 33.3± 11.3 
T. crispa 
2000mg/kg 
142.5 ± 1.9 4.9 ± 0.4 99 ± 10.9 23.4 ± 2.5 4.7 ± 1.1 35.3 ± 8.3 
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Figure 4.1:  Effect of P. macrocarpa on liver and kidney. Rat (1a and 2a) treated with 
5ml/kg vehicle as control group. Rat (1b and 2b) treated with 50mg/kg. Rat (1c and 2c) 
treated with500mg/kg and rat (1d and 2d) treated with 2000mg/kg) of P. macrocarpa 
(hematoxylin and eosin staining, (10x). 
 
Kidney  Liver  
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Figure 4.2:  Effect of T.crispa on liver and kidney. Rat (1a and 2a) treated with 5ml/kg 
vehicle as control group. Rat (1b and 2b) treated with 50mg/kg. Rat (1c and 2c) treated 
with 500mg/kg and rat (1d and 2d) treated with 2000mg/kg) of T.crispa (hematoxylin 
and eosin staining, (10x). 
 
 
 
 
Kidney  Liver  
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4.4 Gastroprotective ability of the plant extract 
The gastroprotective effect and the enhancement of the mechanism defense of gastric 
ulcer by P.macrocarpa or T. crispa were investigated through the induction of gastric 
ulcer in rats using ethanol as a necrotizing agent. This scheme resulted in mucosal inju-
ry characterized by submucosal edema, increased secretory products of the cell, and dis-
turbances in microcirculation. 
Pretreatment with ethanol extract of P.macrocarpa or of T. crispa stems at doses of 
100, 200, 500 and 1000 mg/kg or omeprazole at 20 mg/kg inhibited the formation of 
gastric ulcer lesions in the rats. The intensity of the ulcer was detected by a statistically 
significant (P ≤ 0.05) ulcer area in the pretreated groups (P.macrocarpa, T. crispa or 
omeprazole), which was lower than that of the ulcer control group. The ulcer inhibition 
percentage reflected the results of pretreatment with all doses of the P.macrocarpa or T. 
crispa and was higher than the ulcer control group (Figure 4.3).   
 
Figure 4.3: Effect of P. macrocarpa and T. crispa on the ulcer area (values expressed as mean ± 
SD) and inhibition %. 6 rats / groups. * Significant (P ≤ 0.05) when compared with ulcer control 
group.   
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The stomach pH in the experimental groups pretreated with P.macrocarpa, T. crispa 
or omeprazole increased significantly compared to the ulcer control group P ≤ 0.05 
(Figure 4.4). 
 
 
Figure 4.4: Effect of P. macrocarpa and T. crispa on the stomach pH. Values are presented as 
mean ± SD, 6 rats / groups. * Significant (P ≤ 0.05) when compared with ulcer control group.  
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4.4.1  Histological estimation of gastric ulcer 
The absence of injuries in the gastric mucosa was observed in the vehicle control 
group. In the gastric mucosa during ulcer control, severe injuries were observed. Etha-
nol formed widespread observable hemorrhagic necrosis of the gastric mucosa. In addi-
tion, damage in the gastric mucosa in rats pretreated with omeprazole (20 mg/kg) were 
minor compared to injuries in the ulcer control rats. In the pretreatment with P. macro-
carpa extract at doses of 100 and 200 mg/kg, injuries were observed in the gastric mu-
cosa. However, in rats pretreated with P. macrocarpa extracts (500 and 1000 mg/ kg) 
only mild injuries were seen. The extract reduced gastric injuries that were induced by 
ethanol (Figure 4.5a).   
Microscopy analysis results on the severity of the ulcer lesions are presented in (Fig-
ure 4.5b). The results show damage throughout the gastric mucosa layer and edema and 
leukocyte infiltration in the submucosa layer in the ulcer control group. In the histology 
of the stomach of rats pretreated with P. macrocarpa extracts (100 and 200 mg/kg) 
there was seen a disturbance of the surface epithelium mucosa. Edema and leukocyte 
penetration of the submucosal stratum was also observed. In the rat pretreated with P. 
macrocarpa extracts (500 and 1000 mg/kg) there was observed a minor disturbance to 
the epithelium and absence of edema or leukocyte infiltration of the submucosal stra-
tum. The treated samples exhibited better protection from injury caused by ethanol as 
clearly indicated by the reduced ulcer area, less damage to the gastric mucosa, reduced 
edema in the submucosa layer and decreased leukocyte infiltration. Therefore, P. mac-
rocarpa exhibits gastroprotective influences in a dose dependent way.  
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Figure 4.5a: Effect of P. macrocarpa on the gross appearance of the gastric mucosa in rats. (A) 
Rats pretreated with 5ml/kg Teen20, no injuries to the gastric mucosa are seen. (B) Rats pre-
treated with 5ml/kg Teen20 + ethanol; severe injuries to the gastric mucosa are seen. Ethanol 
produced extensive visible hemorrhagic necrosis of gastric mucosa. (C) Rats pretreated with 
omeprazole (20mg/kg); mild injuries are seen in the mucosa layer. (D & E) rats pretreated with 
P. macrocarpa extract (100 & 200 mg/kg) consecutively; injuries are seen in the gastric muco-
sa. (F&G) rats pretreated with P. macrocarpa extract (500 & 1000 mg/kg) consecutively; mild 
injuries are seen in the gastric mucosa. The black arrow indicates mucosa injury. 
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Figure 4.5b: Effect of P. macrocarpa on the histological appearance of ethanol-induced 
gastric mucosal damage in rat. (A) Rats pretreated with 5mL/kg of Tween20. No inju-
ries to the gastric mucosa are seen (white arrow). (B) Rats pretreated with 5mL/kg of 
Tween20 + 95% ethanol. There is severe disruption to the surface epithelium and ne-
crotic lesions (black arrow) penetrating deeply into the mucosa and extensive edema of 
the submucosal layer and leucocyte infiltration are present (blue arrow). (C) Rats pre-
treated with omeprazole (20mg/kg). Mild disruption of the surface epithelium mucosa is 
seen (orang arrow). (D), (E) rat pretreated with P. macrocarpa extract (100, 200mg/kg) 
consecutively; mild disruption of the surface epithelium mucosa is seen. There is edema 
and leucocyte infiltration of the submucosal layer. (F) Rat pretreated with P. macrocar-
pa extract (500mg/kg); mild disruption to the surface epithelium. (G) Rat pretreated 
with P. macrocarpa extract (1000mg/kg); minor disruption to the surface epithelium 
and no edema or leucocyte infiltration of the submucosal layer (H&E stain 10 ×).  
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A deficiency of injuries in the gastric mucosa was observed in the vehicle control. In 
the gastric mucosa in ulcer control, severe injuries were observed. Ethanol formed 
widespread observable hemorrhagic necrosis of the gastric mucosa. In addition, damage 
in the gastric mucosa in rats pretreated with omeprazole (20 mg/kg) was minor com-
pared to injuries in the ulcer control rats. The group of rats pretreated with T. crispa ex-
tract at doses of 100 and 200 mg/kg were observed to have injuries in the gastric muco-
sa. However, rats pretreated with T. crispa extracts (500 and 1000 mg/kg) only had 
slight damage. The extract reduced the development of gastric injuries that were in-
duced by ethanol (Figure 4.6a).     
Microscopy analysis results of the severity of ulcer lesions are presented in (Figure 
4.6b). Results show damage throughout the gastric mucosa layer and edema and leuko-
cyte infiltration in the submucosa layer of the ulcer control group. In the histology of the 
stomachs of the rats pretreated with T. crispa extracts, (100 and 200 mg/kg) there was 
observed a disturbance of the surface epithelium mucosa. In addition edema and leuko-
cyte infiltrate of the submucosal layer were observed. In the rats pretreated with T. 
crispa extracts (500 and 1000 mg/kg) there was observed a slight disturbance on the 
surface of the epithelium and an absence of edema or leukocyte penetration of the sub-
mucosal layer. The treated samples exhibited better protection from injury caused by 
ethanol as clearly indicated by the reduced ulcer area, less damage to the gastric muco-
sa, reduced edema in the submucosal layer and decreased leukocyte infiltration. There-
fore, T. crispa exhibits gastroprotective effects in a dose dependent manner.  
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Figure 4.6a: Effect of T. crispa on the gross appearance of the gastric mucosa in rats. 
(A) Rats pretreated with 5ml/kg Tween20, no injuries to the gastric mucosa are seen. 
(B) Rats pretreated with 5ml/kg Tween20 + 95% ethanol; severe injuries to the gastric 
mucosa are seen. Ethanol produced extensive visible hemorrhagic necrosis of gastric 
mucosa. (C) rats pretreated with omeprazole (20mg/kg); mild injuries are seen in the 
mucosal layer. (D & E) rats pretreated with T. crispa extract (100 & 200 mg/kg) con-
secutively; injuries are seen in the gastric mucosa. (F&G) rats pretreated with T. crispa 
extract (500 & 1000 mg/kg) consecutively; mild injuries are seen in the gastric mucosa. 
The black arrow indicates mucosal injury.  
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Figure 4.6b: Effect of T. crispa on the histological appearance of ethanol-induced gas-
tric mucosal damage in rats. (A) Rat pretreated with 5mL/kg of Tween20. No injuries to 
the gastric mucosa are seen (white arrow). (B) Rat pretreated with 5mL/kg of Tween20 
+ 95% ethanol. There is severe disruption to the surface epithelium and necrotic lesions 
penetrating deeply into the mucosa (black arrow) and extensive edema of submucosal 
layer and leucocyte infiltration are present (blue arrow). (C) Rat pretreated with 
omeprazole (20mg/kg). Mild disruption of the surface epithelium mucosa is seen (or-
ange arrow). (D), (E) Rat pretreated with T. crispa extract (100, 200mg/kg) consecutive-
ly; disruption of the surface epithelium mucosa is seen. There is edema and leucocytes 
infiltration of the submucosal layer. (F) Rat pretreated with T. crispa extract 
(500mg/kg); mild disruption to the surface epithelium and edema, no leucocyte infiltra-
tion of the submucosal layer. (G) Rat pretreated with T. crispa extract (1000mg/kg); 
slight disruption to the surface epithelium and no edema or leucocytes infiltration of the 
submucosal layer (H&E stain 10 ×). 
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4.4.2  Evaluation of gastrin, pepsin and PGE2 
In groups pretreated with P.macrocarpa, T. crispa  and omeprazole, the results show 
a significant decrease (P ≤ 0.05) in gastrin (Figure 4.7) and pepsin (Figure 4.8) levels 
compared to the ulcer control group. In addition, the PGE2 level in the groups pretreat-
ed with P. macrocarpa at doses of (100, 200, 500, 1000 mg/kg), omeprazole and T. 
crispa at doses of (500 and 1000 mg/kg) significantly (P ≤ 0.05) increased compared to 
the ulcer control group (Figure 4.9).    
 
 
 
Figure 4.7: Effect of P.macrocarpa and T. crispa on the level of serum gastrin 
in ethanol induced gastric ulcer, (6 rats/group). Values are presented as mean ± 
SD. * significant at (P ≤ 0.05) compared with ulcer control group. 
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Figure 4.8: Effect of P.macrocarpa and T. crispa on the level of serum pepsin in 
ethanol induced gastric ulcer; (6 rats/group). Values are presented as mean ± SD. * 
significant at (P ≤ 0.05) compared with ulcer control group. 
 
 
Figure 4.9: Effect of P.macrocarpa and T. crispa on the level of PGE2 in ethanol 
induced gastric ulcer, (6 rats/group). Values are presented as mean ± SD.*significant 
at (P ≤ 0.05) compared with ulcer control group. 
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4.4.3 Estimation of SOD, CAT and MDA level  
The effect of P.macrocarpa and T. crispa on antioxidant enzymes and its gastropro-
tective role were investigated in the pretreated groups. The results show that the two 
plants significantly (P ≤ 0.05) affected SOD (Figure 4.10) and CAT (Figure 4.11) by 
increasing their levels in all pretreated groups compared to the ulcer control group. 
Moreover, the results show that the level of MDA significantly decreased (P ≤ 0.05) in 
all pretreated groups compared to the ulcer control group (Figure 4.12).   
 
 
 
Figure 4.10: Effect of P.macrocarpa and T. crispa on the level of SOD in ethanol 
induced gastric ulcer, (6 rats/group). Values are presented as mean ± SD.*significant 
at (P ≤ 0.05) compared with ulcer control group. 
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Figure 4.11: Effect of P.macrocarpa and T. crispa on the level of CAT in ethanol induced gas-
tric ulcer, (6 rats/group). Values are presented as mean ± SD.*significant (P ≤ 0.05) compared 
with ulcer control group. 
 
 
 
 
Figure 4.12: Effect of P.macrocarpa and T. crispa on the level of MDA in ethanol induced 
gastric ulcer, (6 rats/group). Values are presented as mean ± SD.*significant (P ≤ 0.05) com-
pared with ulcer control group. 
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4.4.4 Estimation of TGF-β1 and TNF-α   
 Results show that the level of TGF-β1 significantly (P ≤ 0.05) increased in pretreat-
ed groups with P. macrocarpa and T. crispa when compared to ulcer control (Figure 
4.13). By contrast, the level of TNF-α significantly decreased (P ≤ 0.05) compared to 
the ulcer control group, in groups pretreated with P.macrocarpa and T. crispa when 
compared with ulcer control group (Figure 4.14).     
 
 
 
Figure 4.13: Effect of P.macrocarpa and T. crispa on the level of TGF-β1 in ethanol in-
duced gastric ulcer, (6 rats/group). Values are presented as mean ± SD. * significant (P ≤ 
0.05) compared with ulcer control group. 
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Figure 4.14: Effect of P.macrocarpa and T. crispa on the level of TNF-α in ethanol induced 
gastric ulcer, (6 rats/group). Values are presented as mean ± SD. * significant (P ≤ 0.05) 
compared to the ulcer control group. 
 
 
 
 
4.5 Mucus barrier of the protective stomach 
The results of the mucus barrier contents presented in Figure 4.15 show statistically 
(P ≤ 0.05) higher mucus content in the groups pretreated with P.macrocarpa extract, T. 
crispa and omeprazole compared to those in the ulcer control group. 
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Figure 4.15: Effects of P.macrocarpa, T. crispa and reference drug (omeprazole) on gastric 
wall mucus content in ethanol induced ulcer in rats. Values are presented as mean ± S.D.* sig-
nificant (P ≤ 0.05) compared with ulcer control group (6 rats/group).  
 
 
 
4.6 Wound healing evaluation parameters 
This study was carried out in order to verify the ability of P. macrocarpa and T. 
crispa to enhance the wound healing process. The circular excision wound model was 
employed for assessing the in vivo wound healing activity of these medicinal plants. 
Two percent concentration solution of gum acacia was used to prepare plant extract at 
doses of 100mg/ml and 200 mg/ml applied to the experimentally created excision 
wounds of rats. 
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4.6.1   Wound area contraction  
A neutral observer who was unaware of the experimental protocol evaluated the 
wound healing rate. Macroscopically, the wounds dressed with P.macrocarpa or T. 
crispa showed considerable signs of dermal healing and healed significantly faster 
compared to the vehicle control group (gum acacia in normal saline) on day 15 after the 
wounds were incurred (Figures 4.16 and 4.17).  
 
 
Figure 4.16: Macroscopical appearance of excision wound healing area treatment. (G1) 
0.2ml of vehicle control (gum acacia in normal saline, 20mg/ml). (G2) 0.2ml Intrasite. 
(G3) 0.2ml of 100mg/ml of P. macrocarpa. (G4) 0.2ml of 200mg/ml of P. macrocarpa. 
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Figure 4.17: Macroscopical appearance of excision wound healing area treatment. (A) 0.2ml of 
vehicle control (gum acacia in normal saline, 20mg/ml). (B) 0.2ml Intrasite. (C) 0.2ml of 
100mg/ml of T. crispa. (D) 0.2ml of 200mg/ml of T. crispa.   
 
 
Measurements of the wound healing progression as induced by the ethanol extract 
and the reference drug on the vehicle control groups are shown in (Figure 4.18). The 
wound   margin was traced after wound creation using transparent paper and the wound 
area was measured using graph paper. Wound contraction was measured over an inter-
val of 5 days until the 15
th
 day. In the excision wound model, the wounds of the groups 
of animals treated with P. macrocarpa and T. crispa at doses of (100 and 200) mg/ml 
contracted at a significantly higher rate by Day 15 (P ≤ 0.05) compared to the vehicle 
control group. 
 
 
 
(A) (B) (C) (D) 
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Figure 4.18: Effects of P.macrocarpa and T. crispa on wound area contraction (mm
2
) in rats. 
Values are expressed as mean ± SD, (5 rats/group). *significant P ≤ 0.05. 
 
 
 
4.6.2 Histopathological evaluation of healed wound area  
 The histology of the wound tissue on the 15
th
 day after wounding was evaluated by 
an observer blinded to the experimental protocol. In the P.macrocarpa  treated groups 
and T. crispa treated groups, the wound enclosure was smaller and the granulation tis-
sues contained comparatively less inflammatory cells and more collagen, fibroblasts and 
blood proliferating capillaries compared to the vehicle control group (Figures 4.19 and 
4.20).  
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Figure 4.19: hematoxylin and eosin-stained sections of the wound on the 15
th
 day after wound-
ing in rats. (A) 0.2ml of vehicle, gum acacia in normal saline. (B) 0.2ml of Intrasite gel. (C) 
0.2ml of P. macrocarpa (100mg/ml). (D) 0.2ml of P. macrocarpa (200mg/ml). S = Scab, E = 
Epidermis, GT = granulation tissue. (Magnification 20x) 
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Figure 4.20: hematoxylin and eosin-stained sections of the wound on the 15
th
 day after wound-
ing in rats. (A) 0.2ml of vehicle, gum acacia in normal saline. (B) 0.2ml of Intrasite gel. (C) 
0.2ml of T. crispa (100mg/ml). (D) 0.2ml of T. crispa (200mg/ml). S = Scab, E = Epidermis, 
GT = granulation tissue. (Magnification 20x) 
 
 
4.6.3  SOD, CAT, and MDA evaluation in the healed wound area 
Antioxidant enzymes (SOD and CAT) and MDA (natural product of lipid peroxida-
tion) were estimated in this study to evaluate the progression of the wound healing pro-
cess and to determine the effect of P. macrocarpa and T. crispa. Results reveal that the 
elevated SOD level was significant P ≤ 0.05 compared to the vehicle control group 
(Figure 4.21). A similar result was obtained with regards to CAT level (P ≤ 0.05), Fig-
ure 4.22. The level of MDA significantly decreased (P ≤ 0.05) in groups treated with P. 
macrocarpa and T. crispa compared to the vehicle control group (Figure 4.23).  
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Figure 4.21: Effects of P. macrocarpa and T. crispa on SOD level in the healed 
wound area in the rats. Values are presented as mean ± S.D., (5 rats/group). 
* Significant (P ≤ 0.05) compared to vehicle control 
 
 
 
Figure 4.22: Effects of P.macrocarpa and T. crispa on CAT level in the healed 
wound area in the rats. Values are presented as mean ± S.D., (5 rats/group). 
*Significant (P ≤ 0.05) compared to vehicle control 
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Figure 4.23: Effects of P.macrocarpa and T. crispa on MDA level in the healed 
wound area in the rats. Values are presented as mean ± S.D., (5 rats/group). 
* Significant (P ≤ 0.05) compared to vehicle control 
 
 
 
4.6.4  Estimation of TGF-β1 and TNF-α in the wounded rat undergoing treatment  
TGFβ1 and TNF-α play a role in the progress of the wound-healing process as in-
flammatory cytokines. Therefore, TGFβ1and TNF-α levels in the treated groups were 
investigated in this study to evaluate the effect of P. macrocarpa and T. crispa on in-
flammatory mediators. In the group treated with two doses of P. macrocarpa or T. 
crispa eetract, the results show that the level of TGFβ1 was significantly (P ≤ 0.05) ele-
vated compared to the vehicle control group and the Intrasite gel treated group. The lev-
el of TNF-α was significantly (P ≤ 0.05) lower compared to the vehicle control group 
(Figure 4.24 and 4.25).   
 
 
 
Chapter Four                                                                                                    Results  
120 
 
 
Figure 4.24: Effects of P.macrocarpa and T.crispa on TGF-β1 serum level in the treated 
wounded rats. Values are presented as mean ± S.D., (5 rats/group) * Significant (P ≤ 0.05) 
compared to the vehicle control. 
 
 
 
Figure 4.25: Effects of P.macrocarpa and T.crispa on TNF-α serum level in the treated wound-
ed rats. Values are presented as mean ± S.D., (5 rats/group) * Significant (P ≤ 0.05) compared 
to the vehicle control. 
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4.6.5   Effect on BAX and BCL2 gene expression  
 The results of RNA concentration and purity (A260 / A280 ≥ 1.65) were measured 
by Nano Drop ND-2000 Spectrophotometer (appendix III). The results of the gel elec-
trophoresis showed two bands of mRNA 28S and 18S that indicate the purity and integ-
rity of the mRNA extraction (Figure 4.26).  
 
 
 
 
Figure 4.26: mRNA integrity profile ethidium bromide stained with agarose gel   
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The gene expression level of the target gene normalized with the endogenous control  
(HPRT1) was convergent in amplification efficiency with the target gene. All genes 
show according to the standard curve results an efficiency of between 90-110% (Table 
4.6).  
 
Table 4.6: Amplification efficiency and slope to the BAX, BCL2, GADPH and HPRT1 
genes 
 
Genes  BAX BCL2 GADPH HPRT1 
Efficiency (%)  94.758 94.112 87.803 92.954 
Slope  -3.454 -3.472 -3.654 -3.503 
  
 
      The analysis data of CT value to the target gene and normalized with the endogenous 
control gene (HPRT1) showed differences in gene expression between the calibrator 
group (vehicle control group) and other treated groups. The relative mRNA expression 
level showed non-significant up-regulation of the BAX gene (Figure 4.27) in the refer-
ence drug, P.macrocarpa treated group at doses of (100 mg/ml) and T. crispa at both 
doses 100 mg/ml & 200 mg/ml except non-significant down-regulation happened in the 
P.macrocarpa treated group at a dose of 200 mg/ml with fold change (1.0604, 1.1933, 
1.4276 and 1.0539) respectively (Table 4.7). On the other hand, the results  showed 
non-significant down-regulation in the BCL2 gene (Figure 4.27) in all treated groups 
except significant (P ≤ 0.05) down-regulation  happened in T. crispa at a  dose of 200 
mg/ml (Figure 4.27) with fold change (1.1358, 1.0461, 1.3102 and 1.0412) respectively 
(Table 4.7).    
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Figure 4.27: Relative gene expression levels for BAX and BCL2 genes of groups treat-
ed with P. macrocarpa and T. crispa, in comparison to the calibrator, in the skin wound. 
Relative gene expression levels were calculated using the delta-delta CT method and 
values are presented as mean ± SD., (5 rats/group) *significantly different at P ≤ 0.05 
versus calibrator (vehicle control group).  
 
 
Table 4.7: The fold change expression of the BAX and BCL2 of groups treated with P. 
macrocarpa and T. crispa, in comparison to the calibrator, in the skin wound. 
 
Groups BAX 
fold change 
BCL2  
fold change 
 Calibrator (Vehicle control) 0 0 
Intra site (reference drug) 1.0604 1.1358 
P.macrocarpa (100 mg/ml) 1.1933 1.0461 
P.macrocarpa (200 mg/ml) 1.0141 1.3102 
T. crispa (100 mg/ml) 1.4276 1.0412 
T. crispa  (200 mg/ml) 1.0539 1.7144* 
    * Significant (P ≤ 0.05), (5 rats/group) 
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4.7 Immunomodulatory effect of P.macrocarpa and T. crispa on the RAW264.7 
cell 
4.7.1 Proliferation effect on the RAW264.7 cell  
The crude extracts and five yield fractions of two plants were investigated for their 
immunomodulatory effect on the RAW264.7 macrophage cell line. Results proved that 
P.macrocarpa and T. crispa stimulated the proliferation of RAW264.7 cell in a dose 
dependent manner. The cell viability showed a significant increase (P ≤ 0.05) with a 
mean viable cell percent ± SD, (104.62 ± 3.04, 116.35 ± 1.29, 127.37 ± 0.96, 136.61 ± 
0.97, 140.52 ± 4.82, 167.54 ± 3.63, 212.44 ± 2.23) respectively for P.macrocarpa at all 
treated doses and (126.43 ± 2.91, 141.59 ± 1.8,  163.62 ± 3.26,  131.28 ± 0.65,  127.96 ± 
1.45, 108.18 ± 1.98) respectively for T. crispa doses of (25, 50, 100, 200, 400 and 800) 
µg/ml. On the other hand, results showed no significant increase in the cell viability at 
doses of 1000 µg/ml for T. crispa (103.79 ± 1.79) after an incubation period of 24h 
compared to control (Figure 4.28).  
 
 
Figure 4.28: Cell viability percentage of RAW264.7 cell treated groups of P. macrocarpa and 
T.crispa compared to control (untreated group). Each value is presented as the mean percent ± 
S.D.*significantly different versus control group, P ≤ 0.05.  
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In order to research the immunomodulatory effect of the two plant fractions on the 
RAW264.7 cell line and choose the best one for applying in the investigation on the ef-
fect of the  intracellular expression of cytokines and the subject for LCMS profiling to 
identify the active constituents, we investigated the effect of five fractions for both 
plants on the proliferation of the RAW264.7 cell line. The isolated fractions appeared to 
have a different effect on RAW264.7 cell proliferation. Results showed a significant (P 
≤ 0.05) increase in the viability of the cell after treatment for a 24h incubation period 
with P.macrocarpa (F1 and F5) in a dose dependent manner and a significant decrease 
in viability of the cell (P ≤ 0.05) after treatment with P.macrocarpa (F2, F3 and F4) in a 
dose dependent manner (Figure 4.29).  
In addition, the treatment with T. crispa (F1, F2, and F5) showed a significant in-
creased viability of the cell (P ≤ 0.05) in a dose dependent manner. On the other hand, 
the viability percentage showed significant decreases (P ≤ 0.05) after treatment for a 
24h incubation period with T. crispa (F3 and F4) in a dose dependent manner compared 
to the control untreated cell (Figure 4.30).  
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Figure 4.29: Cell viability percentage of RAW264.7 cell treated groups with P. macrocarpa fractions (F1, F2, F3, F4 and F5) compared to control (untreated 
group). Each value is presented as mean percent ± S.D.*significantly different versus control group, (P ≤ 0.05).  
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Figure 4.30: Cell viability Percentage of RAW264.7 cell treated groups with T. crispa fractions (F1, F2, F3, F4 and F5) compared to control (untreated group). Each 
value is presented as mean percent ± S.D.*significantly different versus control group, (P ≤ 0.05).
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4.7.2 In vitro stimulation for intracellular cytokines production  
Stimulation of the production of (IFN-γ, IL-6 and IL-8) was measured intracellularly 
by flow cytometry on the stimulated RAW264.7 macrophage cell with 1µg/ml LPS and 
100µg/ml from each P. macrocarpa extract, P. macrocarpa F1, T. crispa extract and T. 
crispa F2. The intracellular expression of the IFN-γ showed significant (P ≤ 0.05)  in-
crease in the stimulation of  the RAW264.7 cell with P. macrocarpa extract, P. macro-
carpa F1, T. crispa extract and T. crispa F2 at a mean percent ± SD (25.55 ± 5.25, 
22.90 ± 5.1, 23.15 ± 4.25 and 22.95 ± 4.35) respectively compared to control 
RAW264.7 cell stimulation with LPS alone (Figure 4.31). 
 In addition, results showed a significant increase in intracellular expression of IL-6 
and IL-8 (P ≤ 0.05) in the stimulation of the RAW264.7 cell with P. macrocarpa ex-
tract, P. macrocarpa F1, T. crispa extract and T. crispa F2. In (Figure 4.32) the results 
show mean percent ± SD for IL-6 intracellular expression (14.57 ± 4.94, 14.0 ± 4.65, 
13.67 ± 6.17 and 13.90 ± 5.53) respectively and (Figure 4.33) shows mean percent ± SD 
for IL-8 intracellular expression (15.45 ± 2.75, 14.60 ± 2.8, 16.0 ± 3.3 and 15.9 ± 2.5) 
respectively compared to control (RAW264.7 cell stimulation with LPS alone). 
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Figure 4.31: Intracellular expression of IFN-γ on RAW264.7 macrophage cell. Flow 
cytometry analysis was used to assess the intracellular expression of IFN-γ. The figures 
show the expression percent of IFN-γ on RAW264.7 cell stimulated with (A)1µg/ml 
LPS alone as a control. (B) 1µg/ml LPS + P.macrocarpa 100µg/ml. (C) LPS1µg/ml + 
P.macrocarpa F1 100µg/ml. (D) LPS1µg/ml + T. crispa 100µg/ml. (E) LPS1µg/ml + T. 
crispa F2 100µg/ml. The number represents the mean percent of the cell ±SD. 
*Significant (P ≤ 0.05) versus control.  
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Figure 4.32: Intracellular expression of IL-6 on the RAW264.7 macrophage cell. Flow 
cytometry analysis was used to assess the intracellular expression of IL-6. The figures 
show the expression percent of IL-6 on RAW264.7 cell stimulated with (A) 1µg/ml LPS 
alone as a control. (B) 1µg/ml LPS + P.macrocarpa 100µg/ml. (C) LPS1µg/ml + 
P.macrocarpa F1 100µg/ml. (D) LPS1µg/ml + T. crispa 100µg/ml. (E) LPS1µg/ml + T. 
crispa F2 100µg/ml. The number represents the mean percent of the cell ±SD. 
*Significant (P ≤ 0.05) versus control.  
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Figure 4.33: Intracellular expression of IL-8 on the RAW264.7 macrophage cell. Flow 
cytometry analysis was used to assess the intracellular expression of IL-8. The figures 
show the expression percent of IL-8 on RAW264.7 cell stimulated with (A) 1µg/ml LPS 
alone as a control. (B) 1µg/ml LPS + P.macrocarpa 100µg/ml. (C) LPS1µg/ml + 
P.macrocarpa F1 100µg/ml. (D) LPS1µg/ml + T. crispa 100µg/ml. (E) LPS1µg/ml + T. 
crispa F2 100µg/ml. The number represents the mean percent of the cell ±SD. 
*Significant (P ≤ 0.05) versus control.  
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4.8 Investigation of active constituents 
The results of LC-MS to identify the phenolic constituents and other active com-
pounds of P.macrocarpa F1 and T. crispa F2 fractions showed about five compounds 
detected for P.macrocarpa F1and four compounds detected for T. crispa F2. Tables 4.8 
and 4.9 show all peaks detected with their retention time and observed m/z and  m/z of 
fragment ions. The P.macrocarpa F1 compounds contain oxoglaucine at m/z 351.2518 
and its fragment at m/z 236.0715 (Figure 4.34), gallic acid at m/z 171.0988 (Figure 
4.35), harmaline at m/z 214.0901, its fragment at m/z 155.9790 (Figure 4.36), myricetin 
at m/z 318.2998 (Figure 4.37) and orotic acid at m/z 157.0183 (Figure 4.38). While T. 
crispa F2 compounds include cordioside at m/z 511.2712 (Figure 4.39), quercetin at m/z 
301.1422 and its fragments at m/z 123.0913, 185.1149 and 155.1538 (Figure 4.40), ei-
cosenoic acid (paullinic acid) at m/z 311.1457 (Figure 4.41) and boldine at m/z 327.1576 
and its fragment at m/z 251.1251 (Figure 4.42).  
 
Table 4.8: P.macrocarpa F1 compound identification by LC-MS data using positive 
ionization mode. 
 
 
Peak 
No.  
 
RT  
(min)  
Interim identifi-
cation  
  
 
Observed 
m/z  
 
m/z of 
fragment 
ions  
observed  
Suggested 
formula 
 
M.W. 
(g/mol)  
 
1 0.924 Oxoglaucine 351.25 236 C20H17NO5 351.35 
2 1.492 Gallic acid 171.09  C7H6O5 170.12 
3 6.768 Harmaline 214.09 155 C13H14N2O 214.26 
4 7.585 Myricetin 318.29 317 C15H10O8 318.23 
5 14.529 Orotic acid 157.01  C5H4N2O4 156.10 
RT: Retention time; M.W: Molecular weight.  
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Figure 4.34:  Mass spectrum (TOF MS ES+) and chemical structure of oxoglaucine 
(peak No. 1) identified in P.macrocarpa F1  
 
 
 
 
 
 
 
Figure 4.35:  Mass spectrum (TOF MS ES+) and chemical structure of gallic acid (peak 
No. 2) identified in P.macrocarpa F1  
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Figure 4.36:  Mass spectrum (TOF MS ES+) and chemical structure of harmaline (peak 
No. 3) identified in P.macrocarpa F1  
 
 
 
 
 
 
Figure 4.37:  Mass spectrum (TOF MS ES+) and chemical structure of myricetin (peak 
No. 4) identified in P.macrocarpa F1  
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Figure 4.38:  Mass spectrum (TOF MS ES+) and chemical structure of orotic acid 
(peak No. 5) identified in P.macrocarpa F1  
 
 
 
 
 
 
Table 4.9: T. crispa F2 compounds identification by LC-MS data using positive ioniza-
tion mode. 
 
Peak 
No.  
 
RT  
(min)  
Interim identi-
fication  
  
 
Observed 
m/z  
 
m/z of 
fragment 
ions  
observed  
Suggested 
formula 
 
M.W. 
(g/mol)  
 
1 1.24 Cordioside  511.27  C25H34O11 510.53 
2 2.41 Quercetin  301.14 123,185,155 C15H10O7 302.24 
3 5.95 Eicosenoic acid 
(paullinic acid) 
311.14  C20H38O2 310.51 
4 12.42 Boldine  327.15 251.1251 C19H21NO4 327.37 
RT: Retention time; M.W: Molecular weight.  
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Figure 4.39:  Mass spectrum (TOF MS ES+) and chemical structure of cordioside 
(peak No. 1) identified in T. crispa F2 
 
 
 
 
 
 
Figure 4.40:  Mass spectrum (TOF MS ES+) and chemical structure of quercetin (peak 
No. 2) identified in T. crispa F2 
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Figure 4.41:  Mass spectrum (TOF MS ES+) and chemical structure of eicosenoic acid 
(paullinic acid) (peak No. 3) identified in T. crispa F2 
 
 
 
 
 
Figure 4.42:  Mass spectrum (TOF MS ES+) and chemical structure of boldine (peak 
No. 4) identified in T. crispa F2 
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CHAPTER FIVE  
5  Discussion and conclusion  
5.1 Discussion  
5.1.1  Quantitation and evaluation of antioxidant contents and activity  
P. macrocarpa and T. crispa were extracted according to the method described in 
(Sec 3.3). (13.5 g viscous dark brown was produceded from 200 g powder of P. macro-
carpa) and (34.88 g viscous dark green was produced from 200 g powder of T. crispa). 
We used ethanol as a solvent to extract antioxidant compounds such as, soluble poly 
phenols that are found in high concentrations in fruits and grains (Antolovich et al., 
2000). However, the extracted amount of antioxidant compounds is dependent on the 
properties of the solvent used in extraction. Polar solvents such as water, methanol, eth-
anol, ethyl acetate and acetone were more suitable to extract solvents in recovering the 
polyphenols from the matrix of the plant (Peschel et al., 2006). Ethanol is a polar protic 
solvent that can be used to dissolve polar compounds and is generally used to recover 
antioxidant compounds from diverse parts of the plant and many different types of 
plants as proven by Sultana et al., 2009. The total phenolic content and total flavonoid 
content were extracted with higher contents (amount) and better antioxidant activities in 
a more polar aqueous solvent (80% ethanol , 80% methanol). 
Antioxidant activity in plants has become important in recent years because of its ef-
fectiveness in general health by playing an important role in the protection of body cells 
from damage by oxidative stress. The secondary metabolites in plants are the most bio-
logically active natural product compounds therefore plants are sources of food antioxi-
dants such as vitamin E, vitamin C, phenolic acids, carotenes and phytoestrogens. Poly-
phenol or phenolic compounds are a group of secondary metabolites; they are composed 
in an optimal structure of one aromatic ring, holding one or more hydroxyl groups. The 
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simplest molecular form is phenolic acid and it ranges from  flavonoids to more com-
plex structure compounds (polymerized compounds) such as lignins or tannins 
(Calderón-Montaño et al., 2011; Gupta et al., 2012). Plants are considered a major natu-
ral source of polyphenol compounds (flavonoids and non- lavonoids), which give the 
color and flavor to plants (Luximon-Ramm. et al., 2002). Phenolic compounds play an 
important role in the life of the plant by contributing in the defense against  microbial 
attacks. Flavonoids have also been involved in UV filtration, symbiotic nitrogen fixa-
tion and flora pigmentation. They also act as chemical messengers and regulators to 
physiological functions. Finally, some flavonoids act as inhibitors to growth organisms 
that cause disease to the plant (Chun et al., 2005).  
The antioxidant activity of P. macrocarpa and T. crispa was evaluated by FRAP and 
DPPH tests and the results are seen in Table (4.1). P. macrocarpa extract has a stastical-
ly significant high antioxidant potential when compared with T. crispa and standard 
ascorbic acid. The FRAP value of P. macrocarpa extract is (17618.52 ± 2115.9) µmole 
Fe
+2
/mg, while for T. crispa and the standard ascorbic acid are (11011.11 ±1145.42, 
7951.85 ± 330.42) µmole Fe
+2
/mg respectively. The total antioxidant activity was as-
sessed by the DPPH test which detected DPPH inhibition %( 86.79 ± 0.4), as well as  
IC50 (14µg/ml) for P. macrocarpa, 55.79 ± 7.9; IC50 (22 µg/ml) for T. crispa and 
69.03 ± 9.3; IC50 (19 µg/ml) for ascorbic acid. The total phenolic and total flavonoid 
contents are displayed in table (4.1). Results  reveal the total phenolic content of P. 
macrocarpa extract is (548.51 ± 76.51mg GAE/ g) of dry fruit weight and the total fla-
vonoid content (213.16 ±1.31 mg QE/g) of dry fruit weight, while total phenolic content 
is (84.598 ± 7.82 mg GAE/ g) and total flavonoid content (62.07 ± 39.76 mg QE/g) in 
the T. crispa stem extract. 
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The findings of this study  are in concordance with previous research  on antioxidant 
activity of various parts of the P.macrocarpa (young fruit, dark fruit, seeds young, old 
seeds, bark, roots and leaves)  (Soeksmanto et al., 2007). It was also found that the eth-
anol extract of young fruit has an antioxidant inhibition of 78.48% and old fruit 83.08 
%. Ethanol extracts of old seeds, young seeds, roots, bark and leaves have antioxidant 
inhibition from (38.39-44.43%). These results indicate the power of antioxidant inhibi-
tion of P. macrocarpa in young fruit and old fruit (Soeksmanto et al., 2007). Other stud-
ies have confirmed high contents of phenolic and flavonoid compounds in the P. mac-
rocarpa fruit extract so the high antioxidant activity in the P. macrocarpa fruit comes 
from the  high-level content of phenols and flavonoids (Altaf et al., 2013; Hendra et al., 
2011b). Rohyami, 2008  proved the presence of flavonoid compounds, tannins and ter-
penoids, whereas the extract tested negative for alkaloids. (Hendra et al., 2011b) proved 
the presence of flavonoid compounds such as kaempferol, myricetin, naringin and rutin 
in the pericarp, while naringin and quercetin was in the mesocarp and the seed had only 
quercetin. Another study was reported isolating gallic acid from the fruit (Faried et al., 
2007).  
On a similar note, (Amom et al., 2011) proved that the extract of T. crispa stem pos-
sesses high levels of antioxidant. (Aminul et al., 2011) found that the extract of the T. 
crispa stem has strong antioxidant scavenging powers compared to ascorbic acid and 
BHT. Amom et al., demonstrated that the T. crispa stem extract has antioxidant proper-
ties resulting from the flavonoid content such as luteolin, catechin, rutin and morin, be-
sides detecting total phenolic content (Amom et al., 2009).  There was a similar result 
with aqueous and methanol extract showing that  both extracts possess high scavenging 
ability and high total phenolic and flavonoid content  (Ibahim et al., 2011; Ihsan et al., 
2011). Many studies have  revealed  positive relationships between phenolic compounds 
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and antioxidant activity because of their ability to scavenge  free radicals through their 
hydroxyl groups (Tosun et al., 2009). Flavonoids usually have more hydroxyl groups so 
they increase radical scavenging activity in the plants when they are found. Moreover, 
this finding was reported by many studies (Ghasemia et al., 2009; Ismail et al., 2004). 
Finally the findings of this study explain that the high antioxidant activity in the P. mac-
rocarpa fruit and the T. crispa stem extract can be attributed to the high-level content of 
phenol and flavonoids. 
5.1.2  Acute toxicity study 
During the 14 days of the experimental period, there was no record of death in rats of 
either sex with both plants at all doses (50, 500, 2000 mg/kg). There were no toxic 
signs, nor were there any changes to the skin and hair, in any of the rats. The results of 
the acute toxicity study indicated that the LD50 of the extract  P. macrocarpa fruit was 
more than 2000 mg/kg. This result confirmed a previous in vitro study, which showed 
that the ethanol extract of P. macrocarpa fruit was not toxic to human mononuclear pe-
ripheral normal cells (Astuti et al., 2007). An in vivo study on rats was performed to in-
vestigate the anti-hypercholesterolemic effect of P. macrocarpa fruit aqueous extract. 
The extract was administered orally at a dose of 40 mg/kg for 84 days and in this period 
no toxic sign was reported (Chong et al., 2011). On the other hand, liver enzymes were 
elevated with a high dose of T. crispa and some inflammatory cells appeared histologi-
cally in the high dose but this had no effect on the activity of the rat, and no death was 
reported. However, this result may be due to  the side effects of the administration of the 
extract. Pranee et al. demonstrated that an acute toxicity study of ethanol stem extract of 
T. crispa in mice revealed that the oral dose of 4 g/kg the body weight did not cause any 
toxic signs. However, the chronic toxicity study of ethanol extract of T. crispa proposed 
that resulted in the renal toxic and hepato toxic potential of the extract observed in rats. 
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Persistent use of high doses of T. crispa in humans must be avoided or stopped immedi-
ately when signs of liver or renal toxicities happen while using T. crispa containing 
medicine. (Pranee et al., 1997).  
 According to the results of the acute toxicity study the P. macrocarpa fruit  and T. 
crispa stem extract should be considered ‘no label’ based on the recommendation of the 
Organization for Economic Co-operation and Development (OECD): very toeic ≤ 5 
mg/kg body weight; toeic > 5 ≤ 50 mg/kg; harmful > 50 ≤ 500 mg/kg and no label > 
500 ≤ 2000 mg/kg. The   results indicated that the P. macrocarpa fruit and T. crispa 
stem extract should be assigned to the lowest toxicity class (Walum, 1998). 
5.1.3  Gastroprotective ability of P. macrocarpa fruit and T. crispa stem  
Gastric ulcer is defined as damage resulting from disturbance in the gastric mucosal 
defense, which means that the ulcer is caused by an imbalance between offensive and 
protective factors of the gastric mucosa. Pepsin and gastric acid are aggressive factors 
whose proteolytic effect is buffered by mucosal glycoprotein, mucin secretion, prosta-
glandins and cell proliferation (Schmassmann et al., 1994). Different therapeutic factors 
including plant extracts are used to inhibit the gastric secretion or stimulate the mucosal 
defense mechanism by increasing the mucus production protecting the surface epithelial 
cells or interfering with the prostaglandin E2 synthesis (Borrelli & Izzo, 2000). Gastro-
intestinal injury is induced by various methods. This study used ethanol induced gastric 
ulcer which is a method widely used for induced acute gastric mucosal injury in the ex-
perimental evaluation of anti-ulcer activity (Abdulla et al., 2010; Mei et al., 2012).  
The injury of ethanol-induced ulcer is dominant in the glandular part of the stomach. 
Administration of absolute ethanol orally in rats is destructive to the stomach and, af-
fects the gastric mucosa by disabling its barrier and exciting microvascular changes a 
few minutes  after its application. A strong and rapid vasoconstriction in combination 
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with vigorous and rapid arteriolar dilation causes induction damage in mucosal capillar-
ies (Glavin & Szabo, 1992; Ko et al., 1994). In a previous study it was reported that 
damage of the rat gastric mucosa induced by ethanol stimulates the formation of leuko-
triene C4 (LTC4) (Peskar et al., 1988), mast cell secretory products and reactive oxygen 
species (Rao et al., 2004). The necrotic lesion of the gastric mucosa is caused by ethanol 
and happens through multiple factors. Ethanol causes a disturbance to the barrier of the 
mucus bicarbonate when it reaches the mucosa and results in the rupture of the cell in 
the wall of blood vessels. These effects are caused perhaps by biological activities, such 
as formation of free radicals, peroxidation of the lipid, intracellular oxidative stress 
which affect the penetrability and depolarization of the mitochondrial membrane before 
cell death (Sannomiya et al., 2005). In addition, ethanol rapidly penetrates into the gas-
tric mucosa and produces linear hemorrhagic lesions, damaged areas in the deep layers 
of the mucosa with necrosis, inflammatory cell penetration, loss of epithelial cells in the 
stomach and cellular apoptosis that are classic features of alcohol damage (Li et al., 
2013b; Luo et al., 2013). Various mediators such as lipoxygenase, cytokines and oxygen 
derived free radicals have an effect in the pathogenesis of ethanol induced gastric muco-
sal damage directly and indirectly (Abdel-Salam et al., 2001). Disturbances in gastric 
secretion, damage to gastric mucosa, alterations in permeability, gastric mucus deple-
tion and free radical production are reported to be the pathogenic effects of ethanol. Ox-
ygen derived free radicals have been implicated in the mechanisms of acute ulceration, 
and scavenging of these free radicals can play a crucial role in gastroprotection and the 
healing of ulcers. Oral administration of ethanol causes severe gastric mucosal damage 
and significantly increases lipid peroxidation levels and decreases antioxidant enzymes 
(Gupta et al., 2005). Proton pump inhibitors (PPI) are the most potent medication avail-
able to inhibit gastric acid secretion. Since their introduction in the late 1980s, they have 
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been used as acid suppressants and to treat acid peptic disorders (Ali et al., 2009). They 
represent a group of drugs that inhibit H
+
/K
+
 ATPase, the enzyme known as “proton 
pump”, found in the luminal compartment of the parietal cell (Meneghelli et al., 2000). 
Omeprazole, a proton pump inhibitor, is known to function not only as a PPI  but also as 
an anti-inflammatory agent, an antioxidant or a stimulator of gastric mucus secretion, 
and is used in gastric ulcers and other acid dyspeptic disorders of the upper gastrointes-
tinal tract in a dose of 20-40 mg orally once daily. PPI commonly has a few different 
effects, the most common side effects are nausea, headache, constipation, abdominal 
pain, flatulence and diarrhea. These side effects are generally mild, self-limiting and 
unrelated to dosage and age. However, long-term side effects of PPI have recently 
gained attention and many studies have been looking at various side effects that may be 
related to long term use of PPI (Ali et al., 2009). In our study, we used omeprazole as 
the reference drug to compare the effect of  P.macrocarpa and T. crispa on gastropro-
tection.  
Currently, the world trend is to use the plants and their derivative compounds in  gas-
troprotection in order to try a natural source medication and to prevent and treat gastric 
disorders. Many studies have been done to investigate the gastroprotection of different 
plants in a number of countries. For example, Cymbopogon citratus is a medicinal plant 
used to treat different diseases, and the gastroprotective potential of its essential oil has 
been investigated and proven to reduce gastric damage induced by ethanol (Fernandes et 
al., 2012). 
 Similarly, Rhizophra mangle has long been used traditionally as an anti-ulcer treat-
ment (de-Faria et al., 2012). Piper tuberculatum is reported to have gastroprotective ef-
fect through increased gastric mucus production and reduction of gastric acid (Moura 
Burci et al., 2013). Citrus lemon has gastroprotective properties against ethanol induced 
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gastric ulcer, the protection being through the involvement of a different mechanism 
(Rozza et al., 2011). In this study, P.macrocarpa and T. crispa were used to investigate 
their ability in gastric protection. The pretreated groups with different doses of 
P.macrocarpa fruit or T. crispa stem extract showed significantly decreased ulcer area 
and increased ulcer inhibition percentage (Figure 3.4) by increasing the production of 
mucin from mucous cells to form the first line of defense to protect the mucosal epithe-
lial layer from damage by the ulcerogenic action of ethanol. Mucus is an important pro-
tective factor of the gastric mucosa. It presents itself as a transparent gel formed by wa-
ter and glycoproteins which covers the gastrointestinal mucosa and protects the gastric 
mucosa against irritant agents such as ethanol and HCL (Shirazi et al., 2000). Results of 
the mucus barrier content analysis disclosed that the quantity of mucus is greater than 
normal when pretreated with the P.macrocarpa fruit or T. crispa stem extract. This sug-
gests a cytoprotective action of the two plant extracts. Additionally, the anti-secretory 
activity of  P.macrocarpa fruit or T. crispa stem extract might be important in the pro-
tection of the gastric mucosa. The cytoprotective effect was confirmed by histological 
examination showing the prevention of mucosal hyperemia and edema. The observed 
results showed that P.macrocarpa fruit or T. crispa stem extract protects the gastric mu-
cosa, this protection is due to the inhibition of gastric acid secretion and rising stomach 
pH (Figure 4.4) by the extract. The anti-secretory activity of P.macrocarpa fruit and T. 
crispa stem extract were investigated by measuring stomach pH.  The obtained data re-
vealed that there was an increase of stomach pH compared to the vehicle control group 
and ulcer control group. Thus, the mechanism of mucosa protection may be the anti-
secretory activity of P.macrocarpa fruit and T. crispa stem extract and its effect on en-
hancing mucin production. Similar results were observed in previous studies, Zanthoxy-
lum rhoifolium showed gastroprotective ability against erosion ethanol by significantly 
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increasing mucus production (Freitas et al., 2011). Indigofera suffruticosa inhibited  
gastric mucosal caused by ethanol by significantly increasing the PGE2 and mucus se-
cretion (Luiz-Ferreira et al., 2011).  
To provide supplementary evidence, we investigated the effect of P. macrocarpa 
fruit and T. crispa stem extract on the level of PGE2 in pretreated groups. This study 
clearly showed a significantly elevated level of PGE2 in the pretreated groups (Figure 
4.9) compared to the ulcer control group. Therefore, this result clearly indicates the in-
volvement of PGE2 in the gastroprotective mechanism. It is known that the protective 
mechanism exhibited for mucus and bicarbonate secretion, depends on PGE2 secretion 
and this in turn depends on the activity of the cyclooxygenase (COX) enzyme system 
(Dey et al., 2006). In the stomach, prostaglandins promote mucus and bicarbonate secre-
tion, maintain the normal response of the gastric environment to intrinsic factors and 
inhibit the inflammatory mediator release from mast cells and free radical production. 
Increased changes in mucosal blood flow around the ulcer in experimental animals 
(Szabo & Tarnawski, 2000) similarly suggest that there is an increase in the 
concentration of PGE2 in ulcerative regions, compared to other parts of the gastric 
mucosa, since PGE2 causes vasodilation. The large blood supply seems to reflect the 
active re-epithelization which requires an abundant supply of glucose and oxygen 
(Zhang et al., 2010). The findings of this study are supported by the results obtained 
through investigating the effect of Decalepis hamiltonii root polysaccharide as an anti-
ulcer agent against ethanol induced gastric ulcer. The cytoprotective is increased due to 
to the enhanced synthesis of PGE2 which is necessary in the proliferation of gastric mu-
cin cells (Srikanta et al., 2010).  
Similar results have been seen in previous studies, through studying the effects of plant 
extracts as gastroprotective drugs (de-Faria et al., 2012; Hiruma-Lima et al., 2002; 
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Megala & Geetha, 2012; Moraes et al., 2009; Rozza et al., 2011). Therefore, the in-
creasing PGE2 production obtained in the pretreatment with P.macrocarpa fruit and T. 
crispa stem extract clearly indicates the stimulation of cytoprotective factors. 
P.macrocarpa fruit and T. crispa stem extracts have prevented ethanol from depleting 
the gastric wall mucus. Prostaglandins or sulfhydryl compounds contribute to protecting 
the stomach from ethanol injury. A copious amount of gastric mucus is secreted during 
superficial mucosal damage and provides a favorable microenvironment for repair by 
restitution. Therefore, it is conceivable that the protection from gastric ulcers observed 
with both the plants that are included in this study provide  general evidence of the close 
relationship between these factors. 
To understand the significance of the gastroprotective ability results of 
P.macrocarpa fruit and T. crispa stem extract, the role of gastrin and pepsin in the gas-
troprotection effect of both plants needs to be investigated. Gastrin is a polypeptide gas-
trointestinal hormone with an important role in modulating various functions of the gas-
trointestinal system. The two major roles are the stimulation of gastric acid secretion 
and cell proliferation. Gastrin levels in  plasma, gastric juice and the antral mucosa tis-
sue are increased in rats with ulcer (Shulkes & Baldwin, 2013). The principle stimulant 
of the gastric acid secretion through stimulating gastrin receptors on the enterochromaf-
fin like cell (ECL) in the oxynatic mucosa is gastrin secreted by antral G cells, which 
causes  accelerated synthesis and release of histamine, which in turn stimulates H2 re-
ceptors on adjacent parietal cells and activates acid secretion. Therefore, gastrin pri-
marily controls acid secretion by the control of parietal cells and ECL cells. While the 
lack of gastric acid does not appear to effect digestion, gastric acid is important for 
maintaining gastric homeostasis. Gastrin acts through the cholecystokinin 2 receptors 
(CCK2 receptors). The CCK2 receptor has a stimulatory effect on gastric acid secretion 
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through the direct effect of CCK2 receptors on the parietal cells (Shulkes & Baldwin, 
2013). Numerous hystiological effects of gastrin are mediated via CCK2 receptors. 
Studies with knockout mouse models (gastrin and CCK2 receptor knockout) and trans-
genic gastrin over-expression mice have supplied supplementary ideas on the role of 
gastrin.  A decrease in acid secretion, parietal cell number and inhibition in functional 
activity of the histamine-ECL cell pathway in mice have been shown (Friis-Hansen, 
2007).  
The results of the current study show that pretreating rats with P.macrocarpa fruit 
and T. crispa stem extract induced a marked decrease in the serum gastrin level com-
pared to the ulcer control group (Figure 4.7). This result indicates the action of both 
plants in more than one antiulcer mechanism. Gastric secretion was decreased after ex-
tract treatment and this may be a negative feedback mechanism in which an increase in 
PGE2, mucus reduces the gastrin released in rats pretreated with P.macrocarpa fruit and 
T. crispa stem extract, thus providing a protective environment against injury caused by 
ethanol. In addition, this may be associated with a lack of CCK2 receptor activation and 
thus there was no more gastrin production. Peptides of the gastrin-CCK family act on 
the comparatively well characterized cholecystokinin (CCK2, gastrin CCKB and 
CCK1) receptors. Gastrin has a high affinity for CCK2, but not for the CCK1 receptor. 
Gastrin plasma concentrations are normally about 5 to 10 times higher than those of 
CCK after a meal. Therefore gastrin is probably a major physiological agonist of CCK2 
receptors. The latter are present on the parietal cells, ECL cells and some smooth mus-
cle cells as well as in the pancreas and brain. Experimental research suggests that there 
is an increase in the CCK2 receptor expression response to tissue injury or damage. This 
may be related to increased cell proliferation as part of the tissue repair mechanism 
(Dockray, 2004).  
Chapter Five                                                                            Discussion & Conclusion                                                                                  
149 
 
Increased levels of gastrin were found in the ulcer control group that were related to 
inducing the proliferation of cells as an important step in the tissue repair mechanism. 
This result was confirmed by the significant decrease in the level of pepsin in the pre-
treated groups compared to the ulcer control group as a result of the decreased gastrin 
level and elevation of stomach pH. This in turn, caused inhibition of the activation of 
pepsinogen to pepsin so that the results in this study show a decrease in the serum pep-
sin level. Pepsin is an enzyme in the stomach responsible for the digestion of proteins 
by processing them into smaller pieces. Pepsin is excreted in the inactive form of pep-
sinogen in the stomach from the chief cells that release pepsinogen. To be activated 
pepsinogen needs a low stomach pH and hydrochloric acid (HCL) for transformation to 
pepsin. HCL is also produced by the gastric mucosa that releases parietal cells in the 
stomach lining. Release of both pepsinogen and HCL from the stomach lining is trig-
gerred by the hormone gastrin and the vagus nerve when food is ingested. HCL creates 
an acidic environment and is necessary to convert the inactive enzyme and to maintain 
the optimum acidity (pH 1-3) for pepsin function. If the pH is more than 5.0 then pepsin 
will denature and become inactive (Tang, 2013). The findings showed a decrease in the 
pepsin level in the groups pretreated with P.macrocarpa fruit and T. crispa stem extract 
compared to the ulcer control group (Figure 4.8). In  groups pretreated with plant ex-
tract, there was a decrease in the gastrin level and a rise in the stomach pH that affected 
the release of pepsinogen and HCL from the stomach cells and converted pepsinogen to 
an active form pepsin. Therefore, any reduction in the proteolytic ability of this broad-
spectrum enzyme will reduce the damage done to these mucosal surfaces. Indeed, pre-
vious studies have shown that raising the stomach pH negates the activity of pepsin 
(Aihara et al., 2003) and decreasing the stomach pH with accompanying elevations of 
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pepsin level increases the risk of producing ulcer lesions (Kotani et al., 2007;  Tobey et 
al., 2001). 
To prove the gastroprotective ability of  both the plants included in this study we in-
vestigated their effect on the activity of antioxidant enzymes and the ability of  both 
plants to scavenge the free radicals resulting from the oxidative stress induced by etha-
nol. Reactive oxygen species (ROS), such as hydroxyl radical and superoxide radical 
anion, are considered major causative factors for mucosal lesions through oxidative 
stress. ROS has a main role in tissue injury through the pathogenesis of several disor-
ders of the digestive tract (Casa et al., 2000). Lipid peroxidation (LPO) is an important 
indicator of hydroxyl radical induced oxidative damage of the membranes and has a 
critical role in the pathogenesis of gastric ulceration. Ethanol increases free radical gen-
eration and decreases endogenous GSH production (Glavin & Szabo, 1992). Endoge-
nous antioxidant enzymes, such as SOD and CAT, scavenge these ROS and prevent 
LPO and tissue damage. Thus in pathological conditions like gastric ulceration, ROS 
may be produced in excess and disrupt the delicate balance between ROS and endoge-
nous antioxidants or antioxidant enzymes (Bhattacharya et al., 2006). Tissue contains 
various endogenous antioxidant enzymes like superoxide dismutase (SOD) and catalase 
(CAT) which scavenge these ROS and therefore prevent tissue damage.  
In such situations, P. macrocarpa and T. crispa can augment the activity of ROS 
scavenging enzymes, prevent LPO by scavenging ROS, decrease the offensive effect of 
ROS and decrease LPO in pretreated groups. Therefore, inhibiting LPO and increasing 
free radical-scavenging antioxidant enzymes SOD and CAT (Figure 4.10 & 4.11) may 
also be involved in the beneficial effect of P.macrocarpa and T. crispa  in preventing 
gastric ulceration. This scavenging ability of P. macrocarpa and T. crispa comes from 
their high phenolic and flavonoid contents. The latter, which has been proven in many 
Chapter Five                                                                            Discussion & Conclusion                                                                                  
151 
 
previous studies as a natural antioxidant source, has the ability to scavenge ROS and 
prevent the oxidative stress which causes damage to cells (Barros et al., 2010; Li et al., 
2013a; Suhartono et al., 2012; Tawde et al., 2012) .In similar research  numerous  me-
dicinal plants have been employed for  their antioxidant potential and  investigated for 
their gastroprotective abilities (Hariprasath et al., 2012; Orsi et al., 2012; Viana et al., 
2013).  
One of the important findings in this study was that the level of pro-inflammatory 
factor TNF-α significantly decreased (Figure 4.14) in groups pretreated with 
P.macrocarpa and T. crispa extract, which increased the level of anti-inflammatory cy-
tokine TGF-β1 (Figure 4.13).  These results indicate that the immunomodulatory effect 
of P.macrocarpa and T. crispa might be  affected through the inflammatory mediator. 
Gastrointestinal mucosa integrity depends on the balance between defensive and offen-
sive factors and many of the components of mucosal defense have proven to be influ-
enced by inflammatory mediators, such as prostaglandins, leukotrienes, and thrombox-
anes (Wallace & Chin, 1997). Prostaglandins can also have anti-inflammatory effects 
through the inhibition of leukocyte recruitment which can contribute to their beneficial 
effects during situations such as inflamed gastrointestinal mucosa (Robert et al., 1985). 
TNF-α is a key mediator of intestinal injury caused by endotoeins and one of the mech-
anisms through which TNF-α can develop inflammatory responses; tissue injury is via 
its regulation of the expression of receptors for other inflammatory mediators, including 
leukotriene B4 and platelet activating factor (Sun & Hsueh, 1988).  
   Prostaglandins are powerful inhibitors of TNF-α released from both the macro-
phage (Kunkel et al., 1988) and the mast cell (Wallace & Chin, 1997), which may cause 
elevation of PGE2 levels during pretreatment with P.macrocarpa and T. crispa . In turn, 
this causes inhibition of the production of TNF-α. Another immunomodulatory effect of 
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P.macrocarpa and T. crispa  is by inciting the production of TGF-β1, an important cy-
tokine that accelerates gastric ulcer healing. The healing of gastric ulcer is a complex 
process controlled by numerous factors, hormones, and cytokines. TGF-β1 is one of the 
multifunctional peptide growth factors that exhibit positive, regulatory healing of gastric 
ulcer by inducing cell migration and angiogenesis and improving extracellular matrix 
production. TGF-β1 eeerts its action by binding to its transmembrane serine/threonine 
kinase receptor, which in turn triggers activation of various intracellular signaling path-
ways (Tanigawa et al., 2005). A previous study has reported that the immunoreactive 
effect of TGF-β1 protein is focused on the epithelial cells and, thus, the proliferation of 
gastric glands (Walsh et al., 2008). In the human gastrointestinal tract, TGF-β1 plays the 
crucial role of mediator in epithelial cell interactions where it regulates epithelial cell 
proliferation, inflammation and tissue repair. Its expression increases after acute epithe-
lial injury and in patients with inflammatory bowel disease.  TGF-β1 null mice died 20 
days after birth because they caught a multifocal inflammatory disease in the stomach 
and intestine (Frey & Polk, 2006; Hellmich & Evers, 2006). Ethanol ingestion may ac-
tivate the innate immune response which results in releasing the proinflammatory cyto-
kines as TNF-α and IL-6.  
 Previous studies associated the level of TNF-α with increased gastric tissue damage 
induced by ethanol (Li et al., 2013b; Mei et al., 2012). Stimulation of TNF-α has a dis-
advantaging effect which includes stimulated tissue injury and inflammation. These ef-
fects have been reported in a previous study that mentioned the abnormal elevated level 
of TNF-α that was noticed in the serum of mice with inflammatory diseases including-
ing acute mucosal inflammation (Wise & Yao, 2003). This present study demonstrated 
the pretreatment with P.macrocarpa and T. crispa  ecould remarkably decreas TNF-α in 
ethanol induced gastric ulcer and thus cause a decrease in the gastric ulcer lesions due to 
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alleviating gastric mucosal inflammation. This result agrees with previous studies 
(Costa et al., 2013; Mei et al., 2012). Decreasing levels of TNF-α in pretreated groups 
are a result of the immune suppressor effect on elevated TGF-β1 (Kuemmerle et al., 
2012).  
5.1.4 Wound healing evaluation parameters 
Cutaneous wound repair follows an ordered and definable sequence of biological 
events, beginning with wound closing, developing, repairing and remodeling of dam-
aged tissue (Roy et al., 2009). The management of chronic wounds is a major problem 
because of the high cost of therapy and presence of undesirable side effects (Umachigi 
et al., 2007). The main finding of this study is that the topical application of   
P.macrocarpa and T. crispa extracts to skin excision wounds in rats resulted in an im-
proved wound contraction rate and a serious reduction in healing time compared to the 
control group (Figure 4.16 and 4.17). This result may be attributed to the enhanced pro-
gression of the wound healing process and the exhibition of noticeable wound margin 
dehydration as a result of  tissue regeneration.  
The histological evaluation of wound areas in treated groups confirmed the display 
of increased cellular infiltration, angiogenesis, increased fibroblasts and collagen depo-
sition (Figure 4.19 and 4.20). The underlying mechanisms of topical P. macrocarpa and 
T. crispa action in the wound area which are caused by the chemotactic influence of the 
plant extract may attract inflammatory cells. The mitogenic activity of the plant extract 
may increase cellular proliferation and contribute significantly to the healing process. P. 
macrocarpa and T. crispa treated groups had significantly smaller wound areas on the 
15
th
 day after wounding compared to the vehicle control group. Reactive oxygen species 
(ROS) are deleterious to the wound healing process because of their harmful effects on 
cells and tissues. Absorbable synthetic biomaterials are degraded by ROS (Aliyev et al., 
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2004). These oxygen species result in damage of the cell. Thus, tissues must be protect-
ed from oxidative damage via intracellular and extracellular antioxidants. Free radical 
scavenging enzymes are a cytoprotective enzymatic group that plays an essential role in 
the reduction, de-activation and removal of ROS as well as in the regulation of the 
wound healing process. SOD converts superoxide to hydrogen peroxide which is then 
transformed into water by the CAT in lysosomes (Johansen et al., 2005). In the current 
study, homogenate tissue from wounds  dressed with P. macrocarpa and T. crispa 
showed a significant decrease in the levels of MDA (Figure 4.23) and inflammatory 
TNF-α (Figure 4.25) indicating a significant elevation in SOD (Figure 4.21) and CAT 
(Figure 4.22) activity in response to oxidative stress. These findings agree with previous 
studies (Gouthamchandra et al., 2010; Nevin & Rajamohan, 2010; Singh et al., 2006; 
Umachigi et al., 2008). The reduced SOD activity in the homogenate wound obtained 
from the vehicle control group has been attributed to the rise of production in reactive 
oxygen radicals which could decrease the action of antioxidant enzymes (El-Razek et 
al., 2012). 
 The plants have a wide variety of secondary metabolites, such as tannins, terpenoids, 
alkaloids, and flavonoids. These metabolites have been screened in vitro and display 
antioxidant, anti-inflammatory and antimicrobial effects which are used to developed 
drugs or dietary supplements (Ali et al., 2012; Amom et al., 2009; Kongkathip et al., 
2002; Yosie et al., 2011). The presence of these antioxidant and anti-inflammatory 
properties could be one of the factors that contribute to the wound-healing potential of 
the P.macrocarpa and T. crispa extracts. The topical application of P. macrocarpa and 
T. crispa restored the activities of these antioxidant enzymes which may help to avoid 
the deleterious effects of free radicals. Several previous studies have reported the utili-
zation of the antioxidant ability of both plants and their ability to induce the activity of 
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antioxidant enzymes in the prevention or treatment of a variety of diseases such as can-
cer, diabetes, atherosclerosis, hyperglycemia, and hypercholesterolemia besides having 
anti-inflammatory ability (Ali et al., 2012; Mohammed et al., 2012; Ruan et al., 2012; 
Ruan et al., 2013; Susilawati et al., 2012; Winarno, 2012). 
TGF-ß1 plays an important role as an inflammatory mediator in the initiation of 
wound healing by activating and stimulating the macrophage to secrete cytokines that 
act as fibroblast growth factors, platelet derived growth factors, TNF-α and interleukin1. 
The proliferative phase TGF-β1 level was elevated as secreted by the macrophage, T 
lymphocytes and platelets. TGF-ß1 is believed to be a major control signal regulating 
fibroblast functions. TGF-β1 has three effects on eetracellular matrie precipitation: it 
enhances the gene transcription of collagen, fibronectin and proteoglycans, which are 
important in the production of matrix proteins, inhibits the production of proteases in 
charge of matrix breakdown and stimulates the metalloprotease inhibitor (Diegelmann 
& Evans, 2004).  
Wounds heal from granulated tissue that serves to fill the dermal defect and provides 
a strucural framework for the deposition of newly synthesized collagen. The substrates 
and inducers provided for re-epithelialization of the wound may also induce the influx 
of macrophages and proliferation of mesenchymal cells and capillaries that compose the 
granulation tissue (Davidson et al., 1985). It has been postulated that by applying agents 
that induce fibroblast and/or endothelial cell proliferation to heal impaired wounds may 
increase the rate and degree of granulation tissue formation and stimulate wound repair 
(Grotendorst et al., 1985). In response to tissue loss, fibroblasts proliferate and migrate 
into the defect until the wound is populated by fibroblasts and extracellular matrix 
(Kwon et al., 2007). Cellular contraction is more important early on than collagen 
contraction in reducing the diameter of the wound (Al- Bayaty & Abdulla, 2012).  
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Many studies concerned with the use of medicinal plants in  treating wound healing 
have reported the important and crucial role of TGF-ß1 in the accelerated wound heal-
ing process. The use of Eleutherine indica in the treated wound, accelerates wound 
healing through the effect of the stimulation of released TGF-β which is bound to the 
fibroblast receptors and initiates  TGF-β-Smad mediated collagen production. Whereas 
Smad is, family proteins to TGF-β type 1 receptor so that transduction the receptor sig-
nals to specific target gene in the nucleus interact directly with activated TGF-ß recep-
tors (Upadhyay et al., 2013). Similar results were produced with Polygonum cuspidatum 
in the treated wound. The immunohistochemistry results showed that TGF-ß1 increased 
significantly in the group treated with plant extract on day 1, 3 and 7 after wounding 
(Wu et al., 2012). Others studies have revealed that the  increased release of TGF-ß1 
improved wound healing (Ganeshkumar et al., 2012; Tang et al., 2007; Wang et al., 
2012b). This was also observed in our study with a significant elevation in  the level of 
TGF-ß1 in groups treated with P.macrocarpa and T. crispa extract compared to the ve-
hicle control group and a significant reduction in the level of TNF-α on day 15 after 
wounding. These results clearly indicate that the effect of both plants in accelerating 
wound healing may be due to the effect of the rapid movement to the proliferative phase 
and the shortening of  the inflammatory phase to enhance wound contraction. To pro-
vide supplementary evidence for this suggestion, previous studies have reported that 
during the second and third week of healing, fibroblasts start to adopt myofibroblast 
phenotype properties via large parcels of actin containing microfilaments which are or-
ganized along the cytoplasmic cover of the plasma membrane, establishing cell to cell 
and cell matrix linkages (Hinz et al., 2004; Welch et al., 1990).  
In some wound cases, myofibroblasts express smooth muscle actin (Desmouliere et 
al., 1995). Essentially, TGF-ß1 stimulates cultured human fibroblasts to express smooth 
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muscle actin and may be responsible for its expression in vivo (Gabbiani, 2003). As-
pects of the biomechanics of extracellular matrix contraction are the crosslink between 
actin bundle arrays, cell-to-cell, cell matrix linkages and collagen. The contraction pro-
cess requires a cytokine signal such as TGF-ß1 or PDGF. As TGF-ß1 was found persis-
tently in the dermal wound during contraction of the tissue  it is the most probable can-
didate for the stimulation of wound contraction (Singer & Clark, 1999). TGF-ß1 plays 
an important function in the modulation of collagenase and as tissue inhibitor of metal-
loproteinase expression in vivo; they both have an important role during tissue for-
mation and theremodeling process (Langholz et al., 1995). 
5.1.5  Effect on BAX and BCL2 gene expression 
Apoptosis is the active process of eliminating cells. Specific signal molecules and 
enzymes initiate and regulate this process. Apoptosis is important in therapeutic manip-
ulation and potentially plays a role in reducing inflammation by removing  inflammato-
ry cells and assisting to change the fibro proliferative mass in cellular scar tissue in 
wound healing (Mutsaers et al., 1997). Activation of caspases-8, -9 and -7 in wounded 
mice on day 3 after injury indicates that the apoptotic pathway may affect cellular elim-
ination during skin wound healing (Zhao et al., 2009). Apoptosis occurs late in the nor-
mal wound healing process to form scar tissue and reduce cell proliferation for myofi-
broblast phenotype and procollagen I mRNA expression. Abnormal control of apoptosis 
cell death may be the cause of impaired wound healing as seen in the diabetic model 
(Darby et al., 1997). However, the reduced fibroblast activity from collagen gel is not 
associated with cell death but many fibroblasts on day 10 of the wound healing process 
formed pyknotic nuclei which are a cytological marker for apoptosis (Desmouliere et 
al., 1995). Others have suggested that apoptosis is a mechanism responsible for the tran-
sition from fibroblast rich granulation tissue to a relatively cellular scar (Desmouliere et 
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al., 1997). The apoptosis signals for wound fibroblasts have not been explained. Fibro-
plasia in wound repair is strongly regulated while in fibrotic diseases such as keloid 
formation and scleroderma, the fibroplasia process is under a dysregulated state. The 
latest evidence suggests that fibroblast apoptosis signals in keloids can be obstructed 
either directly or indirectly (Linge et al., 2005). 
In our study, the Fold change (2
- ΔΔCT
) of real time PCR analysis to the mRNA ex-
pression level of the BAX and BCL2 on the 15
th
 day after wound, showed up-regulation 
in the expression of the BAX gene in the reference drug, P.macrocarpa treated group at 
doses of (100mg/ml) and T. crispa at both doses (100, 200) mg/ml with fold change 
(1.0604, 1.1933, 1.4276 and 1.0539) respectively. While the results showed down regu-
lation in the P.macrocarpa treated group at a dose of (200 mg/ml) with fold change 
(1.0141) when compared to the calibrator group, down-regulation happened in the 
BCL2 genes in the reference drug group, P.macrocarpa and T. crispa treated groups at 
both doses (100 and 200) mg/ml with fold change (1.1358, 1.0461, 1.3102, 1.0412 and 
1.7144) compared to the calibrator group (Table 4.7). These findings may be an indica-
tion that apoptosis signals the end of the inflammatory phase of healing. This data also 
indicates that the apoptosis of granulation tissue begins at wound closure and decreases 
when the wound is healed or closed at about 95%.  As the group with topical treatment 
of P.macrocarpa at a dose of 200 mg/ml showed the beginnings of  down regulation of 
the BAX gene expression, this may indicate a return to the normal situation of a balance 
between pro-apoptosis and anti-apoptosis genes. In addition, these findings agree with 
the gradual granulation tissue absorption observed at wound closure. These findings 
confirm the results of a previous study by Kane et al., which suggested that an inverse 
relationship existed between BCL2 and p53. The expression of BCL2 was increased to 
allow cellular proliferation to occur at the beginning of the injury, whereas p53 expres-
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sion decreased. As the inflammation process declined, the p53 level increased as op-
posed to a decrease in the BCL2 level (Kane & Greenhalgh, 2000). Desmouliere et al. 
investigated the role of apoptosis in the transformation of granulation tissue to scar tis-
sue in their work and suggested that the peak of apoptosis is between 12 days to 25 
days. The generation of apoptotic myofibroblasts and vascular cells were highest during 
this period (Desmouliere et al., 1995). Multiple apoptosis related factors are involved in 
skin wound healing, the peak of expression in these factors is between 3 to 7 days after 
injury, and the expression is in decline, so that the apoptosis process is elevated at the 
start of the wound healing process and reduced at the end of the wound healing process. 
The time dependent expressions of the factors in the apoptotic pathway during skin 
wound healing may be used as potential markers for wound age estimation (Zhao et al., 
2009). In the first stage of the wound healing process, fibroblasts produce a preliminari-
ly cell mass and keratinocytes that are responsible for cell production at a certain stage, 
to lead first to the growth of less undifferentiated cells, which differentiate along the 
lifetime to become highly complex barrier cells. This process is associated with cell 
apoptosis in the final stage. Finally wound healing is successfully completed (Houghton 
et al., 2005). Throughout wound healing, myofibroblasts have a crucial role in matrix 
formation and wound contraction which fades by apoptosis at the end of healing. In a 
normal human wound compared to a hypertrophic scar, there was found to be a decrease 
in levels of anti-apoptosis protein BCL2 while there was an increase in the level of pro-
apoptosis protein BAX in normal wound healing. However, in the case of the hyper-
trophic scar, the level of  both protein  BCL2 and BAX was reversed from what it was  
in normal wound healing. These results indicate that disorder in apoptosis can cause the 
disappearance of myofibroblasts at the  end of wound healing that leads to scar for-
mation (Moulin et al., 2004). 
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Fluctuation of apoptosis in wound healing might be a crucial reason for delayed 
wound healing. The expression of BAX protein increased similarly with increasing 
apoptosis and revealed a good compatible relationship with the wound healing process 
whereas the expression of  BCL2 protein declined apoptosis. BAX and  BCL2 proteins 
play an important role in the apoptosis pathway in regulating wound healing (Cui et al., 
2003). 
5.1.6  Immunomodulatory effect of P.macrocarpa and T. crispa on the RAW264.7 
cell line 
Modulation of the immune system refers to any alteration in immune response that 
can include stimulation, expression or embarrassment of some percentage or stage of 
the immune response. Any biological or synthetic element used for its influence on the 
immune system is an immunomodulator. Immunosuppressants and immunostimulators 
are two common types immunomodulators based on their properties that have the ca-
pacity to increase an immune response or defend against pathogens or tumors (Saroj et 
al., 2012). Substances that have been shown to modify the immune systems are im-
munomodulators which respond to threats against the system. They modulate and poten-
tiate the weapons of the immune system by keeping them in a highly prepared state for 
any threat that it may encounter (Mishra et al., 2008). Modulation of the immune re-
sponse to reduce diseases has long been of interest. There are many recent studies on 
ethnomedicinal plants as immunomodulatory agents. A relatively new and developing 
branch of pharmacology is immunopharmacology which aims to search for immuno-
modulators. The probable use of immunomodulators in clinical medicine comprises the 
reconstruction of immune deficiency (Alamgir & Uddin, 2010). There has been much 
research  on plant extracts in different parts of the world for their possible immunomod-
ulatory properties. Some of these studies have demonstrated the isolation of potential 
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bioactive molecules (Alamgir & Uddin, 2010). Shosaiko-to, a Japanese herb, possesses 
many ethopharmacological effects and these effects are via the modulation of numerous 
host immune responses. Researchers have suggested that its effect in hepatitis B might 
be because of its ability to stimulate INFs and activate natural killer cell activity 
(Borchers et al., 2000). 
Polysaccharide has been isolated from Taxillus chinesis and Uncaria rhyncohpylla, 
two Chinese herbs that have an immunomodulatory effect by  stimulating the mouse 
macrophage to produce TNF-α and nitric oeide in a concentration dependent manner 
(Zhang et al., 2013a). Another plant is Sairei-to, a Japanese – Chinese herbal medicine 
that has been used to treat skin diseases. A study done to investigate the immunological 
changes of skin, kidney, spleen and serum in autoimmuneprone mice treated with 
Sairei-to revealed that this plant can reduce  CD19 and the level of IgG proportion in the 
serum, CD 4/8 ratio in spleen cells, expression of IFN-γ mRNA and the degree of lym-
phoproliferation, while causing an increase in the IL-4 production of the spleen cells 
(Ito et al., 2002). Crude oil seeds of Nigella sativa have been used for thousands of 
years as a spice and food preservative. Many studies have reported its immunomodula-
tory beneficial properties through increasing T cells and natural killer cell mediated 
immune responses. N. sativa oil showed an increase in 55% CD4/CD8 T cells ratio and 
a 30% rise in natural killer cell function in humans treated with its oil for four weeks 
(Salem, 2005). Macrophages are the first line of defense in innate immunity against mi-
crobial infection, professional in phagocytes engulf, kill microorganisms and present 
antigens for exciting adaptive immune responses (Girotti et al., 2004). Macrophages 
play a main function in tissue remodeling through development, wound healing and tis-
sue homeostasis. In addition, it is essential to innate immunity and pathology of tissue 
injury and inflammation (Robert et al., 2011). Through phagocytosis, macrophages se-
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crete cytokines as interleukins, TNF-α, IFNs and inflammatory mediators like nitric ox-
ide (Macmicking et al., 1997; Stojanovic et al., 2011). Macrophages are central in main-
taining homeostasis and have a chief function in host defense against pathogens and in 
attacking cancer cells (Gamal-Eldeen et al., 2006).  
To achieve the P.macrocarpa and T. crispa and their isolated fractions task in acti-
vated macrophage to release immunomodulatory cytokines as IFN-γ, IL-6 and IL-8. a 
RAW267.4 macrophage cell line was used in our study to determine the immunomodu-
latory activities by investigating their intracellular cytokine production.  
The results of the study showed that there was an immunomodulatory effect of 
P.macrocarpa and T. crispa and their effect fraction by increasing the RAW 264.7 mac-
rophage cells proliferation in a dose dependent manner and significant inducing of the 
intracellular expression of cytokines IFN-γ, IL-6 and IL-8. These findings clearly indi-
cate the significant immunomodulatory effect as immunostimulators of  both plants and 
their active fractions (Figure 4.31, 4.32 and 4.33). These findings are valuable and point 
to both isolated fractions from P.macrocarpa and T. crispa, as very appropriate candi-
dates for modulation of macrophage function and inducing the immune system. It is im-
portant to note from the literature that immunomodulatory action plays a crucial role in 
antitumor activity ( Abu et al., 2014; He et al., 2012; Zhang er al., 2013a). Therefore, 
the active isolated fractions from both P.macrocarpa and T. crispa .are potential candi-
dates for antitumor efficacy. Preliminary studies on the antiproliferative efficiency of 
P.macrocarpa and T. crispa extracts support this hypothesis (Faried et al., 2007; Ibahim 
et al., 2011; Radji et al., 2010; Tungpradit er al., 2010). Response to tissue injury is 
called inflammation, this response is categorized in the acute phase by increasing blood 
flow and vascular permeability with accumulation of fluid, leukocytes and inflammato-
ry mediators as cytokines. In the chronic phase, the immune response characteristics are 
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the development of specific humoral and cellular immune responses to pathogens that 
exist at the site of tissue injury. Many agents participate in leukocyte recruitment by in-
creasing expression of cellular adhesion molecules and chemoattraction during the 
course of both the acute and chronic inflammation processes. Varieties of these soluble 
mediators regulate the activation of the resident cells such as fibroblasts, endothelial 
cells, tissue macrophages and mast cells. In addition, their effect in activating newly 
staffing inflammatory cells includes monocytes, lymphocytes, neutrophils and eosino-
phils (Feghali & Wright, 1997). Our results clearly revealed that treatment with both 
plants and their fractions could enhance the immune response and stimulate the produc-
tion of  essential mediator cytokines such as INF-γ, IL-6 and IL-8; these play an im-
portant and main role in the acute and chronic inflammatory response. Stimulation of 
acute phase protein synthesis by the liver is through  IL-6, and acts as a growth factor 
for mature B cells and stimulates their final maturation into antibody producing plasma 
cells; this involves  T cell activation and differentiation and its effect in the induction of 
Il-2 receptor expression and  in addition its role in acute phase response, chronic in-
flammation, autoimmunity, fibrogenesis and endothelial cell dysfunction (Barnes et al., 
2011; Martín-Cordero et al., 2011). IFN-γ effects are identified in murine kupffer cells, 
stimulated macrophages and share in the development of Th1 cells.  Besides this, the 
cellular effects include up-regulation of pathogen recognition, antigen processing and 
presentation, antiviral case, inhibition of cellular proliferation, effect on apoptosis and 
immunomodulation (Schroder et al., 2004).  IL-8 has potential as a neutrophil chemo-
tactic factor. Many types can produce a large amount of IL-8 in response to avariety of 
stimuli such as proinflammatory cytokines, microorganisms and their products and en-
vironmental alteration including hypoxia and hyperoxia. IL-8 is a main mediator in neu-
trophil mediated acute inflammation and has a varied range of actions on different types 
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of cells which include endothelial cells, fibroblasts, monocytes, lymphocytes and neu-
trophils. These functions suggest that IL-8 has an important function in different patho-
logical disorders such as chronic inflammation and cancer (Mukaida, 2003). 
On a similar note, many previous studies have revealed the same effect in medicinal 
plants, algae or their derivative compounds. The polysaccharide-sulfated xylomannans 
isolated from Nemalion helminthoides can stimulate macrophage cells and promote se-
cretion of cytokines in both RAW 264.7 cells and mice. In addition, it can act as an im-
munoprotector against a herpetic infection. These results suggest the possibility of using 
polysaccharide in immunopotentiator supplements or vaccine adjuvants (Pérez-Recalde 
et al., 2014). Astragalus membranaceus polysaccharide could improve immune re-
sponse in the host individual by inducing the secretion of IL-2, IL-12 and TNF-α be-
sides inhibiting tumor progression in vivo (Yang et al., 2013). The same effect of Sar-
gassum fusiforme promotes immune response and can inhibit the growth of lung adeno-
carcinoma in mice (Chen et al., 2012). 
 Immunosuppression is one of the major problems in chemotherapy and radiothera-
py. Thus, it is important to find a new antitumor drug that can enhance immune re-
sponse. Activated macrophages play a crucial role in the immune system against tumor 
growth through their ability in pathogenesis, synthesis, and release of nitric oxide and 
H2O2 that are believed to be cytotoxic against particular tumors (Alonso-Castro et al., 
2012). Besides improved immune cell function, natural killer cells play an important 
role in immune surveillance by the secretion of cytokines such as IFN-γ (Brutkiewicz & 
Sriram, 2002). Kadsura marmorata polysaccharide could stimulate Th1 cells to produc-
tion IL-2, IFN-γ, and TNF-α. In turn, Th1 response can support protective immunity 
against intracellular infections such as bacteria, viruses and protozoa against cancer 
cells (Wang et al., 2013). Another research on Cervus nippon polypeptide showed the 
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ability of this polypeptide to stimulate Th1cells to release cytokines IL-12, IL-2, TNF-α 
and IFN-γ  while causing a decrease in  releasing cytokines IL-10 and IL-4 from Th2 
cells. These results reveal the importance of the ability to modulate Th1/Th2 arms of 
immune system and to use this ability for the treatment of Th2 derived pathological dis-
turbances such as AIDS, viral hepatitis, multiple allergies, cancer and other illnesses.  If 
these two arms of the immune system can be balanced through inducing Th1 cells and 
decreasing Th2 cells, many of the signs associated with these chronic diseases would be 
reduced or eliminated (Zha et al., 2013). 
From our outcomes and previous studies, we conclude that we can employ medicinal 
plants and their isolated compounds as immunomodulators to treat chronic inflamma-
tion diseases, autoimmune diseases or any other immune disorder disease and as anti-
tumor agents.  
5.1.7 Phytochemical investigation of active constituents 
The LC-MS results identified five compounds in the P.macrocarpa F1including ox-
oglaucine (C20H17NO5), gallic acid (C7H6O5), harmaline (C13H14N2O), myricetin 
(C15H10O8) and orotic acid (C5H4N2O4). Previous studies reported isolating many 
phenolic and flavonoid compounds from fruit and various parts of the plant and their 
medicinal potential was attributed to these constituents. Flavonoid content from the fruit 
pericarp of P. macrocarpa was analyzed by HPLC and revealed that the fruit has myri-
cetin (Hendra et al., 2011b). Gallic acid isolated from the fruit was investigated and its 
anticancer effect on a human cancer cell line (Faried et al., 2007). Secondary metabolite 
studies on P. macrocarpa have confirmed the presence of kaempferol-3-O-β-D gluco-
side in the fruit which protect rats from hepatoma caused by oxidative stress (Zhang et 
al., 2006). Moreover, Osimi (Oshimi et al., 2006) isolated three compounds (phalerin, 
mangiferin and icariside C3) from the fruit and showed vasorelaxant activity against 
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noradrenaline induced contraction of isolated aorta. In addition, benzophenone gluco-
side was isolated from the fruit and bark (Simanjuntak, 2008; Winarno & Ermin, 2009). 
Previous reviews confirmed the medicinal potential of the identified compounds. 
Oxoglaucine is an alkaloid and has immunomodulation effects. It prevents the increase 
in CD8 cells that is induced by Candida albicans infection in adult mice and inhibits 
serum accumulation of TNF-α. Thus, treatment of arthritic mice infected with C. albi-
cans with oxoglaucine can enhance the host resistance against the pathogen (Ivanovska 
& Hristova, 2000). Oxoglaucine isolated from Glaucium flavum has an antiviral effect 
against enterovirus (Nikolaeva-Glomb et al., 2010). Other studies have revealed the an-
tiviral properties of oxoglaucine when combined with other enterovirus inhibitors and 
this leads to a reduction of viral replication and inhibits toxicity (Nikolaeva-Glomb et 
al., 2011).  
Gallic acid is a phenolic acid and is known  as an anticancer, proapoptotic, anti-
inflammatory and antioxidant agent (Locatelli et al., 2013; Mansouri et al., 2013; Yoon 
et al., 2013). Harmaline is an alkaloid and has been broadly studied in the last decade 
and is known to have multiple pharmacological properties involving antimicrobial, an-
timalarial, antiplasmodial, hypothermic, antitumor, antioxidant and vasorelaxant proper-
ties (Ahmad er al., 1992; Berrougui et al., 2006; Di Giorgio et al., 2004; El Gendy et al., 
2012). 
 Myricetin is a natural flavonol which is one of the flavonoid compounds that is 
known for its powerful antioxidant ability, having a very important role in metabolism, 
protecting the body from the injury that results from oxidative stress and improving 
immunity and protection against invading agents (Cao et al., 2013; Faller & Fialho, 
2010; Ivanova et al., 2011).  
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Orotic acid is an organic compound that is very important in the biosynthesis of py-
rimidine bases of nucleic acid in  living organisms. In the past, it was believed to be part 
of the vitamin B complex and was called vitamin B13 but now it has been  proved not to 
be a vitamin (Kelley et al., 1970). Besides, it is important in biosynthesis and has re-
ceived much interest in the area of medicine and drugs. Some metal complexes of orotic 
acid with platinum, palladium, magnesium and zinc have shown therapeutic properties 
and are extensively used in medicine as well as potent anticancer agents (Castan er al., 
1990; Maistralis et al., 2000; Newman et al.,  1989).  
The LC-MS results for T. crispa F2 identified four compounds that included cordio-
side (C25H34O11), quercetin (C15H10O7), eicosenoic acid (paullinic acid) 
(C20H38O2) and boldine (C19H21NO4). Cordioside was reported to be isolated from 
T. crispa with three other compounds tinosporaside, columbin and β-hydroxyecdysone 
(Ahmed et al., 2006). Many previous studies have reported the isolation and identifica-
tion of phenolic compounds, alkaloids, flavonoid, diterpenes and triterpenes from T. 
crispa, and showed their biological activities as highly antioxidant compounds, and 
their antiproliferative and anti-inflammatory activity (Koay & Koay, 2013; Yusoff et al., 
2014). An alkaloid isolated from T. crispa had cytotoxic activity against Toxoplasma 
gondii (Lee et al., 2012). Borapetoside C and borapetol B isolated from T. crispa 
showed improved insulin activity ( Lokman et al., 2013; Ruan et al., 2012). Praman et 
al, isolated five compounds (uridine, adenosine, higenamine, salsolinol and tyramine) 
from T. crispa that improved the cardiovascular system and reduce the blood pressure 
(Praman et al., 2012).  
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Cordioside and quercetin is a flavonoid compound well known for its powerful anti-
oxidant activity and is employed in many pharmacological applications such as in im-
munostimulator activities and as an anticancer agent (Govind, 2011; Kapil & Sharma, 
1997; Kumar et al., 2011; Lu et al., 2006; Nieman et al., 2009; van Erk et al., 2005).  
Eicosenoic acid (paullinic acid) is an omega-7 fatty acid found in a variety  of plants. 
Omega fatty acid is considered an essential fatty acid for human health but unfortunate-
ly the body cannot produce it so it must be supplemented with food. Omega fatty acids 
play an important role in  brain function, normal growth and development. Research has 
proven their effect in reducing inflammation and helping to lower the risk of chronic 
diseases, which include cancer, heart disease and arthritis. Omega fatty acid deficiency 
is accompanied by symptoms such as poor memory, fatigue, heart problems, dry skin, 
poor circulation and depression (Fermor et al., 1992; Harris et al., 2008; Henry et al., 
2002; Sen, 2013).  
Boldine is an alkaloid; research was conducted during the early 1990s that proved 
that boldine is one of the most potent natural antioxidants.  There are many studies 
which have focused on its pharmacological properties. The antioxidant properties of 
boldine have made researchers investigate its effects as anticancer, cytoprotective, anti-
inflammatory, anti-atherogenic, anti-diabetic, vasorelaxing and immunomodulator 
agents (Backhouse et al., 1994; Bannach er al., 1996; Gotteland et al., 1997; Jang et al., 
2000; Kubinova et al., 2001; O’Brien et al., 2006).  
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5.2  Conclusions  
This study provides evidence that P.macrocarpa and T. crispa possess immunomod-
ulatory potential, gastroprotective effect and wound healing activity. Our results indi-
cate that P.macrocarpa and T. crispa pretreatment has protective effects against etha-
nol-induced gastric ulcer in rats. Moreover, these results provide evidence that the pro-
tective effects of both plants are carried out through the significant effects of some in-
flammatory mediators, such as PGE2, gastrin, TGF-β1, and TNF-α. Moreover, im-
portant antioxidant enzymes such as SOD and CAT are scavengers of ROS and can pre-
vent gastric injury. This is associated especially with protection of gastric mucus excre-
tion by enhancing  mechanisms to protect the gastric mucosa from offensive factors and 
by decreasing gastric acidity, increasing production of mucus, decreasing the level of 
gastrin, pepsin, TNF-α and MDA and increasing the PGE2  level.  In addition, the anti-
oxidant ability has the effect of  decreasing cell damage.  
The study suggests that P.macrocarpa and T. crispa have significant excision 
wound-healing potential. Topical treatment with P.macrocarpa and T. crispa extracts 
improved the activity of endogenous antioxidants through the elevated activity of SOD 
and CAT that prevented free radical-mediated tissue injury. These extracts also play an 
important function in the inflammation process through increasing the level of TGF-β1 
and decreasing TNF-α. In addition, another important role is the regulation of apoptosis 
gene expression (BAX and BCL2) and its efficacy in the remodeling phase in wound 
healing. The effectiveness of P.macrocarpa and T. crispa in the acceleration of wound 
healing in rats may be due to antioxidant enzymes and a decrease in the MAD level that 
indicates a decrease in damage to the cell. Besides, the results clearly indicate the effect 
of P.macrocarpa and T. crispa in accelerating the wound healing process and this may 
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be due to the implementation of the rapid movement to the proliferative phase and 
shortening the inflammatory phase to enhance wound contraction. 
The most important finding of this study is the immunomodulatory potential of P. 
macrocarpa and T. crispa through enhanced intracellular expression of IFN-γ, IL-6 and 
IL-8 cytokine in the RAW264.7 macrophage cells. These results clearly indicate the po-
tent effect of P. macrocarpa and T. crispa in improving the immune response and their 
effect in the expression of inflammatory mediators such as PGE2, gastrin, TGF-β1 and 
TNF-α that contributes to the gastroprotective ability and wound healing potential 
shown by P.macrocarpa and T. crispa.  
The LC-MS phytochemical investigation results for P.macrocarpa and T. crispa re-
inforce our results, which show that P. macrocarpa and T. crispa possess compounds 
known for their immunomodulatory, cytoprotective and antioxidant properties. In con-
clusion, the results of the study obviously indicate that P. macrocarpa and T. crispa are 
safe and have immunomodulatory, gastroprotective and wound healing potential. There-
fore,  both plants could be considered candidate drugs that require further development 
and pharmacological studies to investigate their therapeutic potential.. Moreover, the 
results are in agreement with the scientific basis of using traditional medicinal plants to 
discover new drugs.  
 
5.3 Future work   
Additional studies are essential to confirm the potential properties for active constit-
uents identified in this study such as bioavailability, pharmacokinetics and other phar-
macological evaluations.   
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APPENDIX I: TISSUE PROCESSING AND STAIN:  
I-PREPARE THE TISSUE FOR PARAFFIN PROCESSED: 
A- FIXATION: 
For paraffin, processed tissue the most usual fixative is formalin. Use 10% formalin for 
fixation to prepare 10% formalin; mix 100ml of Formaldehyde 40%, 900ml Distilled 
water and adjusted the PH at (7 - 7.4) by adding the tablet of PBS and mix well. 
B- TISSUE PROCESSING (AUTOMATED TISSUE PROCESSING, LEICA TP1020): 
 
1- FIXATION: 
10% buffered formalin I for 1 hour 
10% buffered formalin II for 1 hour 
 
2-DEHYDRATION: 
The traditional method of dehydration –removing the water from the tissue - is the use 
of ascending concentrations of alcohols. Dehydration usually commences using 70% 
ethanol, progressing to absolute alcohol.  
 70% ethanol for 1 hour. 
 95% ethanol for 1 hour. 
 95% ethanol for 1 hour 
 95% ethanol for 1 hour 
 First absolute ethanol for 1 hour. 
 Second absolute ethanol 1½ hours.  
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3- CLEANING  
The next step is called "clearing" and consists of removal of dehydrating fluids (alco-
hols) and paraffin wax with a substance that will be miscible with the embedding medi-
um (paraffin). The commonest clearing agent is xylene. 
 Cleaning Alcohol : Xylene (1:1) for 1 hour 
 Xylene I  for  1½ hours 
 Xylene II for 1½ hours 
4- INFILTRATION  
 Infiltration Paraffin wax I for 1½ hours  
 Paraffin wax II for 1½ hours  
 
II-HEMATOXYLIN-EOSIN (H&E) STAINING PROTOCOL  
A-MAIN STEPS OF STAINING:  
 De-waxing with xylene  
 Re-hydration  
 Staining  
 Dehydration with xylene  
 Mounting  
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B- STAINING WITH HAEMATOXYLIN & EOSIN: 
STEP SOLUTIN TIME(MINUTE) 
De-waxing 
Xylene I 3 min 
Xylene II 3 min 
Re-hydration 
Absolute alcohol 2 min 
95% alcohol I 2 min 
95% alcohol II 2 min 
70% alcohol 2 min 
Bring section to water Running tap water 3 min 
Staining 
Hematoxylin stain 10 min 
Running tap water until excess color wash off 
Differentiation 
0.5% acid alcohol 2-3 sec 
Running tap water 2-3 min 
2% sodium acetate 2 sec 
Running tap water 2-3 min 
Rinse in 80% alcohol 2-3 sec 
Staining Eosin stain 5 min 
Dehydration 
95% alcohol I 5 sec 
95% alcohol II 2 min 
Absolute ethanol I 2 min 
Absolute ethanol II 2 min 
Cleaning 
Xylene I 2 min 
Xylene II 2 min 
Xylene III 1 min 
Mounting with DPX DPX mounting media and cover the section with 
cover slip. 
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APPENDIX II: MANUFACTURE INSTRUCTION OF KITS AND 
PROCEDURES 
A- PGE2 (CAYMAN PGE2 ASSAY ELISA KIT; CAT# 400144) 
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B- SOD (CAYMAN, CAT#. 706002) 
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C- CAT (CAYMAN CAT#. 707002)  
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D- MDA (CAYMAN CAT#. 10009055) 
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E- GASTRIN ABNOVA RAT GASTRIN ELISA KIT (CAT#. KA0319 V.01) 
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E- GASTRIN ABNOVA RAT GASTRIN ELISA KIT (CAT#. KA0319 V.01) 
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F- PEPSIN BY CUSABIO RAT PEPSIN ASSAY ELISA KIT (CAT#. CSB-E 
08920R)  
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G- TGF-Β1  ELISA KIT (ABNOVA, CAT#. KA0279; VERSION 4)  
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    H-TNF-Α ELISA KIT (THERMO SCIENTIFIC, CAT#. ER3TNFA) 
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APPENDIX III: RNA CO NCENTRATION, PURITY AND PREPARE 
2% AGAROSE GEL ELECTROPHORESIS: 
A- RNA CONCENTRATION AND PURITY: 
RNA concentration and purity (A260/280 ≥ 1.65) measured by Nano Drop ND-2000 
Spectrophotometer (Thermo Fisher Scientific, Wilmington, DE, USA). 
 
Sample RNA ng/µl A260 A280 260/280 
Vehicle control 1 396.2 9.906 5.807 1.71 
Vehicle control 2 504.1 12.602 6.011 2.1 
Vehicle control 3 366.5 9.161 4.321 2.12 
Vehicle control 4 370.8 9.271 4.484 2.07 
Vehicle control 5 245.1 6.128 2.932 2.09 
Reference drug 1 874.6 21.866 10.196 2.14 
Reference drug 2 453.2 11.329 5.474 2.07 
Reference drug 3 332.5 8.313 3.912 2.13 
Reference drug 4 396.9 9.922 4.873 2.04 
Reference drug 5 675.1 16.877 8.032 2.1 
P.m (100 mg/ml)Sample 1 373.2 9.329 4.588 2.03 
P.m (100 mg/ml)Sample 2 531.9 13.297 6.417 2.07 
P.m (100 mg/ml)Sample 3 366.7 9.167 4.395 2.09 
P.m (100 mg/ml)Sample 4 642.8 16.07 7.683 2.09 
P.m (100 mg/ml)Sample 5 701.3 17.533 8.459 2.07 
P.m (200 mg/ml)Sample 1 477.8 11.946 5.769 2.07 
P.m (200 mg/ml)Sample 2 269.7 6.742 3.26 2.07 
P.m (200 mg/ml)Sample 3 235.6 5.89 2.802 2.1 
P.m (200 mg/ml)Sample 4 270.4 6.759 3.287 2.06 
P.m (200 mg/ml)Sample 5 259 6.474 3.158 2.05 
T. c (100 mg/ml)Sample 1 474 11.851 5.715 2.07 
T. c (100 mg/ml)Sample 3 315.3 7.883 3.743 2.11 
T. c (100 mg/ml)Sample 4 274.9 6.874 3.266 2.1 
T. c (100 mg/ml)Sample 5 359.2 8.98 4.291 2.09 
T. c (200 mg/ml)Sample 1 282 7.05 3.365 2.1 
T. c (200 mg/ml)Sample 2 585.3 14.632 7.025 2.08 
T. c (200 mg/ml)Sample 3 514.3 12.857 6.256 2.06 
T. c (200 mg/ml)Sample 4 551.1 13.778 6.614 2.08 
T. c (200 mg/ml)Sample 5 266.3 6.657 3.152 2.11 
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 B- PREPARE 2% AGAROSE GEL ELECTROPHORESIS:  
Dissolve (2gm) of agarose in 100ml of 1x Tris-acetate EDTA buffer, then add 1µl of 
ethidium bromide to the mixture and pour on the gel boat to the electrophoresis system. 
After gel is solidified, load RNA and run the electrophoresis at 95 volts to migrate the 
RNA bands 28S and 18S. 
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APPENDIX IV: LIST OF CHEMICALS, CONSUMABLES 
AND KITS   
Chemicals, consumables 
and kits 
Brand Used in 
95% ethanol Fisher Scientific, UK Plant extraction 
Sodium acetate trihydrate Sigma-aldrich , Germany 
Ferric reducing antioxi-
dant power (FRAP) 
 
Glacial acetic acid Merck,  Germany 
HCl Fisher Scientific, UK 
2, 4, 6-tripyridyl-s-triazine 
(TPTZ) 
Sigma-aldrich, Germany 
FeCl3 Sigma-aldrich, Germany 
FeSO4-7H2O Sigma-aldrich, Germany 
DPPH (2, 2-diphenyl-1-
picrylhydrazyl) 
Sigma-aldrich, Germany 
Redical scavenging activi-
ty test (DPPH) 
L-ascorbic acid Sigma-aldrich, Germany  
Folin-Ciocalteu reagent 
(phosphomolybdic  and 
phosphotungstic acid) 
Merck,  Germany 
Total phenolic content 
 
Sodium carbonate Anala R, Engalish 
Gallic acid Sigma-aldrich, Germany 
Methanol Fisher Scientific, UK 
Estimation of total flavo-
noid content 
 
Aluminum chloride Sigma-aldrich, Germany 
Potassium acetate Ajax Finechem,  Australia 
Quercetin Sigma-aldrich, Germany 
Tween 20 Sigma-aldrich, Germany 
*Acute toxicity test 
*Gastroprotective ability 
of the plant extract 
*Determination of gastric    
wall mucus content 
Xylazine Ilium, Australia 
Histological evaluation of 
gastric lesions 
 
Ketamine Ilium, Australia 
Omeprazole 
TROGE Medical GMBH, Ger-
many 
Alcian blue ACROS, USA 
D(+) sucrose Fisher Scientific, UK 
Sodium acetate Sigma-Aldrich, Germany 
Magnesium chloride Sigma-Aldrich, Germany 
Ethyl ether Anala R, England 
Formalin Scharlau chemie S.A, Spain 
Paraffin wax Sigma-Aldrich, Germany 
Hematoxylin stain Clin-Tech, UK 
Eosin stain Clin-Tech, UK 
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Chemicals, consumables 
and kits 
Brand  Used in  
PGE2 ELISA kit Cayman Cat# 400144 Assessment of PGE2 
CAT ELISA kit Cayman Cat#.707002 Assessment of catalase  
SOD ELISA kit 
 
Cayman Cat#.706002 Assessment of superoxide 
dismutase 
MDA  Cayman Cat#.10009055 Assessment of malondialde-
hyde 
Bovine serum albumin  JR Scientific, USA  Performance of Protein Con-
centration by the Bradford 
method 
Bradford reagent  Sigma-Aldrich, Germany 
PBS buffer DulbeccoA, Oxoid, England Tissue homogenate sample 
preparations 
Rat gastrin ELISA kit  Abnova Cat#.KA0319 V.01 Assessment of rat gastrin 
Rat pepsin assay ELISA 
kit  
Cusabio Cat#.CSB-E 08920r Assessment of rat pepsin 
TGF-β1 by ELISA kit  Abnova Cat#. KA0279;V.04 Assessment of TGF-β1 
Rat TNF-α by ELISA kit  Thermo Scientific Cat#. 
ER3TNFA 
Assessment of TNF-α 
Gum acacia Sigma-Aldrich, Germany Wound healing ability of 
plant extract  
 
Intrasite gel  Trademark of Smith and 
Nephew Ltd 
RNA solution  Ambion, Austin, Texas, USA -BAX and BCL2 gene ex-
pression in vivo (wound heal-
ing model)  
-RNA extraction 
RNA purification kit Thermo Scientific Cat# K0731 
DNsaeI Qiagen, Hilden, Germany, 
Cat#:79254 
Eliminate genomic DNA 
contamination 
Denaturing agarose  Bio-Rad, Richmond, CA, 
USA 
The RNA concentration and 
integrity 
Ethidium bromide stain Bio-Rad, Richmond, CA, 
USA 
 
High Capacity RNA to 
cDNA kit 
Applied Biosystems, 
Cat#.4387406 
Reverse transcription of total 
RNA extracted  
TaqMan fast advanced 
master mix  
Applied Biosystems Cat#: 
4444557 
Real time amplification assay  
 
Bcl2-associated X protein 
(Bax) 
Applied Biosystems 
Rn02532082_g1 
B cell lymphoma -2  
(BCL2) 
Applied Biosystems 
Rn99999125_m1 
Glyceraldehyde-3-
phosphate dehydrogenase ( 
GAPDH) endogenous con-
trol  
Applied Biosystems 
Rn0177563_g1  
 
Hypoxanthine phosphori-
bosyl transferase 1  
(HPRT1) endogenous con-
trol  
Applied Biosystems 
Rn01527840_m1 
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Chemicals, consumables 
and kits 
Brand  Used in  
silica gel G60, 70 - 230 mesh  Merck, Darmstadt, Germany Column chromatography 
Solvents :hexane, ethyl ace-
tate, methanol, acetonitrile  
Fisher Scientific, UK 
A murine macrophage cell 
line RAW264.7  
American Type Culture 
Collection (ATCC, Rock-
ville, MD) 
In vitro stimulation for  
intracellular cytokine 
production  
 DMEM supplemented with 
4500g glucose/L, 110mg so-
dium pyruvate/L and 1% 
penicillin–streptomycin  
Sigma-Aldrich, UK 
fetal bovine serum (FBS)  Biowest, Inc, France 
3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium 
bromide (MTT) assay 
Merck, Germany 
dimethyl sulfoxide (DMSO)  Fisher Scientific, UK 
LPS (Escherichia coli 
055:B5 
Difco, Detroit, MI,USA 
Fixation/ permeabilization 
solution (BD GolgiPlug
TM
 )  
BD Cytofie/Cytoperm™ 
Plus Fixation / Permeabili-
zation, BD Golgi Plug™ 
protein transport inhibitor, 
Cat. No.555028 
Flow cytometry im-
munostaining of intracel-
lular cytokines 
 
Sodium azide Ajax Finerhem, Austeriala 
Mouse BD Fc Block™ puri-
fied anti-mouse CD16/CD32 
mAb 2.4G2  
BD Fc Block™;Cat.No. 
553141 
fluorochrome-conjugated an-
ti-cytokine antibody: PE An-
ti-Mouse IL-6 
 BD Cat. No: 554401 
APC Rat Anti-Mouse IL-8 BD Cat. No: FAB2164A 
FITC Rat Anti-Mouse IFN-γ  BD Cat. No: 554411 
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APPENDIX V: LIST OF IDENTIFICATION OF ACTIVE    COM-
POUNDS FOR P. macrocarpa & T.crispa   
A- Identification of active compounds in P. macrocarpa  
Number Compound 
1 Benzophenone glucoside 
2 DLBS1425 
3 Gallic acid 
4 Harmaline 
5 Icariside C3 
6 Kaempferol 
7 Mangiferin 
8 Myricetin 
9 Naringin 
10 Orotic acid 
11 Oxoglaucine 
12 Phalerin 
13 Quercetin 
14 Rutin 
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B- Identification of active compounds in T. crispa 
Number Compound 
1 Adenosine 
2 Boldine 
3 Borapetosides  A, B and C 
4 β-hydroxyecdysone 
5 Catechin 
6 Columbin 
7 Cordioside 
8 Cycloeucalenol 
9 Cycloeucalenone 
10 Epinephrine 
11 Higenamine 
12 Hordenine 
13 Luteolin 
14 Morin 
15 Paullinic acid 
16 Pseudoephedrine 
17 Quercetin 
18 Rutin 
19 Salsolinol 
20 Tinosporaside 
21 Tyramine 
22 Uridine 
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APPENDIX V: LIST OF PUBLICATION AND PAPERS  
PRESENTED   
A- CONFERENCES  
* Presented Paper at the 17
th
 National Conference on Medical and Health Sciences  -
Malaysia, May 2012 
* Presented Paper at the International Conference on Medical and Health sciences (IC-
MHS), Malaysia, 2013 
* Presented Paper at International Conference on Innovation Challenges in Multidisci-
plinary Research & Practice on December 2013, Kuala Lumpur, Malaysia 
B- PUBLICATIONS AND SUBMITTED PAPERS 
 Walaa Najm Abood, Mahmood Ameen Abdulla, Salmah Ismail. (2014). In-
volvement of Inflammatory Mediators in the Gastroprotective Action of Phale-
ria Macrocarpa against Ethanol Induced Gastric Ulcer. World Applied Science 
Journal, 2014: 344-350. DOI: 10.5829/idosi.wasj.2014.30.icmrp.48  
 
 Walaa Najm Abood, Iman Fahmi Mustafa, Mahmood Ameen Abdulla, Salmah 
Ismail. (2014). Immunomodulatory effect of an isolated fraction from Tinospora 
crispa on inteacellular expression of IFN- γ, IL-6 and IL-8.  BMC 
Complementary and Alternative  Medicine, 2014, 14:205 
 
Submitted papers: 
 Walaa Najm Abood, Mahmood Ameen Abdulla, Salmah Ismail. Evaluation of 
the Wound Healing Potential of Tinospora crispa in Rats: Role of Inflammatory 
Mediators and Antioxidant Activity, submit to the PLOS ONE Journal.  
 Walaa Najm Abood, Mahmood Ameen Abdulla, Salmah Ismail. Phytochemical 
Analysis and Immunomodulatory Effect of Isolated a New Bioactive Compo-
nents from Phaleria macrocarpa (Scheff) Boerl) , submit to the Records of  
Natural Products Journal. 
